var title_f41_43_42672="Umbilical cord spiraling";
var content_f41_43_42672=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F69238&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F69238&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Umbilical cord spiraling",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 299px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cord spirals normally 1 turn per 3 cm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla J Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42672=[""].join("\n");
var outline_f41_43_42672=null;
var title_f41_43_42673="A lumbricoides adult worm";
var content_f41_43_42673=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F52868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F52868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ascaris lumbricoides adult female worm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Centers for Disease Control and Prevention, Division of Parasitic Diseases Parasite Image Library.",
"     <a href=\"file://www.dpd.cdc.gov/dpdx/HTML/ImageLibrary/Ascariasis_il.htm\">",
"      file://www.dpd.cdc.gov/dpdx/HTML/ImageLibrary/Ascariasis_il.htm",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42673=[""].join("\n");
var outline_f41_43_42673=null;
var title_f41_43_42674="NSAIDs and acetaminophen: Effects on blood pressure and hypertension";
var content_f41_43_42674=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   NSAIDs and acetaminophen: Effects on blood pressure and hypertension",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42674/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42674/contributors\">",
"     Norman M Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42674/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42674/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42674/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42674/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42674/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/43/42674/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonsteroidal antiinflammatory drugs (NSAIDs) have a variety of adverse effects. From a cardiovascular viewpoint, they can both raise the blood pressure and affect overall cardiovascular risk.",
"   </p>",
"   <p>",
"    The effect of NSAIDs and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    on the blood pressure and the development of hypertension will be reviewed here. The cardiovascular effects of NSAIDs are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/4/24648?source=see_link\">",
"     \"Nonselective NSAIDs: Adverse cardiovascular effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=see_link\">",
"     \"COX-2 selective inhibitors: Adverse cardiovascular effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NSAIDS AND BLOOD PRESSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;All nonsteroidal antiinflammatory drugs (NSAIDs) in doses adequate to reduce inflammation and pain can increase blood pressure in both normotensive and hypertensive individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42674/abstract/1\">",
"     1",
"    </a>",
"    ]. The average rise in blood pressure is",
"    <span class=\"nowrap\">",
"     3/2",
"    </span>",
"    mmHg but varies considerably [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42674/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. In addition, NSAID use may reduce the effect of all antihypertensive drugs except calcium channel blockers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42674/abstract/5\">",
"     5",
"    </a>",
"    ]. These effects may contribute to the increase in cardiovascular risk associated with the selective COX-2 inhibitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42674/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=see_link\">",
"     \"COX-2 selective inhibitors: Adverse cardiovascular effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prohypertensive effect is dose-dependent and probably involves inhibition of cyclooxygenase-2 (COX-2) in the kidneys, which reduces sodium excretion and increases intravascular volume [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42674/abstract/5\">",
"     5",
"    </a>",
"    ]. Low dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    has no COX-2-inhibiting or prohypertensive effects. As an example, 75",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    of aspirin did not interfere with antihypertensive therapy, as compared with placebo, in 18,790 patients in the Hypertension Optimal Treatment (HOT) Study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42674/abstract/7\">",
"     7",
"    </a>",
"    ]. However, these conclusions cannot be extended to larger doses of aspirin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ACETAMINOPHEN AND BLOOD PRESSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    produces its analgesic effect by inhibiting the same cyclooxygenase, prostaglandin H2 synthase, that is the target of NSAID and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42674/abstract/8\">",
"     8",
"    </a>",
"    ]. However, acetaminophen blocks this enzyme at its peroxidase catalytic rather than at the cyclooxygenase catalytic site. Therefore, the acetaminophen-mediated inhibition is sensitive to changes in the tissue peroxide levels; higher concentrations of peroxide in activated leukocytes and platelets block the effect of acetaminophen on inflammation and platelet thrombosis. However, acetaminophen is able to inhibit prostaglandins in the central nervous system, thus providing relief of pain and fever. Therefore, acetaminophen is not an NSAID or anti-thrombotic agent.",
"   </p>",
"   <p>",
"    Some [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42674/abstract/9-13\">",
"     9-13",
"    </a>",
"    ] but not all [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42674/abstract/14\">",
"     14",
"    </a>",
"    ] studies have shown an increase in blood pressure and cardiovascular events with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    . In one two-week randomized crossover trial in 33 patients with coronary artery disease, acetaminophen (1 g three times daily) but not placebo increased systolic and diastolic blood pressure as determined by ambulatory monitoring from 122 to 125 mmHg systolic and from 73 to 75 mmHg diastolic; however, measures of endothelial and platelet function did not change [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42674/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are inconclusive data of an increased cardiovascular risk from regular use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    in usual doses that are widely used for pain relief.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All NSAIDs may raise blood pressure and diminish the antihypertensive efficacy of all classes of antihypertensive drugs, except calcium channel blockers. (NSAIDs and blood pressure\" above).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       Aspirin",
"      </a>",
"      , in the low dose that is used as an antithrombotic agent, does not affect blood pressure or interfere with the efficacy of antihypertensive drugs. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'NSAIDs and blood pressure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      may raise blood pressure even at doses commonly used for pain relief. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Acetaminophen and blood pressure'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/1\">",
"      Warner TD, Mitchell JA. COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. Lancet 2008; 371:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/2\">",
"      Grover SA, Coupal L, Zowall H. Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization? Hypertension 2005; 45:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/3\">",
"      Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993; 153:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/4\">",
"      Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 121:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/5\">",
"      White WB. Cardiovascular effects of the cyclooxygenase inhibitors. Hypertension 2007; 49:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/6\">",
"      Messerli FH, Sichrovsky T. Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease? Am J Cardiol 2005; 96:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/7\">",
"      Zanchetti A, Hansson L, Leonetti G, et al. Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy. J Hypertens 2002; 20:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/8\">",
"      Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther 2006; 79:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/9\">",
"      Chan AT, Manson JE, Albert CM, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation 2006; 113:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/10\">",
"      Forman JP, Rimm EB, Curhan GC. Frequency of analgesic use and risk of hypertension among men. Arch Intern Med 2007; 167:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/11\">",
"      Chalmers JP, West MJ, Wing LM, et al. Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients. Clin Exp Hypertens A 1984; 6:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/12\">",
"      Dedier J, Stampfer MJ, Hankinson SE, et al. Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension 2002; 40:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/13\">",
"      Sudano I, Flammer AJ, P&eacute;riat D, et al. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation 2010; 122:1789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42674/abstract/14\">",
"      Radack KL, Deck CC, Bloomfield SS. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med 1987; 107:628.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2385 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-109.230.63.219-ECCCFA66F5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42674=[""].join("\n");
var outline_f41_43_42674=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NSAIDS AND BLOOD PRESSURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ACETAMINOPHEN AND BLOOD PRESSURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=related_link\">",
"      COX-2 selective inhibitors: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/4/24648?source=related_link\">",
"      Nonselective NSAIDs: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_43_42675="Dry powder inhalers";
var content_f41_43_42675=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Examples of various dry powder inhalers",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 442px; height: 455px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    With these devices, the patient inhales the medication in the form of a fine powder rather than an aerosol. (A) Aerolizer, (B) HandiHaler, (C) Neohaler, (D) Flexhaler, (E) Diskus, (F) Twisthaler. With single-dose devices,&nbsp;a powder-filled capsule is placed in the device for each dose. With multiple-dose devices, medication for multiple doses (often a month's supply) is contained within the device.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Panels A, B, D, E, and F: Courtesy of Dean Hess, RRT, PhD.",
"     <br/>",
"     Panel C: Used with permission. Copyright &copy; 2012 Novartis Pharmaceuticals Corporation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42675=[""].join("\n");
var outline_f41_43_42675=null;
var title_f41_43_42676="Mast cell muc connect";
var content_f41_43_42676=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F71689&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F71689&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Electron micrographic features of mucosal mast cells (A) and connective tissue mast cells (B)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 221px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The black arrow in micrograph A points to the scroll-like structures within the granules of mucosal mast cells. It is unclear precisely what these structures are composed of, although the granules contain predominantly tryptase.",
"    <br>",
"     Micrograph B shows a connective tissue mast cell with granules that display a lattice-like grating pattern on electron microscopy. The granules in this type of mast cell contain carboxypeptidase A, chymase, and tryptase.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Courtesy of Mariana Castells, MD PhD, Lawrence B Schwartz, MD, and Shirley Craig, PhD.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42676=[""].join("\n");
var outline_f41_43_42676=null;
var title_f41_43_42677="Choline magnesium trisalicylate: Drug information";
var content_f41_43_42677=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Choline magnesium trisalicylate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?41/35/42548?source=see_link\">",
"    see \"Choline magnesium trisalicylate: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/45/8917?source=see_link\">",
"    see \"Choline magnesium trisalicylate: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F150957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Salicylate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F150941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Arthritis, pain: Oral (based on total salicylate content): 500 mg to 1.5 g 2-3 times/day",
"     <b>",
"      or",
"     </b>",
"     3 g at bedtime; usual maintenance dose: 1-4.5 g/day",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F150951\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/45/8917?source=see_link\">",
"      see \"Choline magnesium trisalicylate: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children: Oral (based on total salicylate content): &lt;37 kg: 50 mg/kg/day given in 2 divided doses; 2250 mg/day for heavier children",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F150942\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Usual dose: 750 mg 3 times/day.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F150943\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid use in severe renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15682638\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F150916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral: 500 mg/5 mL (240 mL) [choline salicylate 293 mg and magnesium salicylate 362 mg per 5 mL]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F150900\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F150920\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Liquid may be mixed with fruit juice just before drinking. Do not administer with antacids.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F150919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of osteoarthritis, rheumatoid arthritis, and other arthritis; acute painful shoulder",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F150955\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;20%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting, diarrhea, heartburn, dyspepsia, epigastric pain, constipation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;2%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache, lightheadedness, dizziness, drowsiness, lethargy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Hearing impairment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1%: Anorexia, asthma, BUN and creatinine increased, bruising, confusion, duodenal ulceration, dysgeusia, edema, epistaxis, erythema multiforme, esophagitis, hallucinations, hearing loss (irreversible), hepatic enzymes increased, gastric ulceration, occult bleeding, pruritus, rash, weight gain",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F150923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to salicylates, other nonacetylated salicylates, other NSAIDs, or any component of the formulation; bleeding disorders; pregnancy (3rd trimester)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F150904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tinnitus: Tinnitus or impaired hearing may indicate toxicity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Use with caution in patients with asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dehydration: Use with caution in patients with dehydration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal disease: Use with caution in patients with erosive gastritis or peptic ulcer.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thrombosis (prophylaxis): Salicylate salts may not inhibit platelet aggregation and, therefore, should not be substituted for aspirin in the prophylaxis of thrombosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use lowest effective dose for shortest period possible in the elderly; they are a high-risk population for adverse effects from NSAIDs. As many as 60% of elderly can develop peptic ulceration and/or hemorrhage asymptomatically. CNS adverse effects may be observed in the elderly at lower doses than younger adults. Tinnitus may be a difficult and unreliable indication of toxicity due to age-related hearing loss or eighth cranial nerve damage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Children and teenagers who have or are recovering from chickenpox or flu-like symptoms should not use this product. Changes in behavior (along with nausea and vomiting) may be an early sign of Reye's syndrome; patients should be instructed to contact their healthcare provider if these occur.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F150909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Salicylates may diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF.  The effects are likely dose-related.  100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: Salicylates may enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Nondihydropyridine): May enhance the anticoagulant effect of Salicylates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Bepridil [Off Market].",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carbonic Anhydrase Inhibitors: Salicylates may enhance the adverse/toxic effect of Carbonic Anhydrase Inhibitors. Salicylate toxicity might be enhanced by this same combination.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Brinzolamide; Dorzolamide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Salicylates may enhance the adverse/toxic effect of Corticosteroids (Systemic). These specifically include gastrointestinal ulceration and bleeding. Corticosteroids (Systemic) may decrease the serum concentration of Salicylates. Withdrawal of corticosteroids may result in salicylate toxicity.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: Salicylates may increase the serum concentration of Divalproex.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Drotrecogin Alfa (Activated): Salicylates may enhance the adverse/toxic effect of Drotrecogin Alfa (Activated). Bleeding may occur.  Management: Weigh potential benefits of drotrecogin against increased bleeding risk in patients who have received  platelet inhibitors including aspirin (over 650 mg daily within 1 week). Monitor for bleeding and stop infusion if clinically important bleeding occurs.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ginkgo Biloba: May enhance the anticoagulant effect of Salicylates. Management: Consider alternatives to this combination of agents. Monitor for signs and symptoms of bleeding (especially intracranial bleeding) if salicylates are used in combination with ginkgo biloba.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Salicylates. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Salicylates may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving salicylates (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: Salicylates may enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Influenza Virus Vaccine (Live/Attenuated): May enhance the adverse/toxic effect of Salicylates. Specifically, Reye's syndrome may develop.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: Salicylates may diminish the diuretic effect of Loop Diuretics. Loop Diuretics may increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Salicylates may increase the serum concentration of Methotrexate. Salicylate doses used for prophylaxis of cardiovascular events are not likely to be of concern.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Acid Phosphate: May increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PRALAtrexate: Salicylates may increase the serum concentration of PRALAtrexate. Salicylate doses used for prophylaxis of cardiovascular events are unlikely to be of concern.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: Salicylates may diminish the therapeutic effect of Probenecid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the anticoagulant effect of other Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: Salicylates may enhance the adverse/toxic effect of Thrombolytic Agents. An increased risk of bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Treprostinil: May enhance the adverse/toxic effect of Salicylates. Bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: Salicylates may increase the serum concentration of Valproic Acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Varicella Virus-Containing Vaccines: Salicylates may enhance the adverse/toxic effect of Varicella Virus-Containing Vaccines. Reye's Syndrome may develop.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Salicylates may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F150934\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Avoid ethanol (may enhance gastric mucosal irritation).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: May decrease the rate but not the extent of oral absorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid cat's claw, dong quai, evening primrose, feverfew, garlic, ginger, ginkgo, red clover, horse chestnut, green tea, ginseng (all have additional antiplatelet activity). Limit curry powder, paprika, licorice, Benedictine liqueur, prunes, raisins, tea, and gherkins; may cause salicylate accumulation. These foods contain 6 mg salicylate/100 g.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F150912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C/D (3rd trimester) (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F150925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Due to the known effects of other salicylates (closure of ductus arteriosus), use during late pregnancy should be avoided.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F150947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F150926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excreted in breast milk; peak levels occur 9-12 hours after dose. Use caution if used during breast-feeding.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F150927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Take with food or large volume of water or milk to minimize GI upset. Liquid may be mixed with fruit juice just before drinking. Hypermagnesemia resulting from magnesium salicylate; avoid or use with caution in renal insufficiency.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F150914\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum magnesium with high dose therapy or in patients with impaired renal function; serum salicylate levels, renal function, hearing changes or tinnitus, abnormal bruising, weight gain and response (ie, pain)",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F150917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Salicylate blood levels for anti-inflammatory effect: 150-300 mcg/mL; analgesia and antipyretic effect: 30-50 mcg/mL",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6875315\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Trilisate (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZA, ZM, ZW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F150903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Weakly inhibits cyclooxygenase enzymes, which results in decreased formation of prostaglandin precursors; antipyretic, analgesic, and anti-inflammatory properties.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Other proposed mechanisms not fully elucidated (and possibly contributing to the anti-inflammatory effect to varying degrees) include inhibiting chemotaxis, altering lymphocyte activity,  inhibiting neutrophil aggregation/activation, and decreasing proinflammatory cytokine levels.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F150922\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Peak effect: ~2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Stomach and small intestines",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Readily into most body fluids and tissues; crosses placenta; enters breast milk",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination (dose dependent): Low dose: 2-3 hours; High dose: 30 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: ~2 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Berde C, Ablin A, Glazer J, et al, &ldquo;American Academy of Pediatrics Report of the Subcommittee on Disease-Related Pain in Childhood Cancer,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1990, 86(5 Pt 2):818-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/43/42677/abstract-text/2216644/pubmed\" id=\"2216644\" target=\"_blank\">",
"        2216644",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chapman BJ and Proudfoot AT, &ldquo;Adult Salicylate Poisoning: Deaths and Outcome in Patients With High Plasma Salicylate Concentrations,&rdquo;",
"      <i>",
"       Q J Med",
"      </i>",
"      , 1989, 72(268):699-707.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/43/42677/abstract-text/2602553/pubmed\" id=\"2602553\" target=\"_blank\">",
"        2602553",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Danesh BJ, Saniabadi AR, Russell RI, et al, &ldquo;Therapeutic Potential of Choline Magnesium Trisalicylate as an Alternative to Aspirin for Patients With Bleeding Tendencies,&rdquo;",
"      <i>",
"       Scott Med J",
"      </i>",
"      , 1987, 32(6):167-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/43/42677/abstract-text/3329766/pubmed\" id=\"3329766\" target=\"_blank\">",
"        3329766",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Department of Health and Human Services, Food and Drug Administration, &ldquo;Labeling for Oral and Rectal Over-the-Counter Drug Products Containing Aspirin and Nonaspirin Salicylates; Reye's Syndrome Warning; Final Rule, (29 CFR Part 201),&rdquo;",
"      <i>",
"       Fed Regist",
"      </i>",
"      , April 17, 2003, 18861-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/43/42677/abstract-text/10177739/pubmed\" id=\"10177739\" target=\"_blank\">",
"        10177739",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Drugs for Pain,&rdquo;",
"      <i>",
"       Med Lett Drugs Ther",
"      </i>",
"      , 1998, 40(1033):79-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/43/42677/abstract-text/9722804/pubmed\" id=\"9722804\" target=\"_blank\">",
"        9722804",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dugandric RM, Tierney MG, and Dickinson GE, &ldquo;Evaluation of the Done Nomogram in the Management of Acute Salicylate Intoxication,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1989, 18(11):1186-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/43/42677/abstract-text/2817562/pubmed\" id=\"2817562\" target=\"_blank\">",
"        2817562",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hawkey CJ, Karrasch JA, Szczepa&ntilde;ski L, et al, &ldquo;Omeprazole Compared With Misoprostol for Ulcers Associated With Nonsteroidal Anti-inflammatory Drugs,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1998, 338(11):727-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/43/42677/abstract-text/9494149/pubmed\" id=\"9494149\" target=\"_blank\">",
"        9494149",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vandenberg SA, Smolinske SC, Spoerke DG, et al, &ldquo;Nonaspirin Salicylates: Conversion Factors for Estimating Aspirin Equivalency,&rdquo;",
"      <i>",
"       Vet Hum Toxicol",
"      </i>",
"      , 1989, 31(1):49-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/43/42677/abstract-text/2652876/pubmed\" id=\"2652876\" target=\"_blank\">",
"        2652876",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Verbeeck RK, &ldquo;Pharmacokinetic Drug Interactions With Nonsteroidal Anti-inflammatory Drugs,&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1990, 19(1):44-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/43/42677/abstract-text/2199127/pubmed\" id=\"2199127\" target=\"_blank\">",
"        2199127",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vertrees JE, McWilliams BC, and Kelly HW, &ldquo;Repeated Oral Administration for Treating Aspirin Overdose in Young Children,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1990, 85(4):594-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/43/42677/abstract-text/2314974/pubmed\" id=\"2314974\" target=\"_blank\">",
"        2314974",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weissmann G, &ldquo;Aspirin,&rdquo;",
"      <i>",
"       Sci Am",
"      </i>",
"      , 1991, 264(1):84-90.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yeomans ND, Tulassay Z, Juhasz L, et al, &ldquo;A Comparison of Omeprazole With Ranitidine for Ulcers Associated With Nonsteroidal Anti-inflammatory Drugs,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1998, 338(11):719-26.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/43/42677/abstract-text/9494148/pubmed\" id=\"9494148\" target=\"_blank\">",
"        9494148",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9259 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-DB96A30595-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42677=[""].join("\n");
var outline_f41_43_42677=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150957\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150941\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150951\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150942\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150943\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682638\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150916\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150900\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150920\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150919\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150955\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150923\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150904\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299035\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150909\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150934\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150912\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150925\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150947\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150926\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150927\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150914\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150917\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6875315\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150903\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150922\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9259\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9259|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?41/35/42548?source=related_link\">",
"      Choline magnesium trisalicylate: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/45/8917?source=related_link\">",
"      Choline magnesium trisalicylate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_43_42678="Breast implant infections";
var content_f41_43_42678=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Breast implant infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42678/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42678/contributors\">",
"     Tahaniyat Lalani, MBBS, MHS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42678/contributors\">",
"     Michael R Zenn, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42678/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42678/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42678/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42678/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42678/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/43/42678/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast augmentation (also called augmentation mammoplasty) is the third most common type of cosmetic surgery procedure in the United States, with almost 270,000 procedures being performed in 2002. Breast implants are performed both for breast enlargement and, in women who have undergone mastectomy for breast cancer, for breast reconstruction. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39386?source=see_link&amp;anchor=H14#H14\">",
"     \"Breast reconstruction in women with breast cancer\", section on 'Prosthetic devices'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Saline filled breast implants have been the main prostheses used for breast augmentation. Although silicone gel implants provide a more natural appearance and feel, unfounded concerns about risk of connective tissue disease associated with silicone implants led to a moratorium on their use in the United States in 1992. This was lifted in November 2006, after further studies led to the conclusion that silicone gel implants expose patients to no demonstrable risk for connective tissue or rheumatologic disease.",
"   </p>",
"   <p>",
"    Silicone implants have the disadvantages that additional surgery may be necessary, since the implants do not last a lifetime, and that periodic imaging studies may be needed to determine if implant rupture has occurred. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39386?source=see_link&amp;anchor=H19#H19\">",
"     \"Breast reconstruction in women with breast cancer\", section on 'Silicone and breast reconstruction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Breast implants are sometimes placed following the use of a tissue expander. In addition, acellular dermal matrix is often used as an adjunct to tissue expander and breast implant reconstructions. This matrix may assist in the shaping of the reconstructive breast and allow tissue expanders to be filled to higher volumes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues related to breast implant infections will be reviewed here. Breast cellulitis, which is another form of breast infection related to breast cancer surgery, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/61/43991?source=see_link\">",
"     \"Breast cellulitis: Clinical manifestations, diagnosis, and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     INCIDENCE AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a worldwide survey published in 1970 of almost 11,000 patients who underwent breast augmentation, infection occurred after 2.5 percent of all operations: 1.7 percent were early-onset postoperative infections and 0.8 percent were late-onset infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/2\">",
"     2",
"    </a>",
"    ]. A similar infection rate (2.0 to 2.5 percent) has been noted in more contemporary series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for infection associated with breast implants have not been adequately assessed in prospective studies with long-term follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, the available data do not permit adequate evaluation of the relative importance of risk factors.",
"   </p>",
"   <p>",
"    Despite these limitations, the following factors are thought to be determinants of the risk of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgical technique appears to be important, with a higher infection risk with periareolar and transareolar approaches in which the endogenous flora may contaminate the implant.",
"     </li>",
"     <li>",
"      Breast reconstruction using implants after mastectomy is associated with as much as a 10-fold increase in the rate of infection compared to breast augmentation alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/4,6\">",
"       4,6",
"      </a>",
"      ]. The higher risk with breast reconstruction may be related to tissue scarring and skin atrophy resulting from prior cancer surgery and radiation therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/5,7\">",
"       5,7",
"      </a>",
"      ]. Lymph node dissection also may be an independent risk factor in these patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Immediate, compared with delayed, implant placement (eg, mastectomy followed by immediate breast reconstruction) increases the risk of infection, perhaps due to contamination of the operative field with endogenous flora during one-stage procedures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/2,5\">",
"       2,5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The use of acellular dermal matrix as an adjunct to the placement of an implant or tissue expander was associated with higher rates of seroma formation and surgical site infections in one large retrospective study involving 283 patients who underwent reconstructive procedures immediately following mastectomy. The rate of infection was higher among patients who received acellular dermal matrix material than those who did not (14.1 versus 2.7 percent). Higher body mass index was also an independent risk factor for infection in this study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The origin of individual implant-associated infection is often difficult to determine. The major causes are thought to be contamination from endogenous flora in early onset infections, while seeding of the implant due to secondary bacteremia from remote sites is thought to be important in some late infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rarely, breast implant infections have resulted from contaminated implants or the use of contaminated saline or contaminated marking solution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Microbiology and epidemiology of infection'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY AND EPIDEMIOLOGY OF INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causative pathogens vary with the time of onset after infection. Most acute and subacute breast implant infections are due to gram-positive pathogens such as coagulase-negative staphylococci, Propionibacterium species, S. aureus, and streptococci. In contrast, late onset infections may be caused by gram-positive or gram-negative bacteria, depending upon the cause of bacteremia. Case reports have described implant infections due to Pseudomonas aeruginosa or Bacteroides fragilis bacteremia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/6,12\">",
"     6,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Implant-associated infections due to nontuberculous mycobacteria usually become apparent several weeks following surgery. Typical clinical features include failure of the primary incision to heal or early dehiscence of a portion of the incision, and odorless serous or seropurulent drainage of fluid that is culture-negative on routine bacterial cultures. Acid-fast stains and cultures should be obtained in all cases of subacute infection, even when routine culture reveals skin flora.",
"   </p>",
"   <p>",
"    Contaminated skin marking solution was identified as a possible source of nontuberculous mycobacteria infection in a small outbreak [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/11\">",
"     11",
"    </a>",
"    ] but a source for nontuberculous mycobacteria is often not identified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In another small outbreak, black sediment in the saline implants of patients undergoing revision surgery was due to contamination with Curvularia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/8\">",
"     8",
"    </a>",
"    ]. This dematiaceous mold was isolated from the sterile supply room where saline used to fill implants had been stored in bottles under a water-damaged ceiling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20460168\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20460176\">",
"    <span class=\"h2\">",
"     General principles of implant infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of prosthetic implant infections involves a complex interaction between the host, the device, and the bacteria causing the infection. In animal models, the presence of a subcutaneous foreign body reduces the minimal inoculum of Staphylococcus aureus required to cause infection by a factor of more than 100,000, to as little as 100 colony-forming units [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/14\">",
"     14",
"    </a>",
"    ]. At least two factors contribute to this increase in risk: foreign bodies do not have a microcirculation, which is crucial for both host defense and the delivery of antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/14\">",
"     14",
"    </a>",
"    ]; and the interaction of neutrophils with the foreign body can induce a neutrophil defect that may enhance the susceptibility to infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adherent bacteria multiply and elaborate exopolysaccharides, also known as glycocalyx. Eventually, microcolonies of bacteria encased in glycocalyx coalesce to form a structure known as a biofilm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A majority of implant infections are caused by microorganisms that grow in biofilms such as coagulase-negative staphylococci (eg, S. epidermidis) and Staphylococcus aureus. Microcolonies of bacteria in biofilms form complex communities, with intraspecies communication and adaptation through a process called quorum-sensing, which regulates both virulence and biofilm formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bacteria near the surface of the biofilm are usually metabolically active and have access to nutrients that diffuse through the upper surface of the biofilm. In comparison, organisms deep within the biofilm are metabolically inactive or in various stages of dormancy, and are protected from host defenses such as phagocytes and antimicrobial penetration. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42680?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical manifestations and diagnosis of prosthetic joint infections\", section on 'Biofilm'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20460198\">",
"    <span class=\"h2\">",
"     Microbiology of the breast",
"    </span>",
"    &nbsp;&mdash;&nbsp;The breast contains endogenous flora derived from the nipple ducts. Bacteria colonizing the nipple ducts may gain access to deeper breast tissue, particularly during surgical or biopsy procedures. In samples obtained from women undergoing breast augmentation or reduction, coagulase-negative staphylococci were the predominant organism, being isolated from 53 percent of specimens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/19\">",
"     19",
"    </a>",
"    ]. Other aerobic organisms, each of which was present in less than 10 percent of specimens, were diphtheroids, lactobacilli, enterococci, and alpha-hemolytic streptococci (3 percent). The major anaerobe was Propionibacterium acnes.",
"   </p>",
"   <p>",
"    The endogenous flora can contaminate the prosthesis during implantation and be responsible for subsequent acute infections. (See",
"    <a class=\"local\" href=\"#H20459910\">",
"     'Clinical manifestations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20459910\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Saline breast implant infections usually present in the acute postoperative period (six days to six weeks after surgery); in contrast, silicone implant infections usually occur more than six months after surgery.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early-onset infections of saline implants are typically associated with fever, breast pain, erythema, and purulent fluid or drainage at the site of the incision. However, some patients develop systemic signs and symptoms of infection at a time when the primary surgical site manifests little or no evidence of infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/20\">",
"       20",
"      </a>",
"      ]. As an example, toxic shock syndrome is a rare complication in the early postoperative period; it results from S. aureus infection that is usually acquired during surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/5\">",
"       5",
"      </a>",
"      ]. Symptoms in patients with toxic shock syndrome may begin as early as 12 to 24 hours after surgery, but the median time is four days after surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/20\">",
"       20",
"      </a>",
"      ]. Despite the severe systemic manifestations, the surgical site typically shows neither inflammation nor purulence. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/52/8010?source=see_link\">",
"       \"Staphylococcal toxic shock syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Subacute infections usually present with chronic pain, persistent drainage of serous or purulent fluid, failure of a portion of the incision to heal or remain healed,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      migration or extrusion of the implant.",
"     </li>",
"     <li>",
"      Late infections, occurring several months to years after implantation, are rare and usually result from secondary bacteremia due to a focus of infection at another body site or an invasive procedure. Early treatment of any potentially severe bacterial infection may limit this risk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another late complication of breast implants is capsular contracture (contraction of the scar around the soft implant) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/5\">",
"     5",
"    </a>",
"    ]. The role of infection in the genesis of these contractures is unproven [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/5,21,22\">",
"     5,21,22",
"    </a>",
"    ], although some have proposed an important role for biofilm from coagulase-negative staphylococci [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20460176\">",
"     'General principles of implant infection'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of breast implant infection is typically first suspected from the clinical features. Ultrasonography should be performed to see if there is a fluid collection surrounding the implant. If fluid is present, aspiration should be performed under ultrasound guidance, since blind aspiration may lead to perforation and leakage of the implant. Aspirated fluid should be sent for Gram stain, aerobic and anaerobic bacterial cultures, and fungal and acid-fast bacilli cultures.",
"   </p>",
"   <p>",
"    If tissue is removed, it should be sent for histopathologic examination and culture. Special stains to reveal acid-fast organisms should be routinely performed and a portion of the specimen should be sent for both bacterial and mycobacterial culture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials or large cohort studies evaluating the management of breast implant infections. Although implant removal is often necessary to achieve cure of implant-associated infections, medical therapy is usually attempted first for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Medical therapy is usually given empirically while the results of microbiologic cultures are pending.",
"     </li>",
"     <li>",
"      Some bacterial infections, such as a superficial cellulitis without periprosthetic fluid, or infections due to coagulase-negative staphylococci or diphtheroids, may be treated successfully with medical therapy alone.",
"     </li>",
"     <li>",
"      Most patients and their surgeons are unwilling to accept the loss of the implant and the discomfort, cost, and disability required for removal, treatment, and replacement of a new implant until they are convinced that an attempt at medical therapy has failed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The potential efficacy of treating breast implant infection with antibiotic therapy alone was evaluated in a retrospective review of patients with breast implant infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/24\">",
"     24",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Eight patients had mild infection, which was defined as warmth, swelling, or cellulitis without drainage. The patients were treated with oral antibiotics and all responded without requiring removal of the implant.",
"     </li>",
"     <li>",
"      Four patients had severe infection, which was defined as persistent swelling despite antibiotic therapy, purulent drainage, atypical organisms such as gram-negative rods or mycobacteria, or systemic signs of infection. Two of the implants were salvaged with antibiotic therapy alone. However, details regarding the duration and route of antibiotics (oral versus intravenous) and the follow-up period were not provided.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H913893\">",
"    <span class=\"h2\">",
"     Antibiotic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;An empiric antibiotic regimen should include coverage for methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococcus as well as gram-negative bacteria. One such regimen is",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (30 to 60",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in two to three divided doses) with",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?34/13/35030?source=see_link\">",
"      piperacillin",
"     </a>",
"     /tazobactam",
"    </span>",
"    (3.375 grams every six hours). If there is clinical response to initial therapy, patients can be switched to suitable oral alternatives such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    ,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    , depending on culture results. In subacute cases or in infections localized to the operative site without signs of systemic toxicity, an oral empiric regimen or deferment of antibiotics pending culture data may be appropriate.",
"   </p>",
"   <p>",
"    Subsequent antibiotic therapy should be based upon culture and susceptibility results.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22153920\">",
"    <span class=\"h2\">",
"     Implant removal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following initial antibiotic therapy, we recommend removal of the implant in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For nontuberculous mycobacterial infection unless there has been a prompt and lasting response to medical therapy.",
"     </li>",
"     <li>",
"      For all fungal infections.",
"     </li>",
"     <li>",
"      When systemic signs of sepsis persist after antibiotic therapy has been instituted.",
"     </li>",
"     <li>",
"      When a prompt and lasting response to antibiotic therapy has not occurred.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among patients who require implant removal, the timing of reimplantation is dependent upon the degree of infection and the causative organism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/5\">",
"     5",
"    </a>",
"    ]. Some experts recommend six months or more before reimplantation, although there are no published trials to support this approach.",
"   </p>",
"   <p>",
"    A case report described a woman with acute implant infection due to S. aureus who was treated with excision of the infected implant, debridement, and pulse lavage, and then switched to a \"clean\" set up with immediate insertion of a new implant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/25\">",
"     25",
"    </a>",
"    ]. The patient was discharged on oral antibiotics after one dose of intravenous antibiotics and remained symptom-free at seven month follow-up.",
"   </p>",
"   <p>",
"    More data are required before this approach can be recommended. We do not perform such \"one-step\" replacement of infected implants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22153946\">",
"    <span class=\"h2\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duration of therapy depends on the severity of infection and plans for removal or retention of prosthesis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mild bacterial cellulitis without periprosthetic fluid: 10 to 14 days (no implant removal or debridement needed)",
"     </li>",
"     <li>",
"      Implant infections treated with removal and debridement: 10 to 14 days for bacterial infections and 8 to 12 weeks for mycobacterial infections",
"     </li>",
"     <li>",
"      Implant infections treated with &lsquo;one-stage&rsquo; replacement, lavage",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      debridement: Some investigators have reported successful salvage with six weeks of antibiotics and negative-pressure wound management [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/24,26-28\">",
"       24,26-28",
"      </a>",
"      ]. However, these are small case series with limited follow-up. We do not advocate this approach and instead strongly favor excision and antibiotic therapy followed by delayed re-implantation. (See",
"      <a class=\"local\" href=\"#H22153920\">",
"       'Implant removal'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A separate issue from infection of the implant is the prevention of surgical site infection. In a survey published in 1993 of 73 plastic surgeons who were experienced in implant surgery, most used topical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    systemic antimicrobial prophylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/6\">",
"     6",
"    </a>",
"    ]. Support for this approach was provided by a 1983 survey of almost 40,000 women undergoing breast augmentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/29\">",
"     29",
"    </a>",
"    ]. The rate of wound infection was significantly lower in the patients treated with systemic antimicrobial prophylaxis (0.42 versus 0.87 percent).",
"   </p>",
"   <p>",
"    The efficacy of antimicrobial prophylaxis is controversial in breast surgery. The Medical Letter treatment guideline on antimicrobial prophylaxis for surgery noted that, although most consultants do not recommend prophylaxis for \"clean\" procedures such as breast surgery, some recommend prophylaxis for procedures that involve placement of prosthetic material such as saline breast implants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/30\">",
"     30",
"    </a>",
"    ]. This practice is widely followed and is appropriate in our opinion.",
"   </p>",
"   <p>",
"    When prophylaxis is given, it should cover the most common organisms responsible for wound infection, particularly staphylococci. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Microbiology and epidemiology of infection'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The first generation cephalosporin",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    (1 to 2 g IV) has been effective for most clean procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42678/abstract/30\">",
"     30",
"    </a>",
"    ]. A single dose should be given within 60 minutes prior to the surgical incision. For procedures lasting more than four hours or when major blood loss occurs, redosing is indicated every one to two half-lives of the drug in patients with normal renal function (every two to five hours for cefazolin). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of control measures to prevent surgical site infection\", section on 'Antibiotic selection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of control measures to prevent surgical site infection\", section on 'Timing of prophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20459812\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infections of breast implants occur in approximately 2 to 2.5 percent of cases. Post-mastectomy implantation is associated with a higher risk of infection compared with breast augmentation alone. The use of particular surgical approaches or acellular dermal matrix may also increase the risk of infection. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Incidence and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most acute and subacute breast implant infections are due to gram-positive pathogens such as coagulase-negative staphylococci, Propionibacterium species, S. aureus, and streptococci. Nontuberculous mycobacteria are also an important cause of subacute infections. Both gram-positive and gram-negative bacteria have been associated with late-onset infections, often secondary to bacteremia. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Microbiology and epidemiology of infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Saline breast implant infections usually present in the acute postoperative period (six days to six weeks after surgery); in contrast, silicone implant infections usually occur more than six months after surgery. Acute infections are usually associated with fever and breast pain, erythema, and drainage. Subacute infections may present with chronic pain, persistent drainage, failed healing of the incision site, or migration of the implant. (See",
"      <a class=\"local\" href=\"#H20459910\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis of implant infections is generally made by microbiological analysis of peri-implant fluid, which should be aspirated under ultrasound guidance and sent for Gram stain, aerobic and anaerobic bacterial cultures, and fungal and acid-fast bacilli cultures. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are no randomized trials or large cohort studies evaluating the management of breast implant infections. Some bacterial breast implant infections can be treated successfully with medical therapy alone. However, implant removal is often necessary for cure, particularly for mycobacterial and fungal infections. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with breast implant infections who present acutely or have evidence of systemic toxicity, we favor an empiric parenteral antibiotic therapy with a regimen effective against methicillin-resistant S. aureus, coagulase-negative staphylococcus, and gram-negative bacteria. An oral empiric regimen or deferment of antibiotics pending culture data is appropriate in subacute cases with localized infection. Patients who respond to initial parenteral therapy can switch to an oral regimen tailored to culture results. The duration of antimicrobial therapy depends on the infecting organism. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The use of perioperative antibiotic prophylaxis is associated with a decreased rate of wound infection following breast augmentation. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/1\">",
"      Chun YS, Verma K, Rosen H, et al. Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications. Plast Reconstr Surg 2010; 125:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/2\">",
"      De Cholnoky T. Augmentation mammaplasty. Survey of complications in 10,941 patients by 265 surgeons. Plast Reconstr Surg 1970; 45:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/3\">",
"      Kj&oslash;ller K, H&ouml;lmich LR, Jacobsen PH, et al. Epidemiological investigation of local complications after cosmetic breast implant surgery in Denmark. Ann Plast Surg 2002; 48:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/4\">",
"      Gabriel SE, Woods JE, O'Fallon WM, et al. Complications leading to surgery after breast implantation. N Engl J Med 1997; 336:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/5\">",
"      Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis 2005; 5:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/6\">",
"      Brand KG. Infection of mammary prostheses: a survey and the question of prevention. Ann Plast Surg 1993; 30:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/7\">",
"      Nahabedian MY, Tsangaris T, Momen B, Manson PN. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg 2003; 112:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/8\">",
"      Kainer MA, Keshavarz H, Jensen BJ, et al. Saline-filled breast implant contamination with Curvularia species among women who underwent cosmetic breast augmentation. J Infect Dis 2005; 192:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/9\">",
"      Young VL, Hertl MC, Murray PR, et al. Microbial growth inside saline-filled breast implants. Plast Reconstr Surg 1997; 100:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/10\">",
"      Chen NT, Butler PE, Hooper DC, May JW Jr. Bacterial growth in saline implants: in vitro and in vivo studies. Ann Plast Surg 1996; 36:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/11\">",
"      Safranek TJ, Jarvis WR, Carson LA, et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1987; 317:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/12\">",
"      Petit F, Maladry D, Werther JR, Mitz V. [Late infection of breast implant, complication of colonic perforation. Review of the literature. Role of preventive treatment]. Ann Chir Plast Esthet 1998; 43:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/13\">",
"      Haiavy J, Tobin H. Mycobacterium fortuitum infection in prosthetic breast implants. Plast Reconstr Surg 2002; 109:2124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/14\">",
"      Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982; 146:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/15\">",
"      Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 1984; 73:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/16\">",
"      Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/17\">",
"      Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001; 33:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/18\">",
"      Vuong C, Gerke C, Somerville GA, et al. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 2003; 188:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/19\">",
"      Thornton JW, Argenta LC, McClatchey KD, Marks MW. Studies on the endogenous flora of the human breast. Ann Plast Surg 1988; 20:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/20\">",
"      Holm C, M&uuml;hlbauer W. Toxic shock syndrome in plastic surgery patients: case report and review of the literature. Aesthetic Plast Surg 1998; 22:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/21\">",
"      Shah Z, Lehman JA Jr, Tan J. Does infection play a role in breast capsular contracture? Plast Reconstr Surg 1981; 68:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/22\">",
"      Rudolph R, Woodward M. Absence of visible bacteria in capsules around silicone breast implants. Plast Reconstr Surg 1983; 72:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/23\">",
"      Pajkos A, Deva AK, Vickery K, et al. Detection of subclinical infection in significant breast implant capsules. Plast Reconstr Surg 2003; 111:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/24\">",
"      Spear SL, Howard MA, Boehmler JH, et al. The infected or exposed breast implant: management and treatment strategies. Plast Reconstr Surg 2004; 113:1634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/25\">",
"      De Lorenzi C. Successful treatment of acute periprosthetic breast infection with curettage, pulse lavage, and immediate device exchange. Aesthetic Plast Surg 2005; 29:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/26\">",
"      Kendrick AS, Chase CW. Salvage of an infected breast tissue expander with an implant sizer and negative pressure wound management. Plast Reconstr Surg 2008; 121:138e.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/27\">",
"      Chun JK, Schulman MR. The infected breast prosthesis after mastectomy reconstruction: successful salvage of nine implants in eight consecutive patients. Plast Reconstr Surg 2007; 120:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/28\">",
"      Washer LL, Gutowski K. Breast implant infections. Infect Dis Clin North Am 2012; 26:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/29\">",
"      Clegg HW, Bertagnoll P, Hightower AW, Baine WB. Mammaplasty-associated mycobacterial infection: a survey of plastic surgeons. Plast Reconstr Surg 1983; 72:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42678/abstract/30\">",
"      Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2012; 10:73.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5536 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-1E1E8CC54B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42678=[""].join("\n");
var outline_f41_43_42678=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20459812\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      INCIDENCE AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      MICROBIOLOGY AND EPIDEMIOLOGY OF INFECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20460168\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20460176\">",
"      General principles of implant infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20460198\">",
"      Microbiology of the breast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20459910\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H913893\">",
"      Antibiotic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22153920\">",
"      Implant removal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22153946\">",
"      Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20459812\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/61/43991?source=related_link\">",
"      Breast cellulitis: Clinical manifestations, diagnosis, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/29/39386?source=related_link\">",
"      Breast reconstruction in women with breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42680?source=related_link\">",
"      Clinical manifestations and diagnosis of prosthetic joint infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/52/8010?source=related_link\">",
"      Staphylococcal toxic shock syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_43_42679="Diet in the treatment and prevention of hypertension";
var content_f41_43_42679=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diet in the treatment and prevention of hypertension",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42679/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42679/contributors\">",
"     Norman M Kaplan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42679/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42679/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42679/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42679/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42679/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/43/42679/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of dietary modifications are beneficial in the treatment of hypertension, including reduction of sodium intake, moderation of alcohol, weight loss in the overweight or obese, and a diet rich in fruits, vegetables, legumes, and low-fat dairy products and low in snacks, sweets, meat, and saturated fat. Individual dietary factors that may reduce blood pressure include increased intakes of potassium, calcium, fish oil, fiber, and milk-based and vegetable-based protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nondietary modalities of lifestyle modification should also be considered, including cessation of smoking and institution of an aerobic exercise regimen. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/20/3395?source=see_link\">",
"     \"Smoking and hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/2998?source=see_link\">",
"     \"Exercise in the treatment and prevention of hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most of the studies on nonpharmacologic therapy evaluated only a single factor to prove its efficacy (eg, weight reduction without sodium restriction). In making recommendations to the individual patient, however, the physician will try to modify all of the factors that may be contributing to the elevation in blood pressure, although it is uncertain if the effects of different modifications are additive.",
"   </p>",
"   <p>",
"    In those with prehypertension or stage 1 hypertension, lifestyle changes may control the blood pressure adequately [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/2\">",
"     2",
"    </a>",
"    ]. However, in those with either higher BP or additional risk (eg, diabetes or chronic kidney disease), drug therapies should first be used to more quickly and effectively control the blood pressure. Once blood pressure is well controlled, lifestyle changes should be strongly advised. If these are successfully achieved, reduction of medications may be possible.",
"   </p>",
"   <p>",
"    This topic will review the effect of comprehensive dietary modification, as well as the effects of individual dietary interventions on blood pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     COMPREHENSIVE DIETARY MODIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have looked at the efficacy of comprehensive dietary modification [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/3\">",
"     3",
"    </a>",
"    ]. In one, antihypertensive therapy was discontinued in patients who had been well-controlled for two or more years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/4\">",
"     4",
"    </a>",
"    ]. The patients were then randomized into two groups: one maintained on a relatively standard diet and one on a diet that stressed salt restriction, weight reduction, and avoidance of excess alcohol intake. At four years, hypertension had recurred in over 90 percent in the control group but in only 60 percent with dietary intervention with evidence of a plateau between the third and fourth years (",
"    <a class=\"graphic graphic_figure graphicRef59980 \" href=\"mobipreview.htm?26/45/27357\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     TOMHS study",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the Treatment of Mild Hypertension Study (TOMHS), 902 patients with mild diastolic hypertension (90 to 100 mmHg) were started on a program consisting of weight reduction, sodium and alcohol restriction, and increased physical activity. Patients were then randomly assigned to placebo or to one of five different antihypertensive drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/5\">",
"     5",
"    </a>",
"    ]. There were initial improvements in all of the dietary parameters that tended to diminish over time (",
"    <a class=\"graphic graphic_figure graphicRef67978 \" href=\"mobipreview.htm?17/57/18334\">",
"     figure 2",
"    </a>",
"    ). Despite the difficulty in maintaining optimal compliance, those patients who remained on the lifestyle program had an average",
"    <span class=\"nowrap\">",
"     8.6/8.6",
"    </span>",
"    mmHg fall in blood pressure at four years.",
"   </p>",
"   <p>",
"    Although the response to nonpharmacologic therapy alone was less than that seen if drug therapy were added [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/5\">",
"     5",
"    </a>",
"    ], dietary modifications have the additional cardiovascular advantage of lowering plasma total and LDL-cholesterol and raising HDL-cholesterol. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44659?source=see_link\">",
"     \"Antihypertensive drugs and lipids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     DASH trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;A different approach was evaluated in the Dietary Approaches to Stop Hypertension (DASH) trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/6\">",
"     6",
"    </a>",
"    ]. Rather than evaluating sodium intake or weight loss, DASH randomly assigned 459 patients with blood pressures of less than",
"    <span class=\"nowrap\">",
"     160/80-95",
"    </span>",
"    mmHg to one of three diets:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A control diet low in fruits, vegetables, and legumes, and high in snacks, sweets, meats, and saturated fat.",
"     </li>",
"     <li>",
"      A diet rich in fruits, vegetables, legumes, and low in snacks and sweets.",
"     </li>",
"     <li>",
"      A combination diet rich in fruits, vegetables, legumes, and low-fat dairy products and low in snacks, sweets, meats, and saturated and total fat (this combination diet is called the &ldquo;DASH diet&rdquo;). The DASH diet is comprised of four-five servings of fruit, four-five servings of vegetables, two-three servings of low-fat dairy per day, and &lt;25 percent fat.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following observations were noted in which the blood pressure reductions were expressed in relation to the fall in blood pressure seen with the control diet:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The fruits and vegetables diet reduced the blood pressure by",
"      <span class=\"nowrap\">",
"       2.8/1.1",
"      </span>",
"      mmHg and the combination diet reduced the blood pressure by",
"      <span class=\"nowrap\">",
"       5.5/3.0.",
"      </span>",
"     </li>",
"     <li>",
"      These effects were more pronounced in patients with hypertension. With the combination diet, for example, the blood pressure fell",
"      <span class=\"nowrap\">",
"       11.4/5.5",
"      </span>",
"      mmHg in hypertensives versus",
"      <span class=\"nowrap\">",
"       3.5/2.1",
"      </span>",
"      mmHg in the normotensives.",
"     </li>",
"     <li>",
"      The antihypertensive effects were maximal by the end of week two with any of the diets and were then maintained for eight weeks.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Low sodium DASH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The low sodium DASH trial evaluated the effect of varying sodium intake in combination with consuming the DASH diet described above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/7\">",
"     7",
"    </a>",
"    ]. In this study, 412 participants were randomly assigned to a control or DASH diet and, within each diet, ate foods with three levels of sodium content (3.5, 2.3, and 1.2 g) for 30 days each. The following results were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Independent of sodium intake, the DASH diet resulted in significantly lower systolic and diastolic blood pressure levels than the control diet. With the high, intermediate, and low sodium intakes, the systolic pressure was 5.9, 5.0, and 2.2 mmHg lower with the DASH diet than with the control diet, respectively. Comparable values for the diastolic pressure were 2.9, 2.5, and 1.0 mmHg lower with the DASH diet.",
"     </li>",
"     <li>",
"      With either diet, lowering the sodium intake reduced blood pressure levels, an effect observed among those with and without hypertension, and among different races and gender.",
"     </li>",
"     <li>",
"      When different phases of diet were compared, the most significant decrease in blood pressure was observed between the",
"      <strong>",
"       high",
"      </strong>",
"      sodium control diet and",
"      <strong>",
"       low",
"      </strong>",
"      sodium DASH diets, as a comparative overall reduction of 8.9 and 4.5 mmHg in systolic and diastolic blood pressures, respectively, was noted with the low sodium DASH diet. This benefit was even more significant among hypertensive individuals. The mean fall in systolic blood pressure was 11.5 mmHg.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, the combination of a low sodium and DASH diet resulted in the most significant benefit, with decreases in blood pressure comparable to those observed with antihypertensive agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     PREMIER trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;The PREMIER trial was designed to assess the additive blood pressure effects of two different behavioral interventions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/8\">",
"     8",
"    </a>",
"    ]. In this study, 810 patients with above optimal blood pressure (120 to 159 mmHg systolic pressure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    80 to 95 mmHg diastolic pressure) were randomly assigned to one of three groups: 1) \"established behavioral intervention\" (eg, weight loss, physical activity, and limitations in sodium and alcohol intake), 2) the DASH diet plus \"established behavioral intervention\", and 3) one-time advice only. Unlike the original DASH study, the subjects prepared their own food. To assess the effects on blood pressure of the interventions, the effect of advice only",
"    <span class=\"nowrap\">",
"     (6.6/3.8",
"    </span>",
"    mmHg decrease) was subtracted from the blood pressure change in the intervention groups.",
"   </p>",
"   <p>",
"    At six months, the DASH diet plus behavioral intervention produced a small additional decrease in blood pressure versus that observed with behavioral intervention alone",
"    <span class=\"nowrap\">",
"     (4.3/2.6",
"    </span>",
"    mmHg and",
"    <span class=\"nowrap\">",
"     3.7/1.7",
"    </span>",
"    mmHg, respectively). The prevalence of mild hypertension at study end was significantly less in the two intervention groups (12 and 17 percent in DASH plus established and established group, respectively) than in the advice only arm (26 percent). At 18-month follow-up, the prevalence of hypertension had increased in all three groups but remained lowest in the two intervention groups (22 and 24 percent in DASH plus established and established group, respectively, versus 32 percent in the advice only) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Prevention'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Overall, the absolute effects on blood pressure of DASH plus those of behavioral intervention were not additive. Possible reasons for this less than expected effect of the DASH diet included the requirement that the subjects prepared their own food, so there was less rigorous adherence to the diet than in the other DASH studies where all the food was provided: a large blood pressure decrease in the advice only control group, and a possible similar physiologic mechanism for blood pressure lowering for both interventions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Diet versus antihypertensive agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are limited data concerning the relative efficacy of lifestyle interventions (particularly diet) versus antihypertensive agents on blood pressure control or cardiovascular outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite this absence of evidence of relative effectiveness, we and most experts feel that diet plays an important role in many susceptible patients in the genesis and maintenance of hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SALT RESTRICTION AND WEIGHT REDUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential beneficial effects of salt restriction and, in overweight patients, weight reduction in hypertensive patients are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/35/24120?source=see_link\">",
"     \"Salt intake, salt restriction, and essential hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/52/34630?source=see_link\">",
"     \"Obesity and weight reduction in hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     OTHER DIETARY INTERVENTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potassium supplements, 40 to 80",
"    <span class=\"nowrap\">",
"     meq/day,",
"    </span>",
"    lower blood pressure, an effect that is largely lost in patients who are also on a low sodium diet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/12\">",
"     12",
"    </a>",
"    ]. Other modalities, such as stress reduction and supplements of calcium, magnesium, or fish oil, appear to induce a small and less predictable reduction in blood pressure in most patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Potassium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potassium supplementation may modestly lower the blood pressure. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/48/13060?source=see_link\">",
"     \"Potassium and hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Fish oil",
"    </span>",
"    &nbsp;&mdash;&nbsp;High dose, but not low dose, fish oil supplements may reduce systemic blood pressure (BP) by up to",
"    <span class=\"nowrap\">",
"     6/4",
"    </span>",
"    mmHg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. A metaregression analysis of 36 trials of fish oil, of which 22 had a double-blind design, found that the intake of a median dose of 3.7",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    of fish oil provided statistically significant reductions of both systolic and diastolic pressures",
"    <span class=\"nowrap\">",
"     (2.1/1.6",
"    </span>",
"    mmHg) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The long-term safety of fish oil in doses high enough to lower the blood pressure are at present unknown. Potential toxicities include a bleeding tendency due to prolongation of the bleeding time, a possible decline in renal function due to decreased production of the renal vasodilator prostaglandin E2, eructations, the sensation of a fishy taste, and a possible deleterious effect on lipid metabolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/16,19\">",
"     16,19",
"    </a>",
"    ]. These considerations plus the generally modest antihypertensive effect argue against the routine use of fish oil supplements.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Fish intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fish intake in combination with weight loss may have additive effects on blood pressure reduction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. In one 16 week randomized trial, fish intake plus weight loss was associated with a reduction in blood pressure from",
"    <span class=\"nowrap\">",
"     133/77",
"    </span>",
"    mmHg to",
"    <span class=\"nowrap\">",
"     119/68",
"    </span>",
"    mmHg, twice that observed with either intervention alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Calcium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there appears to be an inverse relation between dietary calcium intake and BP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/23\">",
"     23",
"    </a>",
"    ], both dietary calcium and calcium supplements have a relatively small effect on BP. This was illustrated in a meta-analysis including all 40 randomized controlled trials available up to June 2003 relating to the relationship between hypertension and either dietary (dairy) or nondietary supplements of calcium, which found a reduction in BP of",
"    <span class=\"nowrap\">",
"     1.86/0.99",
"    </span>",
"    mmHg, with a trend toward larger effects in those with low baseline calcium intake [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effect of supplemental calcium on blood pressure is too small to recommend the use of calcium supplements for the therapy or prevention of hypertension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     High fiber diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;A higher intake of dietary fiber is associated with decreased systemic pressures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/25\">",
"     25",
"    </a>",
"    ]. Multiple meta-analyses have shown benefits with dietary fiber intake on blood pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. As an example, a 2005 meta-analysis of 24 randomized placebo-controlled trials published between 1966 and 2003 on the effects of fiber supplementation found an average fall of",
"    <span class=\"nowrap\">",
"     1.2/1.3",
"    </span>",
"    mmHg with fiber intake (average dose of 11.5",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/25\">",
"     25",
"    </a>",
"    ]. More significant reductions were observed in older (greater than 40 years) and hypertensive individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Protein intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soy (vegetable) or dairy protein intake may reduce blood pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/27-31\">",
"     27-31",
"    </a>",
"    ]. As an example, one study randomly assigned 302 Chinese subjects with untreated hypertension (systolic blood pressure between 130 to 159 mmHg) to soybean protein or carbohydrate complex control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/29\">",
"     29",
"    </a>",
"    ]. After 12 weeks, systolic and diastolic blood pressures were 4.3 and 2.8 mmHg lower among those taking the protein supplement compared to the control group. There was a greater effect among those with hypertension at baseline (blood pressure",
"    <span class=\"nowrap\">",
"     &gt;140/90",
"    </span>",
"    mmHg).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Folate",
"    </span>",
"    &nbsp;&mdash;&nbsp;An inverse association of folate intake with blood pressure or hypertension has been shown in three large prospective cohort studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/32,33\">",
"     32,33",
"    </a>",
"    ], as well as in several randomized trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. In a meta-analysis of 12 randomized trials, supplemental",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    (5",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    or more) significantly reduced systolic, but not diastolic, blood pressure by 2.0 mmHg as compared with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Flavonoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The beneficial effect of fruits and vegetables on blood pressure may be due in part to an increased intake of polyphenols (eg, flavonoids). Significant sources of these compounds in Western countries include tea and cocoa products. The effect of cocoa on blood pressure was evaluated in a 2012 Cochrane meta-analysis of 20 studies consisting of 856 subjects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/37\">",
"     37",
"    </a>",
"    ]. At a median duration of intake of 4.4 weeks, flavanol-rich cocoa products significantly reduced both systolic and diastolic pressure compared with placebo (mean reduction,",
"    <span class=\"nowrap\">",
"     2.8/2.2",
"    </span>",
"    mmHg). A discussion of blood pressure and tea ingestion is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/30/38375?source=see_link&amp;anchor=H6#H6\">",
"     \"Cardiovascular effects of caffeine\", section on 'Blood pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary and lifestyle modifications have been evaluated in a number of studies for the prevention rather than treatment of hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/17,38-44\">",
"     17,38-44",
"    </a>",
"    ]. As illustrated by the following observations, the optimal effect on blood pressure is achieved with correction of multiple contributors to hypertension, including salt intake, obesity, and excess alcohol intake. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/35/24120?source=see_link\">",
"     \"Salt intake, salt restriction, and essential hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/52/34630?source=see_link\">",
"     \"Obesity and weight reduction in hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/33/31258?source=see_link&amp;anchor=H8#H8\">",
"     \"Cardiovascular benefits and risks of moderate alcohol consumption\", section on 'Hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The relative efficacy of such interventions can be illustrated by the results of two randomized trials and a large observational study:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Trials of Hypertension Prevention, phase II randomized 2382 men and women (aged 30 to 54) with a BP",
"      <span class=\"nowrap\">",
"       &lt;140/83-89",
"      </span>",
"      who were 110 to 165 percent of ideal body weight [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/38\">",
"       38",
"      </a>",
"      ]. The patients were randomly assigned to usual care, salt restriction, weight reduction, or both. Sodium restriction was associated with a 50 and 40 meq decline in sodium intake and a 4.4 and 2.0 kg weight reduction at 6 and 36 months, respectively. Compared with usual care, the BP fell at six months by",
"      <span class=\"nowrap\">",
"       3.7/2.7",
"      </span>",
"      with weight loss,",
"      <span class=\"nowrap\">",
"       2.9/1.6",
"      </span>",
"      with salt restriction, and",
"      <span class=\"nowrap\">",
"       4.0/2.0",
"      </span>",
"      with combined therapy. These effects were attenuated at 36 months but, at 48 months, the likelihood of progressing to hypertension was reduced with nonpharmacologic therapy (relative risk 0.78 to 0.82).",
"     </li>",
"     <li>",
"      The TONE trial evaluated 975 older persons (aged 60 to 80) who had a BP",
"      <span class=\"nowrap\">",
"       &lt;145/&lt;85",
"      </span>",
"      mmHg on one antihypertensive medication; 585 were obese [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/39\">",
"       39",
"      </a>",
"      ]. The patients were randomly assigned to usual care or to salt restriction, weight loss (in obese patients), or both. Those assigned to salt restriction had a 40",
"      <span class=\"nowrap\">",
"       meq/day",
"      </span>",
"      decrease in sodium excretion while, in obese patients, a regimen of diminished caloric intake and increased physical activity was associated with a persistent weight loss of 4 to 5 kg; these parameters were unchanged in the usual care group. After three months of intervention, withdrawal of the antihypertensive drug was attempted.",
"      <br/>",
"      <br/>",
"      The primary end point was a diagnosis of high blood pressure at one or more follow-up visits, treatment with antihypertensive drugs, or a cardiovascular event. The reduction in blood pressure compared to usual care were",
"      <span class=\"nowrap\">",
"       2.6/1.1",
"      </span>",
"      mmHg with salt restriction,",
"      <span class=\"nowrap\">",
"       3.2/0.3",
"      </span>",
"      mmHg with weight loss, and",
"      <span class=\"nowrap\">",
"       4.5/2.6",
"      </span>",
"      mmHg with combined therapy. The primary end point at 30 months occurred significantly less often with salt restriction (62 verus 76 percent with usual care), weight reduction in obese subjects (61 versus 74 percent), and combined salt restriction and weight reduction in obese subjects (56 versus 84 percent).",
"     </li>",
"     <li>",
"      The importance of risk factors for essential hypertension in women was evaluated in a prospective cohort study of 83,882 adult women from the second Nurses' Health Study who did not have a history of hypertension, cardiovascular disease, or diabetes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/40\">",
"       40",
"      </a>",
"      ]. Six lifestyle and dietary factors were independently associated with a lower risk of developing hypertension during 14 years of follow-up: body mass index of less than 25",
"      <span class=\"nowrap\">",
"       kg/m2,",
"      </span>",
"      a daily mean of 30 minutes of vigorous exercise, adherence to the DASH diet, modest alcohol intake, infrequent use of nonnarcotic analgesics, and intake of 400",
"      <span class=\"nowrap\">",
"       microg/d",
"      </span>",
"      or more of folate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/43/42679/abstract/40\">",
"       40",
"      </a>",
"      ]. The presence of all six factors was associated with a marked decrease in the risk for hypertension (hazard ratio of 0.22 [95% CI 0.10-0.51]).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/56/40835?source=see_link\">",
"       \"Patient information: Controlling your blood pressure through lifestyle (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/8/9347?source=see_link\">",
"       \"Patient information: High blood pressure, diet, and weight (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are limited data concerning the relative efficacy of lifestyle interventions (particularly diet) versus antihypertensive agents on blood pressure control or cardiovascular outcomes. Despite this absence of evidence of relative effectiveness, we and most experts feel that diet plays an important role in many susceptible patients in the genesis and maintenance of hypertension. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Comprehensive dietary modification'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      High dose, but not low dose, fish oil supplements may reduce systemic blood pressure (BP) but the long-term safety of fish oil in doses high enough to lower the blood pressure are unknown. Fish intake in combination with weight loss may have additive effects on blood pressure reduction. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Fish oil'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dietary calcium and calcium supplements have a relatively small effect on BP. The effect of supplemental calcium on blood pressure is too small to recommend the use of calcium supplements for the therapy or prevention of hypertension. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Calcium'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dietary interventions that may be associated with reduced blood pressure include dietary fiber, soy (vegetable) or dairy protein intake, folate, and possibly polyphenols (eg, flavonoids). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Other dietary interventions'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/30/38375?source=see_link&amp;anchor=H6#H6\">",
"       \"Cardiovascular effects of caffeine\", section on 'Blood pressure'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dietary and lifestyle modifications have been evaluated in a number of studies for the prevention rather than treatment of hypertension. The optimal effect on blood pressure is achieved with correction of multiple contributors to hypertension, including salt intake, obesity, and excess alcohol intake. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/35/24120?source=see_link\">",
"       \"Salt intake, salt restriction, and essential hypertension\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/52/34630?source=see_link\">",
"       \"Obesity and weight reduction in hypertension\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/33/31258?source=see_link&amp;anchor=H8#H8\">",
"       \"Cardiovascular benefits and risks of moderate alcohol consumption\", section on 'Hypertension'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/1\">",
"      Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/2\">",
"      Bavikati VV, Sperling LS, Salmon RD, et al. Effect of comprehensive therapeutic lifestyle changes on prehypertension. Am J Cardiol 2008; 102:1677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/3\">",
"      Sacks FM, Campos H. Dietary therapy in hypertension. N Engl J Med 2010; 362:2102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/4\">",
"      Stamler R, Stamler J, Grimm R, et al. Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program. JAMA 1987; 257:1484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/5\">",
"      Neaton JD, Grimm RH Jr, Prineas RJ, et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993; 270:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/6\">",
"      Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/7\">",
"      Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/8\">",
"      Appel LJ, Champagne CM, Harsha DW, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003; 289:2083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/9\">",
"      Elmer PJ, Obarzanek E, Vollmer WM, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006; 144:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/10\">",
"      Pickering TG. Lifestyle modification and blood pressure control: is the glass half full or half empty? JAMA 2003; 289:2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/11\">",
"      Nicolson DJ, Dickinson HO, Campbell F, Mason JM. Lifestyle interventions or drugs for patients with essential hypertension: a systematic review. J Hypertens 2004; 22:2043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/12\">",
"      He FJ, MacGregor GA. Fortnightly review: Beneficial effects of potassium. BMJ 2001; 323:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/13\">",
"      Kotchen TA, McCarron DA. Dietary electrolytes and blood pressure: a statement for healthcare professionals from the American Heart Association Nutrition Committee. Circulation 1998; 98:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/14\">",
"      John JH, Ziebland S, Yudkin P, et al. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002; 359:1969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/15\">",
"      Stamler J, Liu K, Ruth KJ, et al. Eight-year blood pressure change in middle-aged men: relationship to multiple nutrients. Hypertension 2002; 39:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/16\">",
"      Knapp HR, FitzGerald GA. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med 1989; 320:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/17\">",
"      The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA 1992; 267:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/18\">",
"      B&oslash;naa KH, Bjerve KS, Straume B, et al. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Troms&oslash; study. N Engl J Med 1990; 322:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/19\">",
"      Kasim SE, Stern B, Khilnani S, et al. Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients. J Clin Endocrinol Metab 1988; 67:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/20\">",
"      Geleijnse JM, Giltay EJ, Grobbee DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002; 20:1493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/21\">",
"      Mori TA, Burke V, Puddey IB, et al. Effect of fish diets and weight loss on serum leptin concentration in overweight, treated-hypertensive subjects. J Hypertens 2004; 22:1983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/22\">",
"      Bao DQ, Mori TA, Burke V, et al. Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension 1998; 32:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/23\">",
"      Power ML, Heaney RP, Kalkwarf HJ, et al. The role of calcium in health and disease. Am J Obstet Gynecol 1999; 181:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/24\">",
"      Griffith LE, Guyatt GH, Cook RJ, et al. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens 1999; 12:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/25\">",
"      Streppel MT, Arends LR, van 't Veer P, et al. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med 2005; 165:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/26\">",
"      Whelton SP, Hyre AD, Pedersen B, et al. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens 2005; 23:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/27\">",
"      Appel LJ, Sacks FM, Carey VJ, et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005; 294:2455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/28\">",
"      Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999; 6:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/29\">",
"      He J, Gu D, Wu X, et al. Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann Intern Med 2005; 143:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/30\">",
"      He J, Wofford MR, Reynolds K, et al. Effect of dietary protein supplementation on blood pressure: a randomized, controlled trial. Circulation 2011; 124:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/31\">",
"      Teunissen-Beekman KF, Dopheide J, Geleijnse JM, et al. Protein supplementation lowers blood pressure in overweight adults: effect of dietary proteins on blood pressure (PROPRES), a randomized trial. Am J Clin Nutr 2012; 95:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/32\">",
"      Forman JP, Rimm EB, Stampfer MJ, Curhan GC. Folate intake and the risk of incident hypertension among US women. JAMA 2005; 293:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/33\">",
"      Xun P, Liu K, Loria CM, et al. Folate intake and incidence of hypertension among American young adults: a 20-y follow-up study. Am J Clin Nutr 2012; 95:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/34\">",
"      van Dijk RA, Rauwerda JA, Steyn M, et al. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 2001; 21:2072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/35\">",
"      Mangoni AA, Sherwood RA, Swift CG, Jackson SH. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Intern Med 2002; 252:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/36\">",
"      McRae MP. High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials. J Chiropr Med 2009; 8:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/37\">",
"      Ried K, Sullivan TR, Fakler P, et al. Effect of cocoa on blood pressure. Cochrane Database Syst Rev 2012; 8:CD008893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/38\">",
"      Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med 1997; 157:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/39\">",
"      Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998; 279:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/40\">",
"      Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA 2009; 302:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/41\">",
"      He J, Whelton PK, Appel LJ, et al. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000; 35:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/42\">",
"      Stamler R, Stamler J, Gosch FC, et al. Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial. JAMA 1989; 262:1801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/43\">",
"      Takahashi Y, Sasaki S, Okubo S, et al. Blood pressure change in a free-living population-based dietary modification study in Japan. J Hypertens 2006; 24:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42679/abstract/44\">",
"      Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002; 288:1882.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3878 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-1.234.2.38-C3DAD56939-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42679=[""].join("\n");
var outline_f41_43_42679=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      COMPREHENSIVE DIETARY MODIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TOMHS study",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DASH trial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Low sodium DASH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PREMIER trial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Diet versus antihypertensive agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SALT RESTRICTION AND WEIGHT REDUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      OTHER DIETARY INTERVENTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Potassium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Fish oil",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Fish intake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Calcium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      High fiber diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Protein intake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Folate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Flavonoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3878\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3878|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/45/27357\" title=\"figure 1\">",
"      Dietary modification in HTN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?17/57/18334\" title=\"figure 2\">",
"      Compliance with diet in HTN",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44659?source=related_link\">",
"      Antihypertensive drugs and lipids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/33/31258?source=related_link\">",
"      Cardiovascular benefits and risks of moderate alcohol consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/30/38375?source=related_link\">",
"      Cardiovascular effects of caffeine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/2998?source=related_link\">",
"      Exercise in the treatment and prevention of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/52/34630?source=related_link\">",
"      Obesity and weight reduction in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/56/40835?source=related_link\">",
"      Patient information: Controlling your blood pressure through lifestyle (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/8/9347?source=related_link\">",
"      Patient information: High blood pressure, diet, and weight (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/48/13060?source=related_link\">",
"      Potassium and hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/35/24120?source=related_link\">",
"      Salt intake, salt restriction, and essential hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/20/3395?source=related_link\">",
"      Smoking and hypertension",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_43_42680="Clinical manifestations and diagnosis of prosthetic joint infections";
var content_f41_43_42680=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of prosthetic joint infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42680/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42680/contributors\">",
"     Elie Berbari, MD, FIDSA",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42680/contributors\">",
"     Larry M Baddour, MD, FIDSA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42680/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42680/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42680/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42680/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/43/42680/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology, clinical manifestations, microbiology, and diagnosis of prosthetic joint infections (PJIs) will be reviewed here. Infections associated with other implanted orthopedic devices, such as pins and rods, will not be specifically discussed, but similar principles may apply [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment and prevention of PJIs are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/19/6457?source=see_link\">",
"     \"Treatment of prosthetic joint infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/34/28198?source=see_link\">",
"     \"Prevention of prosthetic joint infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nearly one million total hip arthroplasties (THA) or total knee arthroplasties (TKA) are performed in the United States each year. It is estimated that by 2030, more than four million THA or TKA will be performed in the United States annually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rate of prosthetic joint infection (PJI) in most centers ranges between 0.5 to 1.0 percent for hip replacements, 0.5 to 2 percent for knee replacements, and less than 1 percent for shoulder replacements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/1,3-5\">",
"     1,3-5",
"    </a>",
"    ]. In a study involving over 69,000 patients undergoing elective total knee arthroplasty followed longitudinally from 1997 to 2006, the rate of infection was highest during the first two years following surgery (incidence 1.5 percent). The rate of infection 2 to 10 years after joint replacement was 0.5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/6\">",
"     6",
"    </a>",
"    ]. Depending on the type of surgical procedure, causative pathogen, and comorbid conditions, upwards of 10 to 20 percent of patients experience recurrent PJI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21069092\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a retrospective study evaluating 462 cases of prosthetic hip or knee infection, the major risk factor associated with infection was superficial surgical site infection (odds ratio [OR] 35.9). Other risk factors included presence of systemic or joint malignancy (OR 3.1), prior joint arthroplasty (OR 2.0) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/4\">",
"     4",
"    </a>",
"    ], or National Nosocomial Infections Surveillance System surgical patient risk index score of 1 or 2 (OR 1.7 and 3.9, respectively).",
"   </p>",
"   <p>",
"    Additional risk factors for PJI include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/6,9,10\">",
"     6,9,10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rheumatoid arthritis or other immunocompromised conditions",
"     </li>",
"     <li>",
"      Perioperative and post nonarticular infections",
"     </li>",
"     <li>",
"      Prior infection of the joint or adjacent bone",
"     </li>",
"     <li>",
"      Prior surgery on the joint",
"     </li>",
"     <li>",
"      Prolonged duration of surgery",
"     </li>",
"     <li>",
"      High body mass index (BMI)",
"     </li>",
"     <li>",
"      Postoperative bleeding hematoma formation",
"     </li>",
"     <li>",
"      Advanced age",
"     </li>",
"     <li>",
"      Diabetes mellitus",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a case-control study including 126 patients with PJI matched with uninfected controls, the following risk factors were identified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bacteremia during the previous year (OR 4.25; 95% CI 1.3-3.8)",
"     </li>",
"     <li>",
"      Nonsurgical trauma to the prosthetic joint (OR 21.4; 95% CI 2.6-175.2)",
"     </li>",
"     <li>",
"      Early-onset surgical site infection (OR 5.25; 95% CI 1.7-16.7)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nasal colonization with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/15/8437?source=see_link\">",
"     oxacillin",
"    </a>",
"    -susceptible Staphylococcus aureus or methicillin-resistant S. aureus (MRSA) has been associated with an increased risk of S. aureus surgical site infection following joint prosthesis implantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factors that appear to reduce the rate of PJI include shorter duration of surgery, prophylactic antibiotics given within 60 minutes of the surgical incision, S. aureus decolonization, use of antibiotic-impregnated methylmethacrylate fixation cement, preoperative",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/36/12870?source=see_link\">",
"     chlorhexidine",
"    </a>",
"    wash, and directed laminar airflow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21069313\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of prosthetic joint infections (PJIs) depend on the onset of symptoms: early, delayed, and late onset. Early and delayed infections are mostly acquired during implantation, whereas late infections are primarily due to hematogenous seeding. In one review of 63 consecutive infections associated with hip prostheses, these types of infections occurred with approximately equal frequency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/14\">",
"     14",
"    </a>",
"    ]. The timing of infection is also an important clue as to the identity of the infecting organism, as discussed in the following sections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/15-20\">",
"     15-20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21070478\">",
"    <span class=\"h2\">",
"     Early onset infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early onset infections (&lt;3 months after surgery) are usually acquired during implantation; they are often due to relatively virulent pathogens, such as S. aureus, gram-negative bacilli, or anaerobic or polymicrobial infection. Early onset infection can also arise in the setting of postoperative wound dehiscence with contiguous spread of organisms from the superficial wound to the deeper structures.",
"   </p>",
"   <p>",
"    Most early onset infections present with the acute onset of one or more of the following symptoms: wound drainage, implant site erythema, induration or edema, joint pain, joint effusion, or fever. These infections are frequently associated with hematoma formation or superficial necrosis of the incision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21070485\">",
"    <span class=\"h2\">",
"     Delayed onset infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delayed onset infections (from 3 to 12 months after surgery) are also usually acquired during implantation; they are often due to less virulent pathogens, such as Propionibacterium species, coagulase-negative staphylococci, or enterococci [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most delayed onset infections present with a prolonged indolent course characterized primarily by persistent joint pain, with or without early implant loosening. A minority of patients have signs and symptoms associated with early onset infection. Fever is present in less than 50 percent of cases, and leukocytosis occurs in only 10 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/22\">",
"     22",
"    </a>",
"    ]. Sinus tract associated with intermittent drainage can be seen when the diagnosis is delayed or in untreated patients. Delayed-onset infections may be difficult to distinguish from aseptic failure of the prosthetic joint [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/15,23\">",
"     15,23",
"    </a>",
"    ]. Persistent joint pain is suggestive of infection, whereas mechanical loosening commonly causes pain with joint motion and weight bearing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21070504\">",
"    <span class=\"h2\">",
"     Late onset infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Late-onset infections (&gt;12 months after surgery) frequently develop hematogenously in the setting of infection at another site (such as vascular catheter, urinary tract, or soft tissue infection) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/24\">",
"     24",
"    </a>",
"    ]. In such cases, patients typically present with acute onset of symptoms of infection in a previously well-functioning joint. It is not always possible to determine whether a PJI arose hematogenously, even if the onset of symptoms is acute.",
"   </p>",
"   <p>",
"    In one study involving 50 cases of acute hematogenous PJI, the median onset time after surgery was nearly five years; a distant source for the infection could be identified in approximately one-half of the cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/25\">",
"     25",
"    </a>",
"    ]. Most hematogenous infections are due to S. aureus, beta-hemolytic streptococci, or gram-negative bacilli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/25\">",
"     25",
"    </a>",
"    ]. In a prospective study of 44 patients with prosthetic joints and staphylococcal bacteremia, PJI occurred in 34 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21069582\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29479717\">",
"    <span class=\"h2\">",
"     Pathogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;The timing of infection is an important clue as to the identity of the infecting organism, as discussed in the preceding section. Early- and late-onset infections are often due to relatively virulent pathogens, such as S. aureus or gram-negative bacilli. Delayed onset infections are often due to less virulent pathogens, such as Propionibacterium species and coagulase-negative staphylococci. One review noted the following distribution of microorganisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Staphylococcus aureus &mdash; 22 percent",
"     </li>",
"     <li>",
"      Coagulase-negative staphylococci &mdash; 19 percent",
"     </li>",
"     <li>",
"      Mixed infection &mdash; 19 percent",
"     </li>",
"     <li>",
"      Beta-hemolytic Streptococci &mdash; 9 percent",
"     </li>",
"     <li>",
"      Aerobic Gram Negative Bacilli &mdash; 8 percent",
"     </li>",
"     <li>",
"      Anaerobes &mdash; 6 percent",
"     </li>",
"     <li>",
"      No organisms detected &mdash; 12 percent",
"     </li>",
"     <li>",
"      Other organisms &mdash; 5 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The type of pathogen also varies with the site of implanted joint and underlying comorbidities. For example, Propionibacterium acnes is relatively more common after shoulder arthroplasty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/27\">",
"     27",
"    </a>",
"    ], whereas S. aureus prosthetic joint infection (PJI) is more common in patients with rheumatoid arthritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    S. aureus small colony variants (SCVs) have been identified in some cases of PJIs after treatment failure with standard antimicrobial regimens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/29\">",
"     29",
"    </a>",
"    ]. SCVs are naturally occurring, slow-growing subpopulations of S. aureus with distinctive phenotypic characteristics and pathogenic traits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/30\">",
"     30",
"    </a>",
"    ]. These strains appear to emerge in patients initially infected with normally growing S. aureus. The cause of infection in these cases can be difficult to identify due to the slow growth of SCVs; in some cases, these organisms have an auxotrophic phenotype (eg, a requirement for specific nutritional substances to restore the normal growth rate) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Species identification of coagulase-negative staphylococci in the setting with PJIs is not routinely performed, but may be useful in some circumstances. For example, S. lugdunensis is a coagulase-negative staphylococcus that shares some aspects of virulence with S. aureus but is commonly susceptible to beta-lactam antibiotics, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/15/8437?source=see_link\">",
"     oxacillin",
"    </a>",
"    . In a review of 28 episodes of S. lugdunensis PJI, 24 of 28 isolates demonstrated in vitro susceptibility to oxacillin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/3/12344?source=see_link\">",
"     \"Staphylococcus lugdunensis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Propionibacterium acnes is a relatively common cause of PJI following shoulder arthroplasty (16 percent in one study) but is a rare cause of infection following hip or knee arthroplasty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/5\">",
"     5",
"    </a>",
"    ]. In a retrospective case series of 35 patients with definite or probable P. acnes orthopedic infection, 57 percent became symptomatic &le;30 days after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/33\">",
"     33",
"    </a>",
"    ]. In another case-control study involving 40 patients with PJIs due to Propionibacterium species, prior joint surgery and male gender were independent risk factors for infection (OR 28 and 7, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mycobacterium tuberculosis and rapidly growing mycobacteria are rare causes of PJIs. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/25/5530?source=see_link&amp;anchor=H9#H9\">",
"     \"Rapidly growing mycobacterial infections in HIV-negative patients\", section on 'Prosthetic device infection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/49/37656?source=see_link&amp;anchor=H6350127#H6350127\">",
"     \"Skeletal tuberculosis\", section on 'Prosthetic joint infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A small proportion of patients with clinical signs and symptoms of PJI remain culture-negative and require empiric therapy. Among 897 patients with PJIs in one series, 7 percent were culture-negative. The majority (64 percent) of these patients had received antibiotics prior to the collection of specimens for culture. Outcomes following empiric treatment were similar to outcomes among patients with positive cultures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Biofilm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Susceptibility to infection is enhanced in the setting of a foreign body due to opportunity for formation of a biofilm. Attachment of bacteria to a solid surface is a critical first step in the pathogenesis of foreign body-associated infections. In experimental models, a subcutaneous foreign body reduced the inoculum of S. aureus required to induce infection by more than 100,000-fold to as little as 100 colony-forming units [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/35\">",
"     35",
"    </a>",
"    ]. In addition, the interaction of neutrophils with the foreign body can induce a neutrophil defect that may enhance the susceptibility to infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adherent bacteria multiply and elaborate exopolysaccharides, also known as glycocalyx. Eventually, microcolonies of bacteria encased in glycocalyx coalesce to form a structure known as a biofilm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Although bacteria near the surface of the biofilm are usually metabolically active and have access to nutrients that diffuse through the upper surface of the biofilm, organisms deep within the biofilm are metabolically inactive or in various stages of dormancy, and are protected from host defenses, such as phagocytes. Such organisms are typically highly resistant to antimicrobial agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/37\">",
"     37",
"    </a>",
"    ]. The microenvironment within a biofilm may also adversely affect mechanisms involved in antimicrobial activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/38\">",
"     38",
"    </a>",
"    ] and diffusion of antimicrobial agents through biofilm is often slow or limited.",
"   </p>",
"   <p>",
"    The resistance of bacteria to antimicrobial agents within biofilm is a time-dependent phenomenon. Soon after a biofilm is established, the susceptibility of bacteria to antimicrobial agents often demonstrates a logarithmic decline. One study of P. aeruginosa susceptibility in the setting of adherence to a solid surface showed that bacteria in biofilm less than seven days old remained sensitive to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/35/34352?source=see_link\">",
"     tobramycin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/13/35030?source=see_link\">",
"     piperacillin",
"    </a>",
"    , while the same organism growing in a biofilm more than seven days old had become highly resistant to the same agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Biofilm plays an important role in the following characteristics of PJIs:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The frequent observation that antimicrobial therapy results in a clinical response followed by a relapse within days or months of stopping therapy unless the prosthesis is removed",
"     </li>",
"     <li>",
"      The propensity of PJIs to become manifest weeks or months after surgery",
"     </li>",
"     <li>",
"      The failure of long courses of suppressive antimicrobial therapy in the majority of patients unless the prosthesis has been removed",
"     </li>",
"     <li>",
"      The occasional success of long-term suppressive therapy with low doses of oral antimicrobial agents",
"     </li>",
"     <li>",
"      Difficulty in demonstrating pathogens in aspirates of infected joints in patients with indolent, late-onset PJIs",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prosthetic joint infection (PJI) should be suspected in the following settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/40\">",
"     40",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sinus tract or persistent wound drainage at the site of a joint prosthesis",
"     </li>",
"     <li>",
"      Acute onset of pain at the site of a joint prosthesis",
"     </li>",
"     <li>",
"      Chronic pain at the site of a joint prosthesis, particularly in the absence of a pain-free interval following implantation",
"     </li>",
"     <li>",
"      History of superficial or deep infection or prior wound healing problems",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    PJI must be differentiated from aseptic and mechanical problems, including hemarthrosis, gout, aseptic loosening, dislocation, metallic debris-induced synovitis, and osteolysis. Early onset constant joint pain is suggestive of infection, whereas mechanical loosening commonly causes pain only with joint motion and weight bearing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tools for diagnosis of PJI include plain radiography, laboratory testing for inflammatory markers, synovial fluid evaluation, and tissue biopsy. In general, analysis of joint fluid (with cell count, Gram stain, and culture) or tissue (with histopathology and culture) are required to establish the diagnosis of PJI, identify the causative organism, and guide choice of antimicrobial therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/4,15,23\">",
"     4,15,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1529200\">",
"    <span class=\"h2\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging studies may be of value, but are usually not diagnostic. In general, plain radiographs should be performed in the setting of suspected PJI, although other studies such as leukocyte scans, positron emission tomography (PET) scans, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, or bone scans are not useful for routine diagnostic evaluation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following plain radiography findings may be observed in the setting of PJI: abnormal lucency larger than 2 mm in width at the bone-cement interface, changes in the position of prosthetic components, cement fractures, periosteal reaction, or motion of components on stress views [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/42\">",
"     42",
"    </a>",
"    ]. These findings are related to the duration of infection; three to six months may be required before manifestation of such changes. In addition, these changes are not specific for infection; they are also seen frequently with aseptic processes.",
"   </p>",
"   <p>",
"    Scintigraphy (such as technetium-colloid scans or gallium-67 labeled white blood cell scans) is rarely useful in early infection; scans may be falsely abnormal for up to 12 months following surgery due to periprosthetic bone remodeling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/43\">",
"     43",
"    </a>",
"    ]. In addition, technetium-colloid scans can be positive in the setting of aseptic loosening. In one report of 144 patients who underwent revision hip arthroplasty, bone gallium imaging offered no additional advantage in diagnosis over hip aspiration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/44\">",
"     44",
"    </a>",
"    ]. Joint aspiration had sensitivity and specificity of 57 and 97 percent; imaging had sensitivity and specificity of 38 and 100 percent. A normal scintigraphy study can be considered evidence against the presence of infection, but a positive study is not definitive for establishing the diagnosis of PJI.",
"   </p>",
"   <p>",
"    In a systematic review of 11 studies evaluating the diagnostic utility of PET for imaging patients with suspected PJIs, the pooled FDG-PET sensitivity and specificity was 82 and 86 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/45\">",
"     45",
"    </a>",
"    ]. The accuracy of PET scan was higher in total hip arthroplasty infection and when criteria for PJI were predetermined.",
"   </p>",
"   <p>",
"    The use of CT scan is limited by imaging artifacts caused by metallic implants, and MRI can only be performed when the implants are safe for this modality, such as those composed of titanium or tantalum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory studies may be of value but are usually not diagnostic. Acute phase reactants, such as the erythrocyte sedimentation rate (ESR) and serum C-reactive protein (CRP), are usually elevated in the setting of PJI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. However, these tests must be interpreted cautiously in patients with coexistent chronic inflammatory rheumatic diseases that can also cause elevated acute phase markers. In general, a normal ESR or serum CRP reduces the likelihood of PJI in the majority of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/47\">",
"     47",
"    </a>",
"    ]. Procalcitonin, another inflammatory marker, has very low sensitivity in the diagnosis of PJI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Synovial fluid and tissue",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of PJI is based on isolation of the pathogen by culture of synovial fluid or tissue, prior to initiation of antimicrobial therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Fluid analysis can also be useful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29479790\">",
"    <span class=\"h3\">",
"     Fluid analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to joint aspiration depends on clinical circumstances. Knee joint aspiration often can be performed at the bedside; hip joint aspiration frequently requires guidance by CT or fluoroscopy. If difficulty is encountered in obtaining intraarticular fluid, irrigation with sterile saline can be used to obtain fluid for culture. Synovial fluid analysis should include a total cell count and differential leukocyte count, Gram stain and culture for aerobic and anaerobic organisms, and analysis for crystals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Analysis of joint fluid often reveals an elevated leukocyte count (mainly polymorphonuclear cells). In three different studies, white blood counts higher than 1100, 1700, or",
"    <span class=\"nowrap\">",
"     4200/mcL",
"    </span>",
"    had sensitivities of 91, 94, and 84 percent with specificities of 88, 88, and 93 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/23,51,52\">",
"     23,51,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evaluation for presence of leukocyte esterase may also be a useful tool for diagnosis of PJI. Preliminary study suggests that use of a relatively inexpensive colorimetric strip that detects presence of leukocyte esterase in synovial fluid is relatively sensitive and specific with excellent positive and negative predictive values (100 and 93 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29479724\">",
"    <span class=\"h3\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Joint fluid culture has been shown to establish the infecting microorganism with sensitivities of 86 to 92 percent and specificities of 82 to 97 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. In general, Gram staining generally is positive in less than one-third of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When feasible, holding antibiotic therapy for at least two weeks prior to obtaining cultures has been proven to improve the sensitivity of the culture results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/34,54,55\">",
"     34,54,55",
"    </a>",
"    ]. At least three cultures should be submitted for aerobic and anaerobic bacterial culture. Submission of fungal or mycobacterial cultures should be reserved to patients at risk for these infections or when aerobic or anaerobic cultures are negative [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/40,48,56,57\">",
"     40,48,56,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Periprosthetic tissue should be submitted for culture at the time of surgical debridement or prosthesis removal, particularly in settings where joint fluid examination is not diagnostically conclusive or in the setting of delayed-onset infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/40\">",
"     40",
"    </a>",
"    ]. Multiple (three to six) specimens should be sent for aerobic and anaerobic culture, to minimize sampling error and to optimize detection of fastidious organisms; tissue culture sensitivity is variable (65 to 94 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/15,47,56,58\">",
"     15,47,56,58",
"    </a>",
"    ]. Intraoperative swab cultures should be avoided given low sensitivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/15,56\">",
"     15,56",
"    </a>",
"    ]. Histopathologic examination frequently demonstrates infiltration of polymorphonuclear cells, indicative of an acute inflammatory reaction, though this parameter is only variably present and may not be specific [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/15,47,58\">",
"     15,47,58",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H211965\">",
"     'Histopathology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Cultures demonstrating an organism of low pathogenicity (such as S. epidermidis, Corynebacterium species, Propionibacterium species, or Bacillus species) should prompt consideration of repeat sampling to confirm the microbiologic diagnosis and rule out the possibility of false positive results due to contamination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/56\">",
"     56",
"    </a>",
"    ]. In the presence of sinus tracts, drainage should be sent for culture, but must be correlated with other data since the culture results may reflect skin flora contamination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/15,47,56\">",
"     15,47,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    False-negative culture results may be observed in the setting of prior antibiotic therapy, a low number of organisms, an inappropriate culture medium, infection with fastidious organisms, and delayed delivery to the microbiology laboratory.",
"   </p>",
"   <p>",
"    The diagnosis of delayed-onset infection can be more challenging than diagnosis of acute infection. In a review of 41 cases, only 65 percent of periprosthetic tissue samples were culture-positive (using histologic examination as the gold standard) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/56\">",
"     56",
"    </a>",
"    ]. Prolonged bacterial culture incubation (eg, for two weeks) may be useful for diagnosis of late-onset PJIs in some circumstances; this approach requires evaluation of multiple surgical specimens and correlation between culture and histopathological findings to distinguish pathogens from contaminants. This was demonstrated in a study of 284 patients with suspected late hip or knee arthroplasty infection; the infection detection rate was 74 percent at seven days of incubation, and 26 percent of positive cultures occurred after seven days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/59\">",
"     59",
"    </a>",
"    ]. The predominant pathogenic organisms that grew in culture after seven days of incubation were Propionibacterium species, Coryneform bacteria, and Peptostreptococci.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H211965\">",
"    <span class=\"h3\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histopathological evaluation of intraoperative periprosthetic tissues frozen section is more useful for predicting a diagnosis of culture-positive joint infection than for ruling out this diagnosis (likelihood ratio [LR] 12.0 [95% CI 8.4-17.2] and LR 0.23 [95% CI 0.15-0.35], respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/60\">",
"     60",
"    </a>",
"    ]. The optimum diagnostic threshold number of polymorphonuclear leukocytes (PMNs) per high-power field required to distinguish PJI from aseptic failure is uncertain; thresholds of 5 to 10 PMNs have been used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8187058\">",
"    <span class=\"h2\">",
"     Blood cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood cultures should be obtained in the setting of fever or acute onset of symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/40\">",
"     40",
"    </a>",
"    ]. Blood cultures should also be obtained in the setting of a condition or concomitant infection that increases the likelihood of bloodstream infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Explant sonication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Organisms associated with PJI often adhere to the prosthesis in the form of a biofilm, as discussed above. Sonication of an explanted prosthesis can improve the yield of microbiologic diagnosis compared with tissue culture, especially in the setting of perioperative antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/55,61,62\">",
"     55,61,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A prospective trial compared culture of samples obtained by sonication of explanted hip and knee prostheses with conventional culture of periprosthetic tissue for microbiologic diagnosis of PJI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/55\">",
"     55",
"    </a>",
"    ]. Of 331 patients with explanted hip or knee prostheses, 252 had aseptic failure and 79 had PJI.",
"   </p>",
"   <p>",
"    Sonicate-fluid cultures had a significantly higher sensitivity for the diagnosis of PJI than periprosthetic tissue culture (79 versus 61 percent) and similar specificity (99 percent for both). A significant increase in sensitivity was also seen in patients who had received antimicrobial therapy within 14 days before surgery (75 versus 45 percent).",
"   </p>",
"   <p>",
"    Although sonication is not routine in many microbiology laboratories, the technique is relatively simple and more widespread use may be warranted with further study. For laboratories that cannot perform sonication, vortexing a resected device is a reasonable alternative [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42680/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/21/18769?source=see_link\">",
"       \"Patient information: Joint infection (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1529866\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The rate of prosthetic joint infection (PJI) in most centers ranges between 0.5 to 1.0 percent for hip replacements, 0.5 to 2.0 percent for knee replacements, and less than 1.0 percent for shoulder replacements. Risk factors for PJI are summarized above. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21069092\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical manifestations of PJIs depend upon the timing of infection: early (less than 3 months after surgery), delayed (3 to 12 months after surgery), and late (more than 12 months after surgery) onset. Early and delayed infections are usually acquired during implantation; late infections are usually due to hematogenous seeding. (See",
"      <a class=\"local\" href=\"#H21069313\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most early and late onset infections present with the acute onset of one or more of the following symptoms: joint pain, joint effusion, wound drainage, fever, and implant site erythema, induration, or edema. Most delayed onset infections present with a prolonged indolent course characterized primarily by persistent joint pain, with or without implant loosening. Constant joint pain is suggestive of infection, whereas mechanical loosening commonly causes pain only with motion and weight bearing. (See",
"      <a class=\"local\" href=\"#H21069313\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early and late onset infections are often due to relatively virulent pathogens such as S. aureus or gram-negative bacilli. Delayed onset infections are often due to less virulent pathogens such as Propionibacterium species and coagulase-negative staphylococci. (See",
"      <a class=\"local\" href=\"#H21069582\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PJI must be differentiated from aseptic and mechanical problems. In general, analysis of joint fluid (with cell count, Gram stain, and culture) or tissue (with biopsy and culture) is required to establish the diagnosis of PJI, identify the causative organism, and guide choice of antimicrobial therapy. Imaging and laboratory studies may be of value but are usually not diagnostic. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/1\">",
"      Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001; 33 Suppl 2:S94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/2\">",
"      Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/3\">",
"      NIH consensus conference: Total hip replacement. NIH Consensus Development Panel on Total Hip Replacement. JAMA 1995; 273:1950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/4\">",
"      Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998; 27:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/5\">",
"      Sperling JW, Kozak TK, Hanssen AD, Cofield RH. Infection after shoulder arthroplasty. Clin Orthop Relat Res 2001; :206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/6\">",
"      Kurtz SM, Ong KL, Lau E, et al. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 2010; 468:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/7\">",
"      Went P, Krismer M, Frischhut B. Recurrence of infection after revision of infected hip arthroplasties. J Bone Joint Surg Br 1995; 77:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/8\">",
"      Hanssen AD, Trousdale RT, Osmon DR. Patient outcome with reinfection following reimplantation for the infected total knee arthroplasty. Clin Orthop Relat Res 1995; :55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/9\">",
"      Poss R, Thornhill TS, Ewald FC, et al. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res 1984; :117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/10\">",
"      J&auml;msen E, Nevalainen P, Eskelinen A, et al. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am 2012; 94:e101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/11\">",
"      Aslam S, Reitman C, Darouiche RO. Risk factors for subsequent diagnosis of prosthetic joint infection. Infect Control Hosp Epidemiol 2010; 31:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/12\">",
"      Rao N, Cannella BA, Crossett LS, et al. Preoperative screening/decolonization for Staphylococcus aureus to prevent orthopedic surgical site infection: prospective cohort study with 2-year follow-up. J Arthroplasty 2011; 26:1501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/13\">",
"      Parvizi J, Saleh KJ, Ragland PS, et al. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop 2008; 79:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/14\">",
"      Giulieri SG, Graber P, Ochsner PE, Zimmerli W. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004; 32:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/15\">",
"      Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/16\">",
"      Coventry MB. Treatment of infections occurring in total hip surgery. Orthop Clin North Am 1975; 6:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/17\">",
"      Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996; 78:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/18\">",
"      Fitzgerald RH Jr. Infections of hip prostheses and artificial joints. Infect Dis Clin North Am 1989; 3:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/19\">",
"      Cuckler JM, Star AM, Alavi A, Noto RB. Diagnosis and management of the infected total joint arthroplasty. Orthop Clin North Am 1991; 22:523.",
"     </a>",
"    </li>",
"    <li>",
"     Saravolatz LK. Infections in implantable prosthetic devices. In: Prevention and Control of Nosocomial Infections, Wenzel RP (Ed), Williams &amp; Wilkins, Baltimore 1987. p.385.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/21\">",
"      Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med 2009; 361:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/22\">",
"      Blackburn WD Jr, Alarc&oacute;n GS. Prosthetic joint infections. A role for prophylaxis. Arthritis Rheum 1991; 34:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/23\">",
"      Trampuz A, Hanssen AD, Osmon DR, et al. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 2004; 117:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/24\">",
"      Maderazo EG, Judson S, Pasternak H. Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop Relat Res 1988; :131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/25\">",
"      Rodr&iacute;guez D, Pigrau C, Euba G, et al. Acute haematogenous prosthetic joint infection: prospective evaluation of medical and surgical management. Clin Microbiol Infect 2010; 16:1789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/26\">",
"      Murdoch DR, Roberts SA, Fowler Jr VG Jr, et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 2001; 32:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/27\">",
"      Kanafani ZA, Sexton DJ, Pien BC, et al. Postoperative joint infections due to Propionibacterium species: a case-control study. Clin Infect Dis 2009; 49:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/28\">",
"      Berbari EF, Osmon DR, Duffy MC, et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 2006; 42:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/29\">",
"      Sendi P, Rohrbach M, Graber P, et al. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 2006; 43:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/30\">",
"      von Eiff C. Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians. Int J Antimicrob Agents 2008; 31:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/31\">",
"      Vaudaux P, Kelley WL, Lew DP. Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat. Clin Infect Dis 2006; 43:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/32\">",
"      Shah NB, Osmon DR, Fadel H, et al. Laboratory and clinical characteristics of Staphylococcus lugdunensis prosthetic joint infections. J Clin Microbiol 2010; 48:1600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/33\">",
"      Lutz MF, Berthelot P, Fresard A, et al. Arthroplastic and osteosynthetic infections due to Propionibacterium acnes: a retrospective study of 52 cases, 1995-2002. Eur J Clin Microbiol Infect Dis 2005; 24:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/34\">",
"      Malekzadeh D, Osmon DR, Lahr BD, et al. Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection. Clin Orthop Relat Res 2010; 468:2039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/35\">",
"      Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982; 146:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/36\">",
"      Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 1984; 73:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/37\">",
"      Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/38\">",
"      Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001; 33:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/39\">",
"      Anwar H, Strap JL, Chen K, Costerton JW. Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob Agents Chemother 1992; 36:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/40\">",
"      Osmon DR, Berbari EF, Berendt AR, et al. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis 2013; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/41\">",
"      Gristina AG, Kolkin J. Current concepts review. Total joint replacement and sepsis. J Bone Joint Surg Am 1983; 65:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/42\">",
"      Tigges S, Stiles RG, Roberson JR. Appearance of septic hip prostheses on plain radiographs. AJR Am J Roentgenol 1994; 163:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/43\">",
"      Smith SL, Wastie ML, Forster I. Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clin Radiol 2001; 56:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/44\">",
"      Kraemer WJ, Saplys R, Waddell JP, Morton J. Bone scan, gallium scan, and hip aspiration in the diagnosis of infected total hip arthroplasty. J Arthroplasty 1993; 8:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/45\">",
"      Kwee TC, Kwee RM, Alavi A. FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis. Eur J Nucl Med Mol Imaging 2008; 35:2122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/46\">",
"      Bernard L, L&uuml;bbeke A, Stern R, et al. Value of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature review. Scand J Infect Dis 2004; 36:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/47\">",
"      Spangehl MJ, Masri BA, O'Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 1999; 81:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/48\">",
"      Berbari E, Mabry T, Tsaras G, et al. Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am 2010; 92:2102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/49\">",
"      Spangehl MJ, Younger AS, Masri BA, Duncan CP. Diagnosis of infection following total hip arthroplasty. Instr Course Lect 1998; 47:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/50\">",
"      Lachiewicz PF, Rogers GD, Thomason HC. Aspiration of the hip joint before revision total hip arthroplasty. Clinical and laboratory factors influencing attainment of a positive culture. J Bone Joint Surg Am 1996; 78:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/51\">",
"      Schinsky MF, Della Valle CJ, Sporer SM, Paprosky WG. Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty. J Bone Joint Surg Am 2008; 90:1869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/52\">",
"      Ghanem E, Parvizi J, Burnett RS, et al. Cell count and differential of aspirated fluid in the diagnosis of infection at the site of total knee arthroplasty. J Bone Joint Surg Am 2008; 90:1637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/53\">",
"      Parvizi J, Jacovides C, Antoci V, Ghanem E. Diagnosis of periprosthetic joint infection: the utility of a simple yet unappreciated enzyme. J Bone Joint Surg Am 2011; 93:2242.",
"     </a>",
"    </li>",
"    <li>",
"     The diagnosis of periprosthetic joint infections of the hip and knee. Guideline and evidence report. Adopted by the American Academy of Orthopaedic Surgeons Board of Directors, June 18, 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/55\">",
"      Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007; 357:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/56\">",
"      Atkins BL, Athanasou N, Deeks JJ, et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol 1998; 36:2932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/57\">",
"      Wadey VM, Huddleston JI, Goodman SB, et al. Use and cost-effectiveness of intraoperative acid-fast bacilli and fungal cultures in assessing infection of joint arthroplasties. J Arthroplasty 2010; 25:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/58\">",
"      Pandey R, Berendt AR, Athanasou NA. Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. The OSIRIS Collaborative Study Group. Oxford Skeletal Infection Research and Intervention Service. Arch Orthop Trauma Surg 2000; 120:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/59\">",
"      Sch&auml;fer P, Fink B, Sandow D, et al. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis 2008; 47:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/60\">",
"      Tsaras G, Maduka-Ezeh A, Inwards CY, et al. Utility of intraoperative frozen section histopathology in the diagnosis of periprosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am 2012; 94:1700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/61\">",
"      Donlan RM. New approaches for the characterization of prosthetic joint biofilms. Clin Orthop Relat Res 2005; :12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/62\">",
"      Achermann Y, Vogt M, Leunig M, et al. Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. J Clin Microbiol 2010; 48:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42680/abstract/63\">",
"      Portillo ME, Salvad&oacute; M, Trampuz A, et al. Sonication versus vortexing of implants for diagnosis of prosthetic joint infection. J Clin Microbiol 2013; 51:591.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7664 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-83.177.194.223-190351C039-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42680=[""].join("\n");
var outline_f41_43_42680=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1529866\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21069092\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21069313\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21070478\">",
"      Early onset infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21070485\">",
"      Delayed onset infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21070504\">",
"      Late onset infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21069582\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29479717\">",
"      Pathogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Biofilm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1529200\">",
"      Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Synovial fluid and tissue",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29479790\">",
"      - Fluid analysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29479724\">",
"      - Culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H211965\">",
"      - Histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8187058\">",
"      Blood cultures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Explant sonication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1529866\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/21/18769?source=related_link\">",
"      Patient information: Joint infection (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/34/28198?source=related_link\">",
"      Prevention of prosthetic joint infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/25/5530?source=related_link\">",
"      Rapidly growing mycobacterial infections in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/49/37656?source=related_link\">",
"      Skeletal tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/3/12344?source=related_link\">",
"      Staphylococcus lugdunensis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/19/6457?source=related_link\">",
"      Treatment of prosthetic joint infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_43_42681="The gynecologic history and pelvic examination";
var content_f41_43_42681=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   The gynecologic history and pelvic examination",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42681/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42681/contributors\">",
"     Daniela A Carusi, MD, MSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42681/contributors\">",
"     Donald Peter Goldstein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42681/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42681/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/43/42681/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/43/42681/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/43/42681/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of the gynecologic history and the pelvic examination is part of the assessment of female patients in many clinical contexts. Clinician familiarity with the gynecologic evaluation can help reduce anxiety for both patients and health care professionals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The gynecologic history and physical examination in adult women are reviewed here. The initial assessment of pregnant women, evaluation of breast complaints, general approaches to patient interviewing as well as pelvic examination in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/1/42010?source=see_link\">",
"     \"Initial prenatal assessment and patient education\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/15/24825?source=see_link\">",
"     \"Breast masses and other common breast problems\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/58/12200?source=see_link\">",
"     \"Approach to the patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43316?source=see_link\">",
"     \"Gynecologic examination of the newborn and child\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GYNECOLOGIC HISTORY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individual women vary tremendously in their knowledge of, and comfort with, their own bodies. While some may be quite open in disclosing their sexual, reproductive, and genital concerns, others will find such discussions embarrassing or socially inappropriate. Thus, it is essential that providers maintain a sensitive and nonjudgmental approach during this encounter.",
"   </p>",
"   <p>",
"    The history should be obtained in a relaxed and private setting, before the patient is asked to disrobe. She should be interviewed alone under most circumstances, unless there is a hearing or language barrier. Questioning should proceed from very straightforward, objective information to more delicate issues. The provider should evaluate and respond to the patient's comfort level and make every effort to remain supportive.",
"   </p>",
"   <p>",
"    It is particularly important to avoid making assumptions about a woman's background; as an example, that she is sexually active or is heterosexual.",
"   </p>",
"   <p>",
"    One should begin the history with an open-ended question that will elicit the woman's gynecologic concerns. She should be encouraged to describe the situation in her own words and without frequent interruptions. Maintaining eye contact, nodding, and brief clarification of important points convey the provider's attention to the woman's issues. The provider can then ask questions to proceed with the evaluation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/3/8249?source=see_link\">",
"     \"Patient-centered interviewing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/23/19831?source=see_link\">",
"     \"A patient-centered view of the clinician-patient relationship\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Basic history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The basic components of the gynecologic history are the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Menstrual history (",
"      <a class=\"graphic graphic_table graphicRef61980 \" href=\"mobipreview.htm?35/45/36571\">",
"       table 1",
"      </a>",
"      ) &ndash; the shorthand for menstrual history is age at menarche x cycle length x number of days of bleeding (eg, 13x28x5)",
"     </li>",
"     <li>",
"      Obstetric history (",
"      <a class=\"graphic graphic_table graphicRef51970 \" href=\"mobipreview.htm?16/27/16827\">",
"       table 2",
"      </a>",
"      ) &ndash; the shorthand for obstetric history is gravida (number of pregnancies) para (number of term births; number of births from 20 to &lt;37 weeks of gestation; number of failed or terminated pregnancies at &lt;20 weeks; living children) (eg, G2P112)",
"     </li>",
"     <li>",
"      Sexual history (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Sexual function'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Type of contraception, past and current (if appropriate)",
"     </li>",
"     <li>",
"      Current symptoms or history of pelvic, vaginal, or vulvar infections &ndash; vaginal discharge, vulvar or vaginal lesions, fever, pelvic pain, abnormal genital tract bleeding, prior sexually transmitted infections or pelvic inflammatory disease (diagnosis, frequency, and treatment)",
"     </li>",
"     <li>",
"      Cervical cytology (Pap test) history &ndash; date and result of last test; diagnosis and follow-up of abnormal Pap smears",
"     </li>",
"     <li>",
"      History of other gynecologic problems, such as ovarian cysts, uterine fibroids, infertility, endometriosis, or polycystic ovarian syndrome - mode of diagnosis and treatment",
"     </li>",
"     <li>",
"      Symptoms of pelvic organ prolapse or urinary or anal incontinence",
"     </li>",
"     <li>",
"      History of gynecologic procedures (eg, endometrial biopsy, laparoscopy, hysterectomy) &ndash; date, indication, complications",
"     </li>",
"     <li>",
"      Screening for intimate partner violence. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/15/6393?source=see_link\">",
"       \"Intimate partner violence: Diagnosis and screening\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Specific questions are essential in order to obtain accurate information. As an example, some patients may not include miscarriages or abortions when asked about past pregnancies; therefore, the provider should specifically inquire about these events. Some patients will equate undergoing a pelvic examination with having a Pap test, and erroneously state that this test was recently performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/2\">",
"     2",
"    </a>",
"    ]. Other patients may make inaccurate assumptions about whether their ovaries or cervix were removed with a hysterectomy. Therefore, written records of cervical cytology testing results, operative procedures, and pathology results should be obtained whenever possible.",
"   </p>",
"   <p>",
"    A comprehensive gynecologic history includes a complete summary of the woman's medical, surgical, social, and family history. A review of symptoms is taken that focuses on the genitourinary areas (",
"    <a class=\"graphic graphic_table graphicRef74722 \" href=\"mobipreview.htm?33/11/33980\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Problem focused history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common gynecologic concerns relate to vaginal discharge, abnormal bleeding, pelvic pain, urinary problems, sexual dysfunction, and infertility. When a patient identifies one of these issues, detailed questioning can guide further evaluation and diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Vaginal discharge",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many reproductive age women have daily vaginal discharge. Normal vaginal discharge is composed of mucoid endocervical secretions in combination with desquamated vaginal wall epithelium and normal bacteria. Physiologic discharge is typically clear, white, or light yellow in color. The volume of discharge varies considerably among women and timing in the menstrual cycle. For women who present with vaginal discharge, questions should be asked regarding the onset, duration, frequency, color, consistency, volume, and odor of the flow. Discharge that is malodorous, pruritic, copious, purulent, bloody, or accompanied by fever requires investigation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/49/36633?source=see_link\">",
"     \"Approach to women with symptoms of vaginitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Abnormal genital tract bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women commonly present with a complaint of &ldquo;vaginal bleeding.&rdquo; A complaint of vaginal bleeding most often represents uterine bleeding, but the source may be any part of the genital tract, or the urinary or gastrointestinal tracts (",
"    <a class=\"graphic graphic_table graphicRef74527 \" href=\"mobipreview.htm?25/45/26334\">",
"     table 4",
"    </a>",
"    ). Pregnancy should be excluded in any woman of reproductive age with abnormal genital tract bleeding. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35113?source=see_link\">",
"     \"Overview of causes of genital tract bleeding in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pertinent data are the onset of a change in bleeding, amount, duration, and frequency of bleeding (",
"    <a class=\"graphic graphic_table graphicRef69390 \" href=\"mobipreview.htm?14/2/14379\">",
"     table 5",
"    </a>",
"    ). In women of reproductive age or in the menopausal transition, the use of a menstrual chart to document bleeding patterns is helpful in determining whether the changes are sufficiently abnormal to justify investigation (",
"    <a class=\"graphic graphic_figure graphicRef76376 \" href=\"mobipreview.htm?36/52/37710\">",
"     figure 1",
"    </a>",
"    ). Irregular bleeding occurs commonly during the menopausal transition and may be a symptom of serious underlying pathology.",
"   </p>",
"   <p>",
"    Uterine bleeding is abnormal when it is associated with a change in the woman's normal menstrual pattern or it occurs after menopause. The average menstrual cycle lasts up to seven days and the amount of menstrual blood loss is 35 to 40 mL per cycle, but the range is wide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Menorrhagia is defined as menstrual blood loss greater than 80 mL. However, the term menorrhagia is applied variably to ovulatory or anovulatory uterine bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/5\">",
"     5",
"    </a>",
"    ]. Prolonged menses are defined as longer than seven days. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/24/23944?source=see_link\">",
"     \"Terminology and evaluation of abnormal uterine bleeding in premenopausal women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Menopause is defined by 12 months of amenorrhea after the final menstrual period. Postmenopausal bleeding refers to any uterine bleeding in a menopausal woman (other than the expected cyclic bleeding that occurs in women taking sequential postmenopausal hormone therapy). While menopause may occur in some women in their 40s, other causes of amenorrhea and abnormal uterine bleeding should be considered, particularly for patients in their early 40s. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/41/2711?source=see_link\">",
"     \"Postmenopausal uterine bleeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34697?source=see_link\">",
"     \"Etiology, diagnosis, and treatment of secondary amenorrhea\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Pelvic pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;The characterization of pelvic pain should include the time of onset, duration, location, quality, and severity. The relationship of the pain to menstruation, physical activity, or sexual activity and alleviation of the pain with analgesics, hormonal contraceptives, or position change are useful components of the pain history. Associated gastrointestinal or urinary symptoms could point to a nongynecologic source of the pain. However, ovarian torsion is often accompanied by nausea and vomiting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/30/16874?source=see_link\">",
"     \"Differential diagnosis of abdominal pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/26/41384?source=see_link\">",
"     \"Causes of chronic pelvic pain in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Urinary incontinence and pelvic organ prolapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary incontinence occurs among women of all ages and requires evaluation when the involuntary loss of urine is bothersome. Historical factors, such as leakage of urine with physical activity (exercise, lifting, coughing, sneezing) versus an overwhelming urge to void with leakage of urine before reaching a toilet, can help to differentiate stress incontinence from detrusor instability. A careful voiding and intake history will help the clinician determine the underlying cause. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/14/29929?source=see_link\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women with pelvic organ prolapse may complain of a vaginal bulge, vaginal pressure, or the need to place a finger in the vagina to void or defecate. Such symptoms should be evaluated further with physical examination. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/33/40473?source=see_link&amp;anchor=H21524755#H21524755\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Sexual function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many sexual problems result from",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cause reproductive dysfunction and gynecologic problems. Sexual issues include prevention of sexually transmitted infections, contraception, sexual dysfunction, and prevention and management of sexual assault.",
"   </p>",
"   <p>",
"    Many women are reluctant to express concerns regarding these matters, but welcome the opportunity to discuss them when approached in an interested and compassionate manner. The importance of an assessment of sexual function was demonstrated in a questionnaire study of over 1000 women seen for a primary care visit; 98 percent reported one or more sexual concerns, but only 18 percent of clinicians asked about sexual health [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/6\">",
"     6",
"    </a>",
"    ]. Women who discussed their sexual concerns with their clinician found the discussion helpful. In another study, among 3000 women with a sexual problem that caused personal distress, only 6 percent of those who sought medical advice scheduled a visit specifically for a sexual problem, and about 80 percent of the time, the woman, rather than the physician, initiated the conversation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to questions regarding basic gynecologic health, contraception and safe sex practices, all women should be asked an open-ended question, such as: do you have any sexual concerns? This question also provides an opportunity to discuss sexual issues and pertinent sexual history.",
"   </p>",
"   <p>",
"    A brief set of screening questions is adequate to determine whether a problem exists that requires further inquiry. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42904?source=see_link\">",
"     \"The sexual history and approach to the patient with sexual dysfunction\"",
"    </a>",
"    .):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Do you have sexual concerns?",
"     </li>",
"     <li>",
"      Are you currently having or have you ever had sexual relations?",
"     </li>",
"     <li>",
"      If not, when did you last engage in sexual activity?",
"     </li>",
"     <li>",
"      If so, with men or women or both?",
"     </li>",
"     <li>",
"      Have you recently had any new partners or sexual contacts?",
"     </li>",
"     <li>",
"      Do you protect yourself from pregnancy and sexually transmitted infections?",
"     </li>",
"     <li>",
"      Would you like to be screened for sexually transmitted infections?",
"     </li>",
"     <li>",
"      Do you need contraception or preconceptional counseling?",
"     </li>",
"     <li>",
"      Are you currently experiencing or have you experienced previous sexual abuse?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The patient&rsquo;s answers to these questions will guide the subsequent discussion and help the clinician provide care regarding safe sex, contraception, sexual dysfunction, or sexual abuse or assault. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/12/35018?source=see_link\">",
"     \"Prevention of sexually transmitted infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/24/39306?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of contraception\", section on 'Choosing a method of contraception'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/42/25258?source=see_link&amp;anchor=H20#H20\">",
"     \"Sexual dysfunction in women: Epidemiology, risk factors, and evaluation\", section on 'Diagnostic evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20601?source=see_link&amp;anchor=H2#H2\">",
"     \"Evaluation and management of adult sexual assault victims\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Infertility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many women become very concerned when they have not conceived a pregnancy after a few months of trying, while others have had years of unprotected, regular intercourse without recognizing that an underlying medical problem may exist. Infertility is defined as failure of a couple to conceive after 12 months of regular intercourse without use of contraception in women less than 35 years of age, and after six months of regular intercourse without use of contraception in women 35 years and older [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/8\">",
"     8",
"    </a>",
"    ]. Before proceeding with an infertility evaluation, the provider should confirm that the couple is having regular, frequent intercourse during the middle of the menstrual cycle. Once the diagnosis is established, the infertility history should focus on three factors: ovulation, tubal and uterine problems, and male factors (",
"    <a class=\"graphic graphic_table graphicRef53077 \" href=\"mobipreview.htm?40/25/41371\">",
"     table 6",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40921?source=see_link\">",
"     \"Evaluation of female infertility\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PELVIC EXAMINATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6245040\">",
"    <span class=\"h2\">",
"     Timing issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic examination is indicated in any patient with genital or pelvic symptoms and in other patients for preventive care. (See",
"    <a class=\"local\" href=\"#H6245405\">",
"     'Frequency of examination'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6245397\">",
"    <span class=\"h3\">",
"     Age at initial examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American College of Obstetricians and Gynecologists (ACOG) recommends a first reproductive health visit between the ages of 13 and 15 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. The scope of the examination in adolescents depends upon the individual needs of the patient. A reproductive health visit may be limited to age-appropriate education regarding reproductive health matters. A pelvic examination is not included unless indicated due to symptoms or for screening for a sexually transmitted infection.",
"   </p>",
"   <p>",
"    Prior to a first pelvic examination, the components and benefits of the examination should be explained. Every effort should be made to communicate with and reassure the patient, and the exam should be stopped if the patient is too anxious or uncomfortable. Education regarding the pelvic examination includes potential testing for sexually transmitted infections and cervical cancer screening. Many women erroneously equate a speculum examination with a Pap test, and may incorrectly think that they have been screened for cervical cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6245405\">",
"    <span class=\"h3\">",
"     Frequency of examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pelvic examination has traditionally been performed routinely to detect genital tract lesions and masses, and sexually transmitted diseases, and to confirm normal findings prior to initiating contraception. The efficacy of the pelvic examination as a screening tool in asymptomatic women is the subject of debate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    ACOG recommendations regarding pelvic examinations in adolescents and women in their early 20s are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Annual screening for gonorrheal infection for all sexually active adolescents",
"     </li>",
"     <li>",
"      Annual screening for chlamydial infection for all sexually active women age 25 years or younger",
"     </li>",
"     <li>",
"      Initiate cervical cancer screening at age 21 years",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The United States Centers for Disease Control and Prevention also advises annual screening of sexually active adolescents and young women for gonorrheal and chlamydial infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/51/37689?source=see_link&amp;anchor=H16#H16\">",
"     \"Sexually transmitted diseases: Overview of issues specific to adolescents\", section on 'Screening and diagnostic testing'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=see_link&amp;anchor=H22#H22\">",
"     \"Screening for cervical cancer: Rationale and recommendations\", section on 'Initial screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Annual pelvic examination is recommended by ACOG for women age 21 years and older, although they advise that the patient should decide whether to have a pelvic examination if she is asymptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/11\">",
"     11",
"    </a>",
"    ]. Annual screening for chlamydial and gonorrheal infection is advised for women who are at high risk for infection (new sexual partner, multiple sexual partners, sexual partner with multiple sexual contacts) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Testing for genital gonorrheal or chlamydial infection may be performed with a cervical or vaginal swab or a urine specimen. Cervical and vaginal swabs have comparable sensitivity, but vaginal swabs do not require a speculum examination and can be obtained by the patient if less invasive testing is preferred. Although urine specimens are also acceptable for women, the sensitivity of testing appears to be lower compared with vaginal samples. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=see_link&amp;anchor=H11473962#H11473962\">",
"     \"Diagnosis of gonococcal infections\", section on 'Optimal samples for testing in patients with genital infection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/13/8408?source=see_link&amp;anchor=H1790519#H1790519\">",
"     \"Screening for Chlamydia trachomatis\", section on 'Diagnostic screening tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This examination may be performed in association with cervical cancer screening. However, annual screening for cervical cancer is not recommended for all women; the frequency depends upon age, prior history of cervical abnormalities, cervical cytology, and human papilloma virus testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/10\">",
"     10",
"    </a>",
"    ]. The cervical cancer screening recommendations from United States professional organizations are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef82951 \" href=\"mobipreview.htm?24/21/24925\">",
"     table 7",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=see_link&amp;anchor=H24#H24\">",
"     \"Screening for cervical cancer: Rationale and recommendations\", section on 'Screening frequency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no evidence that annual pelvic examination reduces mortality from ovarian cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]; even pelvic examination under anesthesia has been shown to have limited sensitivity at detecting adnexal masses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/14/10474?source=see_link\">",
"     \"Screening for ovarian cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/1/20499?source=see_link\">",
"     \"Pelvic examination under anesthesia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pelvic examination is also often used as a prerequisite to obtain hormonal contraceptives. While the incentive to prevent pregnancy may motivate sexually active women to obtain an examination, this requirement may act as a barrier to effective pregnancy prevention. A full health history and blood pressure check are important in the provision of hormonal contraception, but many experts advised that hormonal contraception may be safely prescribed without a full pelvic examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/17\">",
"     17",
"    </a>",
"    ]. Offering contraception without a pelvic examination may bring women into the health care system who might otherwise receive limited care, and provide an opportunity to counsel patients on the value of full gynecologic care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/24/39306?source=see_link\">",
"     \"Overview of contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2506475\">",
"    <span class=\"h3\">",
"     When to discontinue examinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;ACOG advises continued pelvic examinations until a women&rsquo;s age or other health issues are such that she would not choose to intervene on conditions detected during the routine examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6245684\">",
"    <span class=\"h2\">",
"     Preparing for the examination",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6245575\">",
"    <span class=\"h3\">",
"     Patient consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should request permission before starting a pelvic examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/19\">",
"     19",
"    </a>",
"    ]. Written consent is not required, with the exception of examination under anesthesia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/1/20499?source=see_link&amp;anchor=H2#H2\">",
"     \"Pelvic examination under anesthesia\", section on 'Informed consent'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Adolescents may undergo a pelvic examination without their parents' knowledge or permission if the examination is performed in the context of testing or treatment for sexually transmitted infections. Laws vary by jurisdiction regarding confidential access to human immunodeficiency virus testing, contraception, and abortion services. On the other hand, parental consent is required for childhood examinations, adolescent pelvic examinations, and pelvic examinations unrelated to sexual contact [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/20\">",
"     20",
"    </a>",
"    ]. Permission from a legal guardian is required for a nonemergent pelvic examination of a patient who cannot consent to her own health care. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/24/5512?source=see_link\">",
"     \"Consent in adolescent health care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3878502\">",
"    <span class=\"h3\">",
"     Chaperone",
"    </span>",
"    &nbsp;&mdash;&nbsp;No universal guidelines exist regarding the use of a chaperone during the examination. Surveys of both patients and providers demonstrate variable usage and preferences. Some patients who generally prefer female providers are open to a male provider if a chaperone is present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Other patients may actively object to having a chaperone present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/22\">",
"     22",
"    </a>",
"    ]. Although charges of inappropriate conduct during a pelvic examination are rare, both male and female providers should consider utilizing a chaperone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6245676\">",
"    <span class=\"h3\">",
"     Patient anxiety or refusal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some women have had difficult experiences with sexual abuse or assault or with prior pelvic examinations, and may feel substantial anxiety regarding the examination. For such patients, the examination may be nearly unbearable, and may deter the patient from seeking appropriate health care. Such anxiety may manifest as tense and withdrawn body language, extreme discomfort with the examination, or refusal to have an examination at all.",
"   </p>",
"   <p>",
"    It is widely recognized that a pelvic examination may be uncomfortable. In one study, approximately 1000 women in a variety of clinical settings were asked to explain the parts of the examination that were uncomfortable, the reasons for the discomfort, and to suggest ways the provider could have improved the process [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/24\">",
"     24",
"    </a>",
"    ]. Physical discomfort (37 percent), embarrassment (20 percent), disliking the attitude of the examiner (7 percent), and experiencing problems during a previous examination (5 percent) were the major concerns reported. Techniques suggested to improve the examination process included explaining each step of the examination in advance, providing more information about the reproductive organs, warming the instruments, and increased gentleness. Other surveys have recommended that providers make an effort to maintain eye contact during the examination and give the patient choices where possible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At first recognition of the patient's discomfort, the provider should stop the physical examination and address the patient's concerns. In some women, performing the bimanual examination with one finger before the speculum examination is helpful in decreasing anxiety. In addition, a narrow speculum (narrow Pederson, Huffman, or pediatric) can be used to decrease discomfort.",
"   </p>",
"   <p>",
"    If it becomes clear that the patient has been abused or is suffering from severe anxiety, the provider may need to delay the examination in order to elicit help from a therapist or social worker. Often by discussing the examination ahead of time and agreeing to stop uncomfortable procedures at the patient's request, the provider can give the woman some control over the situation, which may alleviate some of her anxiety regarding the examination. Importantly, the provider should never proceed in the setting of patient refusal, no matter how medically necessary he or she perceives the examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Patient positioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pelvic examination is traditionally performed in the dorsal lithotomy position in order to allow optimal exposure of the internal and external genitalia and palpation of the pelvis. Unfortunately, laying the patient in a horizontal position does not allow eye contact between the provider and patient, and may increase her sense of vulnerability. This may also be a physically difficult position for women with cardiorespiratory or musculoskeletal limitations. Elevating the head of the table 30 to 45 degrees makes it easier for the woman to relax, thereby facilitating bimanual examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Equipment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The basic equipment needed to perform a pelvic examination includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      An examining table with stirrups (or means for elevating the buttocks when stirrups aren't available [eg, the patient is on a stretcher or in bed])",
"     </li>",
"     <li>",
"      Good light source (preferably cold light)",
"     </li>",
"     <li>",
"      Speculum of appropriate size (eg, Huffman speculum for virginal patients)",
"     </li>",
"     <li>",
"      Materials to obtain cervical cytology",
"     </li>",
"     <li>",
"      Materials to test for common infections &ndash; chlamydia, gonorrhea, herpes simplex virus",
"     </li>",
"     <li>",
"      Cotton swabs for obtaining samples of vaginal discharge",
"     </li>",
"     <li>",
"      pH indicator paper",
"     </li>",
"     <li>",
"      Dropper bottles of saline and potassium hydroxide for performing wet preps",
"     </li>",
"     <li>",
"      Large cotton swabs to absorb excess vaginal discharge or blood",
"     </li>",
"     <li>",
"      Test kits for fecal occult blood",
"     </li>",
"     <li>",
"      Water soluble lubricant, disposable gloves, material to drape the patient",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Components of the examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pelvic examination traditionally includes the internal and external genitalia, and pelvic organs. Comprehensive examination also includes evaluation of some components of the urinary and gastrointestinal tracts, including the urethra, anus, and rectum. A more comprehensive examination, involving the abdomen, breast, and other sites, may be indicated to provide complete primary care or to evaluate gynecologic problems that involve other organ systems. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/15/24825?source=see_link&amp;anchor=H14#H14\">",
"     \"Breast masses and other common breast problems\", section on 'Physical examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/24/40323?source=see_link&amp;anchor=H3#H3\">",
"     \"History and physical examination in adults with abdominal pain\", section on 'Physical Examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Abdomen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of the abdomen should be performed using the standard techniques of inspection, auscultation, palpation, and percussion. The examiner should observe for abnormalities of skin color and intestinal peristalsis, hernias, organomegaly, masses, fluid collection, and tenderness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     External genitalia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The external genitalia are inspected and palpated (",
"    <a class=\"graphic graphic_figure graphicRef72614 \" href=\"mobipreview.htm?24/50/25379\">",
"     figure 2",
"    </a>",
"    ). The hair distribution, skin, labia minora and majora, perineal body, clitoris, urethral meatus, vestibule, and introitus are evaluated for developmental abnormalities, skin lesions (eg, discoloration, ulcers, plaques, verrucous changes, excoriation), masses, and evidence of trauma or infection. In patients with vulvar pain, the vestibular epithelium should be touched with a dry cotton swab to identify the location of the pain. Visible vulvar lesions may need to be cultured or biopsied. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/30/37349?source=see_link\">",
"     \"Diagnostic evaluation of vulvar lesions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/8/20618?source=see_link\">",
"     \"Differential diagnosis of vulvar lesions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/46/37609?source=see_link\">",
"     \"Clinical manifestations and diagnosis of localized, provoked vulvodynia (formerly vulvar vestibulitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Bartholin and paraurethral glands",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Bartholin gland openings are located at the 4 and 8 o'clock positions just outside the hymenal ring. The glands are not palpable when healthy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/54/22375?source=see_link\">",
"     \"Disorders of Bartholin gland\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The paraurethral glands, the largest of which are Skene's glands, are adjacent to the distal urethra; the gland ducts open into the urethra or just outside the urethral orifice. If enlarged or tender, an attempt should be made to express exudate, which suggests infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Speculum examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vagina is first inspected using a speculum of appropriate size, lubricated with warm water or a water soluble lubricant. Lubricants do not appear to interfere with sampling for cervical cytology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/32/35337?source=see_link&amp;anchor=H25#H25\">",
"     \"Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing\", section on 'Gel lubricants and other contaminants'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Atraumatic insertion is aided by assisting muscle relaxation at the opening of the vagina. This may be accomplished by advising the patient to relax her legs to the sides and also by inserting a finger into the distal vagina and gently applying downward pressure. The speculum is then inserted and downward pressure applied. The speculum is advanced in a direction free of resistance and opened as the apex of the vagina is reached.",
"   </p>",
"   <p>",
"    Vaginal lesions, anomalies, or atrophic mucosa are noted. If abnormal discharge is identified, the volume, color, consistency, and odor should be noted and a sample taken with a cotton swab. The pH of physiologic vaginal discharge is less than 4.5; an elevated pH may be due to infection (eg, bacterial vaginosis) or exogenous substances (eg, semen). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/30/31208?source=see_link&amp;anchor=H4#H4\">",
"     \"Vaginal cancer\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12473?source=see_link&amp;anchor=H13#H13\">",
"     \"Diagnosis and management of congenital anomalies of the vagina\", section on 'Anomalies of the vagina'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/49/36633?source=see_link\">",
"     \"Approach to women with symptoms of vaginitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/49/36633?source=see_link&amp;anchor=H5#H5\">",
"     \"Approach to women with symptoms of vaginitis\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The degree of vaginal wall relaxation and uterine prolapse is evaluated, if indicated, by removing the top blade of the speculum and using the posterior blade as a retractor. It is helpful to ask the patient to bear down to determine the degree of uterovaginal descensus. Additional testing can be performed in patients with complaints of urinary incontinence. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/46/8937?source=see_link&amp;anchor=H1120407#H1120407\">",
"     \"Pelvic organ prolapse in women: Diagnostic evaluation\", section on 'Approach to the examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/14/29929?source=see_link&amp;anchor=H20#H20\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\", section on 'Clinical testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lesions or discharge of the cervix are noted. Cervical cultures and cervical cancer screening are performed, as appropriate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/32/23048?source=see_link\">",
"     \"Congenital cervical anomalies and benign cervical lesions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/32/35337?source=see_link&amp;anchor=H2#H2\">",
"     \"Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing\", section on 'How to obtain a sample'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=see_link\">",
"     \"Screening for sexually transmitted infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=see_link&amp;anchor=H16#H16\">",
"     \"Screening for sexually transmitted infections\", section on 'Screening sexually active patients'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Bimanual examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The index and middle fingers of the dominant hand are normally used to examine the vagina and uterus, although some providers find that switching hands during the examination facilitates evaluation of the adnexa. Only a single finger can be inserted comfortably in patients with a narrow introitus or small vaginal orifice. The abdominal hand should be used to sweep the pelvic organs downward, while the vaginal hand is simultaneously elevating them.",
"   </p>",
"   <p>",
"    The uterus is assessed for size, shape, symmetry, mobility, position, and consistency. The uterine size and consistency vary according to reproductive status (parity, menopausal status) (",
"    <a class=\"graphic graphic_figure graphicRef73522 \" href=\"mobipreview.htm?33/49/34580\">",
"     figure 3",
"    </a>",
"    )&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef76299 \" href=\"mobipreview.htm?38/39/39547\">",
"     table 8",
"    </a>",
"    ). The position, or axis, of the uterus is described by its variation in the anterior-posterior (sagittal) plane. There are several normal variations of uterine position (",
"    <a class=\"graphic graphic_figure graphicRef57760 \" href=\"mobipreview.htm?26/35/27192\">",
"     figure 4",
"    </a>",
"    ); the terms used to describe this are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Axial &mdash; the axis of the uterus is the same as the vaginal axis",
"     </li>",
"     <li>",
"      Version &mdash; position of the entire uterus relative to the axis of the vagina; eg, anteverted, retroverted",
"     </li>",
"     <li>",
"      Flexion &mdash; position of the uterine fundus relative to the axis of the cervix; eg, anteflexed, retroflexed",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A uterus can be both verted and flexed in the same direction (eg, anteverted and anteflexed); it is rare for a uterus to be verted and flexed in opposing directions (eg, anteverted and retroflexed).",
"   </p>",
"   <p>",
"    The adnexal areas are checked for the presence of appropriately sized, mobile ovaries (eg, about 2 by 3 cm), which are normally somewhat tender. Palpable ovaries in postmenopausal women are not a \"normal\" finding (detectable in about 30 percent of postmenopausal women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]) and require investigation, although most are associated with benign or no disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/29-34\">",
"     29-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ability to palpate the ovaries during a clinical examination in the office depends upon several factors, including the patient's body habitus, the examiner's experience, the time taken to perform the examination, and the presence of other pelvic abnormalities. Ovaries can be difficult to palpate, even by experienced clinicians under ideal circumstances. In one series in which bimanual examination was performed under anesthesia before various gynecological surgery procedures, ovaries were detected in 30 percent of women &ge;55 years of age versus 51 percent of women under 55 years of age, in 9 percent of women weighing over 200 pounds versus 55 percent of women weighing under 200 pounds, and in 12 percent of women with a uterine weight over 200 g versus 51 percent of women with a uterine weight under 200 g [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/27\">",
"     27",
"    </a>",
"    ]. Overall, the bimanual examination has a sensitivity of less than 60 percent, whether for detecting adnexal masses in general or for distinguishing benign from malignant masses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When adnexal masses are detected, they should be described as to location, size, consistency, mobility, and degree of tenderness. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/1/24601?source=see_link\">",
"     \"Approach to the patient with an adnexal mass\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/57/19352?source=see_link\">",
"     \"Differential diagnosis of the adnexal mass\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Rectovaginal examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another potential component of the gynecologic assessment is the rectovaginal examination. This allows optimal palpation of the posterior cul-de-sac and uterosacral ligaments, as well as the uterus and adnexa. Studies of rectovaginal examinations under anesthesia show poor sensitivity in detecting adnexal masses and uterosacral and posterior cul-de-sac disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. There are no professional society guidelines regarding the use of the rectovaginal examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If a rectovaginal examination is performed, anorectal findings should be documented (eg, hemorrhoids, rectal mass). If indicated, stool on the examining glove can be tested for occult blood. However, a single sample does not suffice for colorectal cancer screening; screening is better accomplished by home collection of stool samples. Screening for colorectal cancer is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37034?source=see_link&amp;anchor=H9#H9\">",
"     \"Screening for colorectal cancer: Strategies in patients at average risk\", section on 'Tests used for screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When performing the rectovaginal examination, using a lubricated examining glove and asking the patient to strain against the examiner's finger will usually allow the sphincter to relax and decrease discomfort. The same finger should not be used to examine both the vagina and rectum to avoid transmission of HPV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/40\">",
"     40",
"    </a>",
"    ] or contamination with blood, which may alter fecal occult blood testing, if performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6244552\">",
"    <span class=\"h1\">",
"     SPECIAL CONSIDERATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6245199\">",
"    <span class=\"h2\">",
"     Examination of infants and children",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first genital inspection should be performed on the newborn. This will confirm patency of the anus and vagina, and help identify congenital anomalies and ambiguous genitalia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/21/24922?source=see_link&amp;anchor=H39#H39\">",
"     \"Assessment of the newborn infant\", section on 'Genitalia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Young girls should undergo a focused genital examination when the patient or parent identifies a gynecologic symptom. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/3/10295?source=see_link&amp;anchor=H7#H7\">",
"     \"The pediatric physical examination: The perineum\", section on 'Females'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43316?source=see_link&amp;anchor=H3#H3\">",
"     \"Gynecologic examination of the newborn and child\", section on 'History and physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6245207\">",
"    <span class=\"h2\">",
"     Examination of women with limited mobility or obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;In rare cases, the gynecologic examination may not be possible in the office setting. Examples include severe physical limitations, patient intolerance due to pain or anxiety, or examination of small children. In such cases, the examination may need to be performed with conscious sedation or general anesthesia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/1/20499?source=see_link\">",
"     \"Pelvic examination under anesthesia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43316?source=see_link&amp;anchor=H3#H3\">",
"     \"Gynecologic examination of the newborn and child\", section on 'History and physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Suggestions for facilitating gynecologic examination of disabled women are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef51647 \" href=\"mobipreview.htm?23/2/23595\">",
"     table 9",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20370127\">",
"    <span class=\"h2\">",
"     Examination after hysterectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for pelvic examination are the same for women who have undergone hysterectomy as for other women. The exception to this is that most women who have undergone total hysterectomy (the cervix has been removed) do not require Pap tests. In the past, many clinicians performed vaginal Pap tests in this patient population. However, the risk of vaginal intraepithelial neoplasia (VAIN) or vaginal cancer is extremely low in women who have undergone total hysterectomy for benign disease (excluding CIN 2,3) and, for this reason, screening guidelines in the United States from the US Preventive Services Task Force (USPSTF), the American Cancer Society (ACS), and the American College of Obstetricians and Gynecologists (ACOG) concur that these women do not need post-hysterectomy vaginal cytology. Vaginal cancer screening is advisable in women with risk factors for vaginal cancer. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=see_link&amp;anchor=H26#H26\">",
"     \"Screening for cervical cancer: Rationale and recommendations\", section on 'Prior hysterectomy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=see_link&amp;anchor=H36#H36\">",
"     \"Screening for cervical cancer: Rationale and recommendations\", section on 'Women who have undergone hysterectomy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/2/30762?source=see_link&amp;anchor=H31#H31\">",
"     \"Cervical intraepithelial neoplasia: Management\", section on 'Post-hysterectomy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/15/40185?source=see_link&amp;anchor=H9531352#H9531352\">",
"     \"Cervical cytology: Interpretation of results\", section on 'Vaginal cytology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Examination of women following hysterectomy or other gynecologic surgery (eg, oophorectomy) is generally the same as for other women, but the examination and documentation of the findings should reflect the patient&rsquo;s current anatomy. As an example, in a patient who has undergone a total hysterectomy, the examiner should note that the cervix is surgically absent and record the condition of the vaginal cuff (eg, well-healed). In some cases, women are not certain of the details of their surgical procedure, including whether the cervix or one or both ovaries or tubes were conserved. The definitive documentation of this is in the operative note. If this is not available, the clinician can confirm the absence of the cervix on examination and the absence of the ovaries with pelvic imaging, if this information is needed for clinical reasons.",
"   </p>",
"   <p>",
"    Women who have had a total hysterectomy continue to be at risk of sexually transmitted infections of the urethra. Thus, women at risk of,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    with symptoms of, these infections should be tested for gonorrhea or chlamydia with urine testing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=see_link&amp;anchor=H11473962#H11473962\">",
"     \"Diagnosis of gonococcal infections\", section on 'Optimal samples for testing in patients with genital infection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/13/8408?source=see_link&amp;anchor=H1790519#H1790519\">",
"     \"Screening for Chlamydia trachomatis\", section on 'Diagnostic screening tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     DOCUMENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are six critical elements of good record-keeping:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Accuracy",
"     </li>",
"     <li>",
"      Objectivity",
"     </li>",
"     <li>",
"      Legibility",
"     </li>",
"     <li>",
"      Timeliness",
"     </li>",
"     <li>",
"      Comprehensiveness",
"     </li>",
"     <li>",
"      Absence of alterations",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All entries should be dated, signed, and checked for accuracy. Documentation guidelines related to reimbursement are available from the Centers for Medicare &amp; Medicaid Services [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When a paper medical record is used, a preprinted form is useful for documentation of the history and physical examination (",
"    <a class=\"graphic graphic_figure graphicRef76095 graphicRef56135 \" href=\"mobipreview.htm?40/44/41678\">",
"     figure 5A-B",
"    </a>",
"    ). In electronic medical records, if templates are used, care must be taken to ensure that the information is reviewed and is correct for the individual patient and encounter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/43/42681/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10697154\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The gynecologic history should be obtained in a private setting, before the patient is asked to disrobe. She should be interviewed alone under most circumstances. It is particularly important to avoid making assumptions about a woman's background (as an example, that she is sexually active or heterosexual). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common gynecologic concerns relate to vaginal discharge, abnormal bleeding, pain, urinary problems, breast disorders, sexual dysfunction, and infertility. When a patient identifies one of these issues, detailed questioning can guide further evaluation and diagnosis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Problem focused history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pelvic examination traditionally includes the internal and external genitalia, pelvic organs. The abdomen and breasts are also commonly examined. The pelvic examination is traditionally performed in the dorsal lithotomy position in order to allow optimal exposure of the internal and external genitalia and palpation of the pelvis. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Pelvic examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no defined age at which the first gynecologic examination is performed, as this depends upon the probability of identifying a gynecologic problem. (See",
"      <a class=\"local\" href=\"#H6245397\">",
"       'Age at initial examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No universal guidelines exist regarding the use of a chaperone during the examination. Although charges of inappropriate conduct during a pelvic examination are rare, both male and female providers should consider utilizing a chaperone. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Equipment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/1\">",
"      Carr SE, Carmody D. Outcomes of teaching medical students core skills for women's health: the pelvic examination educational program. Am J Obstet Gynecol 2004; 190:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/2\">",
"      Lyons MS, Lindsell CJ, Trott AT. Emergency department pelvic examination and Pap testing: addressing patient misperceptions. Acad Emerg Med 2004; 11:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/3\">",
"      Cole SK, Billewicz WZ, Thomson AM. Sources of variation in menstrual blood loss. J Obstet Gynaecol Br Commonw 1971; 78:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/4\">",
"      Hallberg L, H&ouml;gdahl AM, Nilsson L, Rybo G. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966; 45:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/5\">",
"      Woolcock JG, Critchley HO, Munro MG, et al. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril 2008; 90:2269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/6\">",
"      Nusbaum MR, Helton MR, Ray N. The changing nature of women's sexual health concerns through the midlife years. Maturitas 2004; 49:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/7\">",
"      Shifren JL, Johannes CB, Monz BU, et al. Help-seeking behavior of women with self-reported distressing sexual problems. J Womens Health (Larchmt) 2009; 18:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/8\">",
"      Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril 2008; 90:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/9\">",
"      Committee opinion no. 460: the initial reproductive health visit. Obstet Gynecol 2010; 116:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/10\">",
"      American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG Committee Opinion No. 483: Primary and preventive care: periodic assessments. Obstet Gynecol 2011; 117:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/11\">",
"      Committee on Gynecologic Practice. Committee opinion no. 534: well-woman visit. Obstet Gynecol 2012; 120:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/12\">",
"      Stormo AR, Hawkins NA, Cooper CP, Saraiya M. The pelvic examination as a screening tool: practices of US physicians. Arch Intern Med 2011; 171:2053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/13\">",
"      Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     file://consensus.nih.gov/1994/1994OvarianCancer096html.htm (Accessed on November 03, 2010).",
"    </li>",
"    <li>",
"     file://www.uspreventiveservicestaskforce.org/uspstf/uspsovar.htm (Accessed on November 03, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/16\">",
"      Padilla LA, Radosevich DM, Milad MP. Accuracy of the pelvic examination in detecting adnexal masses. Obstet Gynecol 2000; 96:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/17\">",
"      Stewart FH, Harper CC, Ellertson CE, et al. Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA 2001; 285:2232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/18\">",
"      Harper C, Balistreri E, Boggess J, et al. Provision of hormonal contraceptives without a mandatory pelvic examination: the first stop demonstration project. Fam Plann Perspect 2001; 33:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/19\">",
"      Gupta S, Hogan R, Kirkman RJ. Experience of the first pelvic examination. Eur J Contracept Reprod Health Care 2001; 6:34.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.guttmacher.org/statecenter/spibs/ (Accessed on February 09, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/21\">",
"      Ekeroma A, Harillal M. Women's choice in the gender and ethnicity of her obstetrician and gynaecologist. Aust N Z J Obstet Gynaecol 2003; 43:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/22\">",
"      Patton DD, Bodtke S, Horner RD. Patient perceptions of the need for chaperones during pelvic exams. Fam Med 1990; 22:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/23\">",
"      Committee on Ethics, American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 373: Sexual misconduct. Obstet Gynecol 2007; 110:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/24\">",
"      Petravage JB, Reynolds LJ, Gardner HJ, Reading JC. Attitudes of women toward the gynecologic examination. J Fam Pract 1979; 9:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/25\">",
"      Broadmore J, Carr-Gregg M, Hutton JD. Vaginal examinations: women's experiences and preferences. N Z Med J 1986; 99:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/26\">",
"      Hilden M, Sidenius K, Langhoff-Roos J, et al. Women's experiences of the gynecologic examination: factors associated with discomfort. Acta Obstet Gynecol Scand 2003; 82:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/27\">",
"      Ueland FR, Depriest PD, Desimone CP, et al. The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size. Gynecol Oncol 2005; 99:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/28\">",
"      Granberg S, Wikland M. A comparison between ultrasound and gynecologic examination for detection of enlarged ovaries in a group of women at risk for ovarian carcinoma. J Ultrasound Med 1988; 7:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/29\">",
"      Oyelese Y, Kueck AS, Barter JF, Zalud I. Asymptomatic postmenopausal simple ovarian cyst. Obstet Gynecol Surv 2002; 57:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/30\">",
"      McDonald JM, Modesitt SC. The incidental postmenopausal adnexal mass. Clin Obstet Gynecol 2006; 49:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/31\">",
"      Rulin MC, Preston AL. Adnexal masses in postmenopausal women. Obstet Gynecol 1987; 70:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/32\">",
"      Barber HR, Graber EA. The PMPO syndrome (postmenopausal palpable ovary syndrome). CA Cancer J Clin 1972; 22:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/33\">",
"      Miller RC, Nash JD, Weiser EB, Hoskins WJ. The postmenopausal palpable ovary syndrome. A retrospective review with histopathologic correlates. J Reprod Med 1991; 36:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/34\">",
"      Flynt JR, Gallup DG. The postmenopausal palpable ovary syndrome: a fourteen-year review. Mil Med 1981; 146:686.",
"     </a>",
"    </li>",
"    <li>",
"     Myers ER, Bastian LA, Havrilesky LJ, et al. Management of Adnexal Mass. Evidence Report/Technology Assessment No.130 (Prepared by the Duke Evidence-based Practice Center under Contract No. 290-02-0025). AHRQ Publication No. 06-E004, Agency for Healthcare Research and Quality, Rockville, MD February 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/36\">",
"      Dragisic KG, Padilla LA, Milad MP. The accuracy of the rectovaginal examination in detecting cul-de-sac disease in patients under general anaesthesia. Hum Reprod 2003; 18:1712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/37\">",
"      Davisson L, Clark K, Powers R, Hobbs G. The rectovaginal examination: physician attitudes and practice patterns. South Med J 2006; 99:212.",
"     </a>",
"    </li>",
"    <li>",
"     Patient Care. In: Guidelines for Women's Health Care: A Resource Manual, 3rd ed., Hillard, PJ, Berek, JS (Eds), American College of Obstetricians and Gynecologists, Washington, DC 2007. p.168.",
"    </li>",
"    <li>",
"     AHRQ. The Guide to Clinical Preventive Services. www.preventiveservices.ahrq.gov/#uspstf (Accessed on November 29, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/40\">",
"      Hurd WW. Rectovaginal examinations and human papillomavirus: can we decrease the risk of colorectal infection? Am J Obstet Gynecol 2008; 198:260.e1.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cms.gov/MLNEdWebGuide/25_EMDOC.asp (Accessed on December 21, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/43/42681/abstract/42\">",
"      Committee opinion no. 472: Patient safety and the electronic health record. Obstet Gynecol 2010; 116:1245.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3253 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-36135ECCB4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42681=[""].join("\n");
var outline_f41_43_42681=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10697154\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GYNECOLOGIC HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Basic history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Problem focused history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Vaginal discharge",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Abnormal genital tract bleeding",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Pelvic pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Urinary incontinence and pelvic organ prolapse",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Sexual function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PELVIC EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6245040\">",
"      Timing issues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6245397\">",
"      - Age at initial examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6245405\">",
"      - Frequency of examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2506475\">",
"      - When to discontinue examinations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6245684\">",
"      Preparing for the examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6245575\">",
"      - Patient consent",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3878502\">",
"      - Chaperone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6245676\">",
"      - Patient anxiety or refusal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Patient positioning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Equipment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Components of the examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Abdomen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - External genitalia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Bartholin and paraurethral glands",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Speculum examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Bimanual examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Rectovaginal examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6244552\">",
"      SPECIAL CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6245199\">",
"      Examination of infants and children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6245207\">",
"      Examination of women with limited mobility or obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20370127\">",
"      Examination after hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      DOCUMENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10697154\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/3253\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3253|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/52/37710\" title=\"figure 1\">",
"      Menstrual calendar",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/50/25379\" title=\"figure 2\">",
"      Vulvar anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?33/49/34580\" title=\"figure 3\">",
"      Uterine size by age and parity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/35/27192\" title=\"figure 4\">",
"      Uterus position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/37/35421\" title=\"figure 5A\">",
"      History physical exam A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/16/26893\" title=\"figure 5B\">",
"      History physical exam B",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3253|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/45/36571\" title=\"table 1\">",
"      Gyn menstrual history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/27/16827\" title=\"table 2\">",
"      Obstetrical history 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/11/33980\" title=\"table 3\">",
"      Review of symptoms in gyn",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/45/26334\" title=\"table 4\">",
"      Causes genital tract bleeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/2/14379\" title=\"table 5\">",
"      Assessing menstrual blood loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?40/25/41371\" title=\"table 6\">",
"      Infertility history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/21/24925\" title=\"table 7\">",
"      US recs cerv cancer screen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/39/39547\" title=\"table 8\">",
"      Normal uterine dimensions on ultrasound examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/2/23595\" title=\"table 9\">",
"      Examination of disabled women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/23/19831?source=related_link\">",
"      A patient-centered view of the clinician-patient relationship",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/33/40473?source=related_link\">",
"      An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/58/12200?source=related_link\">",
"      Approach to the patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/1/24601?source=related_link\">",
"      Approach to the patient with an adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/49/36633?source=related_link\">",
"      Approach to women with symptoms of vaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/21/24922?source=related_link\">",
"      Assessment of the newborn infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/15/24825?source=related_link\">",
"      Breast masses and other common breast problems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/26/41384?source=related_link\">",
"      Causes of chronic pelvic pain in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/32/35337?source=related_link\">",
"      Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/15/40185?source=related_link\">",
"      Cervical cytology: Interpretation of results",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/2/30762?source=related_link\">",
"      Cervical intraepithelial neoplasia: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/46/37609?source=related_link\">",
"      Clinical manifestations and diagnosis of localized, provoked vulvodynia (formerly vulvar vestibulitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/14/29929?source=related_link\">",
"      Clinical presentation and diagnosis of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/32/23048?source=related_link\">",
"      Congenital cervical anomalies and benign cervical lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/24/5512?source=related_link\">",
"      Consent in adolescent health care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12473?source=related_link\">",
"      Diagnosis and management of congenital anomalies of the vagina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=related_link\">",
"      Diagnosis of gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/30/37349?source=related_link\">",
"      Diagnostic evaluation of vulvar lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/30/16874?source=related_link\">",
"      Differential diagnosis of abdominal pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/57/19352?source=related_link\">",
"      Differential diagnosis of the adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/8/20618?source=related_link\">",
"      Differential diagnosis of vulvar lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/54/22375?source=related_link\">",
"      Disorders of Bartholin gland",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34697?source=related_link\">",
"      Etiology, diagnosis, and treatment of secondary amenorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20601?source=related_link\">",
"      Evaluation and management of adult sexual assault victims",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40921?source=related_link\">",
"      Evaluation of female infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43316?source=related_link\">",
"      Gynecologic examination of the newborn and child",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/24/40323?source=related_link\">",
"      History and physical examination in adults with abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/1/42010?source=related_link\">",
"      Initial prenatal assessment and patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/15/6393?source=related_link\">",
"      Intimate partner violence: Diagnosis and screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35113?source=related_link\">",
"      Overview of causes of genital tract bleeding in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/24/39306?source=related_link\">",
"      Overview of contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/3/8249?source=related_link\">",
"      Patient-centered interviewing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/1/20499?source=related_link\">",
"      Pelvic examination under anesthesia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/46/8937?source=related_link\">",
"      Pelvic organ prolapse in women: Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/41/2711?source=related_link\">",
"      Postmenopausal uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/12/35018?source=related_link\">",
"      Prevention of sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/13/8408?source=related_link\">",
"      Screening for Chlamydia trachomatis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=related_link\">",
"      Screening for cervical cancer: Rationale and recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37034?source=related_link\">",
"      Screening for colorectal cancer: Strategies in patients at average risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/14/10474?source=related_link\">",
"      Screening for ovarian cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=related_link\">",
"      Screening for sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/42/25258?source=related_link\">",
"      Sexual dysfunction in women: Epidemiology, risk factors, and evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/51/37689?source=related_link\">",
"      Sexually transmitted diseases: Overview of issues specific to adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/24/23944?source=related_link\">",
"      Terminology and evaluation of abnormal uterine bleeding in premenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/3/10295?source=related_link\">",
"      The pediatric physical examination: The perineum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/57/42904?source=related_link\">",
"      The sexual history and approach to the patient with sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/30/31208?source=related_link\">",
"      Vaginal cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_43_42682="Breech1";
var content_f41_43_42682=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F70941%7EOBGYN%2F51966%7EOBGYN%2F59678%7EOBGYN%2F73540%7EOBGYN%2F52537&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F70941%7EOBGYN%2F51966%7EOBGYN%2F59678%7EOBGYN%2F73540%7EOBGYN%2F52537&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    The fetus emerges spontaneously (A), while uterine contractions maintain cephalic flexion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 262px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Premature aggressive traction (B) encourages deflexion of the fetal vertex and increases the risk of head entrapment or nuchal arm entrapment.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Gabbe, SG, Niebyl, JR, Simpson, JL (Eds). Obstetrics: Normal and Problem Pregnancies, 4th ed, Churchill Livingstone New York 2003. Copyright &copy; 2003 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    Delivery of the lower limbs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    After spontaneous expulsion to the scalpulae, external rotation of each thigh (A) combined with opposite rotation of the fetal pelvis results in flexion of the knee and delivery of each leg (B)",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Gabbe, SG, Niebyl, JR, Simpson, JL (Eds). Obstetrics: Normal and Problem Pregnancies, 4th ed, Churchill Livingstone New York 2003. Copyright &copy; 2003 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    Delivery of the upper limbs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 209px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A towel is wrapped around the fetus for better traction. When the scapulae appears under the symphysis, the operator reaches over the left shoulder, sweeps the arm across the chest (A), and delivers the arm (B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Gabbe, SG, Niebyl, JR, Simpson, JL (Eds). Obstetrics: Normal and Problem Pregnancies, 4th ed, Churchill Livingstone New York 2003. Copyright &copy; 2003 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Beginning delivery of the head",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 448px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Following delivery of the arms, the fetus is slightly elevated. The fetal face and airway may be visible over the perineum. Excessive elevation of the trunk is avoided.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Gabbe, SG, Niebyl, JR, Simpson, JL (Eds). Obstetrics: Normal and Problem Pregnancies, 4th ed, Churchill Livingstone New York 2003. Copyright &copy; 2003 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Delivery of the head",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 448px; height: 322px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFCAcADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqhrmof2Vpk180TSxQYeUKeVjyN7AY52rlsd8YoAv0VQvdTgtrO2uk/fwTywxI8RBBEjqqtnuPmB47VfoAKKKKACiiigAqhqOrWWnSpFdzFJHjkmVQjMSibdx4B6bl/P2NX6zdd0a21q1SK5MsUkTeZDcQPslgfGNyN2PJ9QRwQQcUAX4JoriFJoJElicBkdGBVgehBHWopbuKK8gtpCRLOGMfHB24yM+uDnHsfSuGsr2+8IeJbXT9XRH0jVZDHDewRhIo7knKq6Z+RpORx8pYDGC5FdN4sPk2NterkPaXcMvBx8pcI/8A447UAbZrP8P3z6notpdyoqTSIDIq9FccMB7ZBqkurfYX8QvqEpa30/8A0gHA+WIxBiOPQq/WvL9P+A3h7VbC31DVL3XoL+7jWeeKC92IjsMlQu3gAmgD22ivGv8Ahnbwl/0E/Ev/AIMf/saP+GdvCX/QT8S/+DH/AOxoA9lorxr/AIZ28Jf9BPxL/wCDH/7Gj/hnbwl/0E/Ev/gx/wDsaAPZaK8a/wCGdvCX/QT8S/8Agx/+xo/4Z28Jf9BPxL/4Mf8A7GgD2WivGv8Ahnbwl/0E/Ev/AIMf/saP+GdvCX/QT8S/+DH/AOxoA9lorxr/AIZ28Jf9BPxL/wCDH/7Gj/hnbwl/0E/Ev/gx/wDsaAPZaK8a/wCGdvCX/QT8S/8Agx/+xo/4Z28Jf9BPxL/4Mf8A7GgD2WivnLx/8LPh/wCCtKS61DU/FM93cN5VnYwX+6a6l7Ii7fpk9B+VcVpvwnnNg0+qz6sl1O+Ut4L6ULbL837ssYiJW+XlgQOeB6gH2FRXyDf/AA0sLSK5c3PiFVD/ALtpLqR/k3ICcBAWA3deOo68ipo/hnpvmxRGbxA4aMOZPtcgx8o7FQOTk/e6H2oA+uKK+VPh34fTwr8f/DVja399OksN6ZY55t20rG4AIDsOnPbtxX1XQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUhAYEEZB4INLRQB80aZ43m0SDx94Xlhf7BoGotPpEzN8qCKTzltMnodsbbM9QGHYCvpCxuor6yt7u2cPBPGssbDurDIP5GvD/hTpGn6942+MumaxaRXljcarGssMq5DD97+RHUEcg16H8MD/ZmmXPhW4cm50GX7NGHbLPanJt3/wC+MKT/AHkagDtKKKKACiiqGs6vZaNaifUJvLDsEjRQWeVz0RFHLMfQCgC+favM5vEnijwuBNr9jd6nbK4W4+zWm9gucebCYs5XuUdVYDOGbAz0P/FVaxJvjkttA09hlQ0YuLwj358uM+37z8KP+EQmlKte+KPEdwwGCFuUgBPriJFoA15F07xP4f8A3UqXWnX0QZJYzkEHkMp7EHBB7EVha1eyS/DG5ur1gbkWmHZeAZRxkfVhUdt4CXTExoXiPX9POXfb9pW4jZ2YszFJVYZLEk4x1Ncz4iGraTpmieG9fa2fTpNRhkl1kYiieKJzO6yqT+7kYxgDGVOTjB4oGibxHfQah4mvtEaTB1bVbbTmXBO6KCBbiX6Ahtmf9qvVa8d8H2zyX/hjVL0zvf8AiLUrnWSsh/1FuIJPKjA7Da8WfVj9MexUCCiiigAooooAKKKKACiiigAooooAK5b4g+NtO8FaXHPerLc3103k2VjAN0t1LjhVHp6k8D8qd4+8ZWHg3So57sG4vrp/IsbGMgSXUp6KvoOmWPAHXtXiiadqms63/bGs3P2vW7h9k8lvkR2UAeIiCAMuR947mBBb1wcEANN0+8v9RuvE+v6hDeeJLiKRA0U0TQWcWwnyYMvtIXK7mI5OevJPQWv2SLzLiVbOVi6/uoWiIdhuAIUNjb+OelRW7Tw2iW1lDdRCAYcTPNGFJjbAXbKBkBB04x3GanfdHKEt57lZml3rG08reYFdt+CZRyQAPTjpzQMybsaRBZvHDHKgAZnSS2hEecRYG5Rn0PTJJ9KeGuY4ZIYpEjjKuijZsCfI4yuIiG9CD04wKNU+1y+X/ZMUE8So0jRyNuxhIxs3ed1ITGD79OtZd2iy6taRRS28MCkFisyMFQFjwWkYDkDOAR1HNAhvhnzJP2g/B09xI8lxLa3pdzGUVsRsPlyi5H+TX0zXzD4TmtZv2hvCRsYwkItLrG1o2Qk24Y7SgHGWI/Cvp6gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKR3WNCzsFUdSTgCq0Oo2MzBYby2kY8AJKpz+tAFqiiigAooooAKKKKACiiigAooooA8X+Bn/JTPi7/ANheP/2rXZePtNu7K/svF+hwST6lpiGK7tYhlr2yJy8YHd1Pzp7gj+KuN+Bn/JTPi7/2F4//AGrXtFAFPR9TtNZ0q11HTJ0uLO6jEsUiHIZT/np2q5XlniSXUvh14ps7/Q9Pmv8AwvrE/lX2nwEb7W5Y5E0IJA+c8MndsEctz6FomtadrloLnS7pLiPowGVdD3V1OGVh3BANAEfifW7fw9os+oXQLBMKkYODI7HCoPckis3wrpk8s763rcatqk4xGWz+4j/uIp+4D3/iPG7nhWXcUeveNYbeZEkstDVbkhuc3bg7OP8AYTLfWRT2rqqACiiigArI8W6DZ+J/Dl/o2pIr2t3GY2BGcHqD+BAP4Vr1R1u0a90yaKHAuABJAx/hkU7kP/fQFAHC/Dm9u/FPiG+12/sEsU0qJtEhix1mV83Lr/0zLJGq98Ka9IrivhFcPf8AhF9UaNok1O/ur2KNxhlR5mKg++K7WgAooooAKKKKACiiigAooooAK5fx/wCMbPwfpSTTRtd6hcv5NlYRECS5lPYZ6KOrMeFHNSeOvFtp4S0yOaWN7vULl/JsbCEjzbqU/wAK56AdWY8KOTXj1vp2oalqUmt6pqf2rWbo+W89s+YoIthfyICGBSMKwJbq7YJ4oHYQQalc6tca1r99bz6lLBIlwWjiaGKLdIhtoA0n3AyZ3Yy5+9gYFSukcEaxnUdPitB+8EaeSGOxoWCqu8k/KpG3JHH0rQuGv3uHwZ4XjIiSKPzHLgu3fzwAc4zx69uhfXTCOK4mkuGgXJwBKP3mwEgnzuMnAyTtHJPrQBgXDXVrfiaB3eMKYltioYN8siBwBkgkE8An5uOeK1bV2kjmu7MqHlZ5ESNpOAemR5LKDhccE8nnqKpX76nI8Kwz/YGh3hWhMmWw6r1M2ATuOO3zVTtrWyb7DePcoL2SDyxCdrKcxoSpZtwIBJGenzdx1YjdktLy509WGnAWhBZkeKQ715+YEQZXAXgY+hwRmzcW7JKJnju4C7rH5flyRgF3BHzGE4OSO/cniqyyWzz3xDCR2JULIkBLsd4G4heoJIHYgfmqPIrubVrRlDiYIrRBsgICD+6IyCAewwvtSGYHh5WP7QXgq4KyqtxYXMgV3DYJt/mHXruyDwOnHFfStfNPh6GWL9oTwb9pCLM1rfZCeXjAR1B+RV6gZ5H0r6WoEFFFFABRRRQAUUUUAFFFFABRRXPeJ/FVpoTpaxwXOpavMpeDTrJd80g/vHsiZ43sQPx4oA6GsHWfF+gaNdpaahqlul9IQEtIyZZ2z6RJlz+VcjqVj4p8SXP2LVL8aerKHfTdKmKCKM9PtFzjexJBGyIJnB5xzW34Q8F+F/h9aXE2n29raTXLZuLyVsPIxOdu5iSFz0XP5nmgC1ca1r90M6J4czGVysup3QtQTn+4qu/T1Cmof7K8U6oy/wBra3b6Zb7cNb6RFl2PvNICQP8AdRT71otr7TH/AIlmk6ler2kEawp9QZSuR9AafBqmoqrve6LNEo2hRDMkzMScYxxjHXOcUAZ9v4C8Oo6yXdi2pTjnzdSme7Yn1/eEgfgBV6Twj4bkCh/D+kMF5XNnHx9OOK26KAKem6ZZ6YkiWECwJI24ohO3PsOg/CrlFFABRRRQAUUUUAFFFFABRRRQB4v8DP8Akpnxd/7C8f8A7Vr2ivF/gZ/yUz4u/wDYXj/9q17RQBV1XT7XVtNubC/iEtrcxmKRCSMqR6jkH3HIrzE6HBY38GmeJ9V1a0u1Pl6draTqDOvUK0zKSsmAAUY4fGVzkgesVT1jTLLWtLudO1W2jurG5QxywyDKup/z17UAcp8OLeXS4fEq6pqsuoTJqzB7y6CIzL5MIQNtAXhdo4Az+NdvXlUnhl/A+l+ILSxiafQ9SjMsItoCHtbhUwN6pnKvtT51AwRyOc16VpGoW+raXaahZOJLa6iWWNh3DDNAFuiiigAqq9wk7XNtBMYrlQVBZOQSBhgDwwGRyMjPFWqp6nptrqUSpdRklDujkRijxt6qwwQfoaAOZ+ELy/8ACBWFtdJHHeWTzWdzHH91ZY5XVgPbIyPYiuyrzCwtbz4a+INQu9QvrrUvC+tXIlluZVXfp1w2E3SbQAYnwoLADaRlupavT6ACiiigAooooAKKKKACud8ceK7PwloxvLpWnuZD5dpZxsBJcy44Vc9B3LHhQCT0pfG3i3TfB+k/bdTdmkc7La1iG6a5kxwiL3PqegHJwK8ejubjWtd/tnWZNOuNSlcwLFHNKfsKc4hjxtOfu7yc7ySOAAKAIbC4utVv21zWr6yk126UIypcx7LaPcpW3iCy8ockk5BcjJ7CrM/kqqJdz27OsB8tIriKR1AjdSAhZmbg8jPbtVv7XeKm6WOeCLYrlmEwDMoGW4kx+Y/PFUbqKe7Fs828qsqNE7NLjzckDAebB4JBBH+FAyyNPS7vJp/JuoCR83nWu4qgORyIMd8/eOATzxUsc9x5Bmaa3gMgZxGYypH7qUAMTb4I/dt16BfQiq0AeaTN9HapcKUZJDDHHgMkeJNxc85Ugj/aORUqRCa0Oy9hWJSfJZZrfYM+aGOM45HuO9ADbvT7WJZb67co0IjhaMW84ESCVCfmRFJypyMdS3sayIFuIbO5FvA3mvbMo3lwAxtxt2ljjdtBzzjJxnPNaXnW1s4mu5bZLmEgI0JhDMMx8AZJbhc8dMLisZ7aK6ilewsktriFV2OpEgI+aMjd5JwxHU+p9DyAbct3P9nRpbhLZ0bayi4yoLF2KOftCqcErzxg46cVbjuIJR5Dt50gTJmE4Vw2wEgEXHDcD8881hWUk7+WY4DJPxIuIyyxZZWIUxxdMSgnIHv3rcWW6aP7QxvDMEeMhPNAACOWUAoAc7QPYmmBz+hyrJ+0H4I+YGVbK9SUCbfhgsg/56OV428Zr6Tr5v0pZh+0b4Pa5SQSNaXmWdmbeRE3IyB9OB2zX0hSEFFFFABRRVXUtRstMtjcaleW1nbjrLcSrGo/EkCgC1RXCTfFLw9M8kWgDUPEVwnGzR7N7hc+nm4EY/FqifxT44vFX+y/ADQB+BJqeqQxbOerJHvP5UAegVHPNFbxmSeRIkHVnYAfma4+Lw54n1Hc+v8Ai2a3Drj7LotuluiH/ro4eQ/XK/Sqlv8ACjw4dThv9XbUdeuIgVT+2btrtAD6I+VH1AzQBV8ZfFTS9NtGXR3ubotIIH1OGxmuLO0z1d5EGG2j+FSecA45IoeFfEvh+PRbqfwjevfNK+b/AMSampiiLd2aVwu8gfdjQbR0+UV6naW0FnbR29pDFBbxKFSKJAqoB2AHAFcfqfhTTNJ1pvEWnaTZOdpN7D5IJdQdwlj44kU5OBjdk9wKADSrq71GJk8KRNDZTMZJtZv0JadiMboozgucYwxwgAG0MOBu6b4ftLSYXE7TX991+1Xj+Y4P+yPup9EAFa0brIiuhDKwyCKdQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeI/A+5gj+KXxZgkmiWaTV0KRswDMP3vQdTXt1fJGn2mkXHxT+JUusabp975OpOYzdW5lI+/kKQ6lenr2H1rsrTRdKsjnQNe1jw9CHCobG8kKFvMAOY5pXRsDjbjPcA9KAPoWivE7bxF470KKOb+2ND8R2hIzFqJh0+crtDcSI7R8A91/pnptH+Lehy3i6f4lhufDepFtgj1ADyJG/6ZzrmNh6cg+1AHo1cD4jivPBM+oeIdGRrrS59r39nJMdtsA+WnhXsMM5dcjJwRzkHu4ZY54klhkSSJxuV0OQw9QR1onhjuIJIZlDxSKUZT0IIwRQA8EEZHIPejvXM+A7x/7Om0a9m8zUtGcWkxJ+Z0xmKT/gSFTn+8GHatq41Oyt7V7iW6iEKOYiwOfnB27Bjq2eMDnPFAFyiiigClq+nrqdlJaySvHHICrhVVg6kEFWVgQVIPIIrj9GtfEngjS4NP8AJk8UaVB8kMkTLFeQxjorK7BZQBgAhlOB0Nd7WOfFOgC4e3OuaWJ0ba0Zu49wbOMYz1z2oAz9N8daFd3qWNzcS6ZqT/ds9Tia2lb/AHd+A/8AwEmuorA8aXmiWujhfEVtFeW9xIsENo8Ima4lbO1EQ/eY8/TkkgAmuH8JeCdUvoZbm41TX/Duiy/8eeh2983mW4BPLyNllzx+7Q7VHc0Aer0VxcOn694TikbTbi88Sad942t7ODdxnv5crYDj/YfHs3ajRfG13rtk9zpHhu/kEbmOSKeeCGWFx/BIhfKt7H2PNAHaVg+M/FOn+EtGa/1FmZ2YRW9tHgy3Mp4WNB3Yn8B1OAKyLjxX4itLaQ3HgXVJLkqfIS1u7eVHbsGYsNn1wR9a8yudE8ZXuqP4o8S+Gby71RY5AkMc1vImnx8/Jbp5o3Fl+8xwzZwMDggGfdtc+I9TGueIGWae5iaJI4mDQ28bbx9mTIKnOzLP95z6AAVrQWqBbP7JLHLdpMd0ipEBE7sg5BtzyFIGewHX1rQ31vrNrpl/p1yXtblBKJXikiEUZMgA4k+XlWzk/wBBVaytLBSYWe2n8lAJleWN1hJMDN5nmOPvEjnGeOD6sZo3Vstre+YySSzMpjgjhgyQhUk4P2XG7HfrzirMthdGX/TELxyOscLBMOWL7A2Ps4A6k9e3YGqmmzQLZQpcraTSqwDTSGFRgCXYuQTz+7x75XHApQlojFLiWE3PnGYsBb7ELueABkk8+/A5xSEVNPFpYT20UjSm8BTZKEeDDGMM7Z3oCA2Rnk/MADV7UpJpI0cuvnby6LNdsU2hm+bH2n7pJx+YxzxBYTxQzTwJcRXE5hUh4LcBQSuBh4xyAVPB4GMY70tnqiTrEs/M+AHcgpHI4ZSxX5Mnh+V9Mn1NFwLM0k/2d1xOJ2YkM0hVAQByMXeQMpn/ACaq6gvl3h+33LSyNthRxORkbyxyGkO0ccDJPB9MVPp/mfYzJFBfMksfmNOyHY5KScjEeDjC59CR15pYdLLPKPJ1AXKskqOzSsXzKo3Y2jlQCvY49uaBmMgillLxeXZMsBZJTJGwCGOEoeFJwMg4AHTqRxW7iG4Rx58I8uMqPKw22QmbIA8g8HngnqfzqQaZcbIrVt/mQw5Zmt5G5EMaht+8YGMckHGGHOTm6kVrbtPaPHBblJikcsk0TCcMHckBpVIUGTnjufXNAGBo0UaftGeEHRQrSWt7IeFDEGNiC2EXnk8HP5V9J18w+H5IbP4+eDpLiWOGNbK8Ls7xhV/dNz8rsB+OK9cbxbrXiyYw/D+1gGmAlX1+/U/Zzjr5EQIaY/7WVTjqaBHoEjrHGzyMqIoyzMcAD1Jri7j4k6HLdyWfh5bzxJexnDx6RF56If8AblyI1/Fs1EPhrp+okS+Mb/UPE0+Q229l2Wykf3bePbHj6hj712WnWFpptpHa6dawWlrGMJDBGI0X6AcCgDhntPiB4kZhd3tl4R09uBFZ4vLxh3zIwEaH/dVvrVnSvhd4atLlLzUoLjXtRU5F3rMzXbg+qhvkX/gKiu5ooAZFFHDGscKLHGowFUYA+gp9FFABRRRQAUUUUARwQwwKUgjSNSzOVUYG5iST9SSTUlY+k7m17XHOdqyRRDPqIwx/9DrYoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPk/SNPa6+J3xKnjtzM8Gr44IBAKTc/dJODg8c12cl3JZ6pLdBGjheNXkj8uRS7LKCdqhOpyoPORnNcXplhd3vxJ+J4stZvNLcasFJhjt5I3J8wDeJuw56epHetm7sPFtvfI0Fxo2vqszSsssiWdw425YMmWi4+U8EHK/jQO50un6rLb7ZZpbsyyYlVXmkJRAPmIBbpkHPH1rUu/KvreN7yxS6tJd/nRXUUjxvGzDBMZYg5L4+7u/lXG6NrNk2qfZ71JdO1S7eOKSC7iREny7k7ZDlJMZQHazZI6Hv0Mb2kysfLP7pP3kbQRMpAELHlU4Oc4+XuenSgDPTw7f+G5J73wNqkuiXIcs2msWm05jk/KYmBKZwfmVh7DpXc6F8SHtL620j4g6eNA1SdjHb3QffY3jDj91L/CT/AHHwenU1jPfGa5WBJYYUXeGiYDcGYSENzBnnBHX2IOec670XSb2A2N3bvcWs8haS2dSolyYTyFi5zjOe3b1AB3vjfQdQS/h8UeExH/wkFpH5clvI+2PUbcEkwOezAklH/hOexNYPwnuDfeGdC17xC3kSXKbLC2kOSZJCWklx/fdi2P7qAdMtXL6L40n+HCXPh7xPd3Fzoz2ck2jajck+YpSPcbWUkDLD+Bu4wPYdH8IfBq3Xgzw7rPiOSebWP7Pijt9krxCzgKjEcYUjaWXaXbqxJ7AAAHey68socaXazXpQkNL/AKqFcdSZG4IH+yGPtWGL/wAbT3QewtdAnsyQ+6R5Y1ZCM4ST5ix5HOwL1qpq66vp+uf2Ekom0nW7S4gt5biZna2nCEqMsSzBl3EjJ+7kY5rpfCWqrfeHo5ri3+wS2xe2uIJHB8l4yVYbu44yD3BBoEcpqOtzeJvEWneE72x1DSt0Ul3qQ3MiyxoVVYo5hgOrs6k7edowcEkV3MWk6dFZR2kVhaJaRrtSFYVCKPQLjFYniC/tr/R7u+0YC5v7GJpbedYS20H7xjYjDHAPAJyQKoWnio66BpTGTTdRkCyfumDm6tjtzPbMCQUJYDceVGTgHFAFWy0JND8ZaP8AbkSeziimg069ncvJG7YKwYPCkIJAGGNw4PIGehbxKlr4oGi6rbtZm4XdYTs26O7IyWQHs4AB2nkjJGcGneJ4LCz8Kz/aTNHbWgWZJE3SyRurBlcZOWIYA45z05ziuW1PxjZaroUthd6BPrOpiVrSTTo1TBukPT5juRfuuHIwFYHOeKBliy8QXWv+KdGSzu4m05luHmiUSRgtFKUyHB+ZvuZjYYAyT2FaWsvHo/jvTNR+dIdQtZrS4WOIuZJIwJYzheSwUTAcZ5xXB+FLG68D+KNM0/xRqsC3PiCWe4skildxZzjZvtw0hJkR4wo3N/EnAywrsvjSkf8AwrnVLmSJJWs2iuo1foWSVSAfY8gjuCRQB19rf2l3Zi7trmGW2I3eargrj3PavPvHXxFijs5tP8JSC81GT9y19EN8FluDfOTzvcbWwi55HzYFcLe+GNItj9ntdDsbfy7hyUWybbIu+JsMe7Bd+DnvVLVIyjQFXurgOzwkhsryhCKvmP8AKwZmyvQjjGTyWEatvbR6fY2NrZQSpaWpjhRIVLNsDuCSywFjnAJPH3uvNT3CXZASETG3k2mdGRhgBVBLZhUgfKgzknjp1rPgubFhLqF3d21sRbxkqtnGsgUuTlTv98kkfriphNbXLC8nnQuUAd1eAByu7CgM42kY6/kcZFMDQQvpyXVtaLKqjrJH5sZVcvt+cyEOdz+3T6Go7nzHwA98y78FTIyIUbBK8zjp8x/L0qG0axuXnksoUlDgSu8k0YZcOCAx8wLgHjGMe/PM93d3MEOyQRrbLGQ227jZ1VUZsnfkY+U9OmQcnBpDMjUNJ+1zeSYNo2h3mV/nbLOhBBlcHkk56deKjsBHaxfYy8EjQMskcqCNmeT91lSHfhjjB4xznpgV0KwStNIF3yH/AJZwq2F/1mRyIAMcnBGQcn0qK30+YsqR6bduwRid0cvAMCjBXy8HBQd/oPViM4i3FtGL1IJcQb3lfyIQ2VuQMsoK5yEAwDyM/S4mHHl5tri3mBkJPkkbSUYKMQgAkrjntjqal1TR9Vli866mjggaR5GGyV1/j2qCmzIJkyMDrxj0zo9UWGeOJ2urtpQ7Ku2aMphckFCw5GxiM4JBPbFIZb/s2zlt7O3ubZcRtkhCq5B425SEDp1X6HtmpdRvI9KuT9tvL2GGWRvJhWaSR7h2MZMcUQQFm5yFVs5HYZIjjnvtZvJdH8MRx3moox86Zg62tiCzAmRllbMgxxH97nnaM16H4L+H+m+G7ptTuZJNV8QyLtl1S6VfMxj7kYAxGn+yv4k0Aeb6H8H7nxZ4g0/XvH8EMVjZIBa6VgmSYYGGuTuZR0H7tSR6kndn3iKNIYkiiRY40UKqKMBQOgA9KfRQIKKKjuZ4raCSa4dY4kG5mboBQBJRXJeLbzWL2/j0TwxKtvcFDJeXuAfsynhAMgje3J6HhTwNwI6ezieC0ghlme4kjRVaZwA0hAwWOABk9eKAJqKKKACiiigAoJABJIAHJJorjfiFr1vbPpnh1ZEOpa3L5McbPtAiX5pGfkfLgbfUlsCgDZ8KP9o0tr/BH2+V7lcjHyE4T/xwLWzSRqERUUAKoAAAwBS0AFRyzwwvGsssaNK21AzAFz6D1NZOqa7FbiSO0MUsyHbJI8gSGA/9NHPAI/ujLe3esOz0m31u+t7uRDfPHKsz6lcQ7eUbcsdupHypkDLDqO7EkgA7aiiigAooooAKKKKACiiigAooooAKKKKAPlfwpI6/Gjx8iyxojawC+6RlLAM2AMDAG4jJPpjua9AMV/JMZBOu2JBJLFG8v3mgI2koD0ZQfYn1xXBeF3aL4qfEx4ppI5hqq7Au8B/3hyDtkQenXP4d+zniR7qbzkXe3JiLZ52yAk7ZWOznbgjn1oGXbxIdUDWtxZvdRFwZrYpI8cuDkoS0JBHPXrx2zXN/2PcW0anwgL5IBEoFre+dJCSY42OHC74Dg5wSy5UYAzWwVSxsZGFlHaRtcODazRiESNhS3DQsDxgZzjHfjiuXsoIVZooC0KjfH5ETBcIQRxASSMYwB2HHagNjIsNTL+IJLW8gvrG7RHAtJn/ezYZxvRiWWRBvAyCT7AHFamkzW90XeCKKBISjeYoXCfIucMZRkjy2JOM/rgk0fT9S02eCSxjueFlEIPleUSFK/MIQ0Z2yMNy4P45xgm2v/D1tKGM+o6LGMI0Uubq3+WckvuUecqlmbcgDAICVNAG74v0qDxhouoaJcy7YZYwY1aWLCTICquP3/YlcjqeeuatfCfxhMbCzuZmQW9nCbfW7RXCvYyxxogm8vq0bCNW3DONzds4t6Vq1te29ndaZdS3VpMVaO4WSdw2JUHTOOhz7YxjrWJ4i8L6R4ghlbUtHOoSSRhYrna3nLiJSQJdwJGAMKePmOO9AHtPizT7jUdGP9nCI6jbOl1aGQ4XzUOQCewYZU+zGuTuobi4vn18WUmoeHb9LW8FpaviWKZAMyupYBxtIBUZ/1Q4Jrm7LVNf8L2cFjoFxcXdgd0cEOoWxuDbxg4Ta4dXKgdn3HjGR0rkbTSPEel28cUHj7xBZoFaRRHBFJFnDSPtjJ3BRgnHOBxmgR714mvLuPRYtR0VhMY2WXAkRY3iP3mYsRlQpLcEHIHNcBpEkF3rcuk6TOoZ1k1nw9eSL/qG37bi1bH8IZuV/uyYH3QawNB1HxH4R09rS9vtP8X2EsjzpDcqlhJE/mH7rbmXbvycEADjB7VF41TUvHWraZN4rgstD0exDtBBa6ujzXjvsVgZUxtQKwOB1yMkDoDPWo76DxXYPYgQQzRSCPULSdUlkt2XBC7TkHJwQ3TGCOox5dBrmqeHvHfiWz8HacmuNdJaWy6he3kccX2iNCH8xxguQkkKkKM8ckGsS28IeHdKtrhdM0zTXldZNoT/SGcqJV/1r5YrlV6DGV/CpI737HHbWFhIbO3t5hFEkW6OEP5i4GwRgchjkY5zkigRi+IPhtJ4x1Ia7478ZzPqLQq6LZpFHBbgqGRE3ybgOeu0ZwcnvXQXXhoa3paaXrXjHXtS0tH4trm/tkxtL7fMZDvbG1G5bkkelaRneULBa3EsUphIYRKyMQItpPyrkL8oAO0cjp2qO5F09o0fmXsMjSNKzytLhlLbhuBA9cDaOTigZg2fhZJbof2X4h8VWULMZFeW7Nz5i5i5ZGRgRxx/e2rU9g3iiwmmnWHTPESM27y4LYWFyHA2EgSIyE/Meu3gDHWrd5pjuhRtN2XSOgMzQbmxsZmG4OARwozk4HY1YWTT/ALGn2LU4ZJVbzGEcyKdolTou8AfLgduetMDPl1Cw1vUmS9ludL1X7OM2l1bZmKqAfl2RKGQYI+Qtxg8Vo2umXFtqd4IJbx9+DKYpZTuwZyu35QCD19ulF/Hp2raT/Z+pW8d7bSDaY7jY5B2feVllAH3T8wPFZt1A2h3TtG01/bRh/wB+YUa4tVZ3KjgsZkJUtnBkGO46IRuzzXUdslxHeXTyko5aOV3LBzEckhx/eHGOBmpDYraC0SSW/vGEUuDJLK4ORIACPMGfutj0z16Y5e1ubKF3RjFfOkcbqhaNgWxExK/IMglSMZ565ORWnZahHc30EE0lvti5ji3/AMRkKBxiNuAXQcYxjrimMmurE6fFcXyqsjbzI8U1uspJaT7uWYNjkdMcg5FWY5LnTLG0F/FMkrN5MrpahQ25JAC3yj5QiH1ABA9My6fI2pTyyQqZIWi2qIztCnaxOQIQ3QDj3HNSRm7028TS7LT5LuchTHZiRonWPLjzHkKDZHwMsc91GTikBWlk0bSLZLi6SylhjaNQRbxTM7YTIVVyzZ3YAUE5Jq5oXgi88Tw+TqFg2h6GFVXGUF9dLjIjO0fuFG9gf4yP7tT+C/CM2pavDf3Gq3N/HaghtQ+ZUbcoBisyeiYADzj5nxtBA3Y9E8NTxXLTHSRDHotuzW8QjTHnSK2HfPcAgrnuQxyeKANHR9KsdF0+Kx0q1itbSL7scYwM9yfUnqSeSetXaKKBBRRTElR3kRSS0ZCtweDgH+RFAD686+M/iO503SbHRtDhiuvEGrXCLa28gYoERleSR9vOwAAH/eFdZ4o8QW/h+w86SKa7u5MrbWVuN01y4Gdqj9STwBySK+eNO1Dx6uoar4k8RWOm6ml40bC1tbsSvbwIxzBGFUxsSDgBmxnJwSRQM1tN8Ka7Kl2JfHHiiW/upXlklsJdkMcjdW2R7lABGAHkTgAYGKxk0y08LavPc/EW81LXdMjZNmpnX2F1BuIHzW0UxJVWPVSSOuD273RPFHhzxfbQW+nQTxXj77aSx1sGN0dcblUMQGOWGQpOP7tbNr4dl0ZVtrKx+ysnO6wg2pz1z5cafpn60ALaaT4Tv4LZ9I8b6tFFKgaFYPEMjZU8jAdmP9a008CGWHMXjTxayNyHXUEP5HZXm3iDwtbaJczarHo9tc291OJdSS/s5pNrEhftCF4mUMoJzkkYJbGRze0nwxoRe3MMU2jahMrCOPSp5IJpHOd2xFYGTaVb95JhcqxCYoA7iD4fXNpci5tfGnimSZeVjvbtZ4c9tybVyPbIqp/wl/iTT9fuNNXSovFUMP8ArrjRwLd7Vv7kiyvsZuRgK+eOVGRnkNb8K+M3jaHwt4+1u1cBlNvdkX7GTPR5UjAi75G5u2K6f4eaktykfhe9iuvDGq2FurNpSBQZR/FNHL83mqWySRggn5smgC2fiMl9rC6ElneeH9RlX5ZtciECEd/J+YiZx1wDjvntXRaT4P0WyS8ke2XULq/wbu7vcTSXGOgYkY2jsoAUdgKkudBtp7drTWA2tWErKBb30EcwRv72do4+uT6GsKb4YaJE8kmh3Ws6DK4xnTNQkjQD0EbFowPbbQI25PCtqqqunXup6aFIIW1u22D2CPuUD6CmzeFzcII7vXNbmhz8yC5WLcPQmNVbH41yd94J8c2/OkfEbUJYgf8AUXlnb72XHaURnB99prm7DRfHq6tJE3jWa81BI940nU4xZ71GMvHLASHGTjO04zyAcUDPWNM8K6JpjRNZ6bArxACN3BkZAOylskfhW1XjK+JbuPU/7N8baOdGLELbyavq7yWlwSP4HSMIWHHDkHngda7LQE8R6EskU8FnqOhLg2otbh3uYEx935wBIo7fNuA4+agDtKKxW8UaOu4G7PmopZoRE5lUDqSmNw/KnyeJNIXSZtRjv7ee1iQsTDIHJP8AdAB+8TwB1ycUCsarOqsqsyhm+6CeT9Kp6lqUViYo8GW6nbbDboRvc9z7ADkk8D8qyrPw/DqUX2zxLaQXd/N8wjlUOtqvURp6Ed2HLHnpgDV0/SNP053exs4YZJPvuq/M3fk9TQBeooooAKKKKACiiigAooooA+XPC8Jn+J/xRCW6yyrqeUJU/KdzDqI2/LjP4cdx/wATEBZL8TRK2QLe2idc5MnBYw5+7wBgZz7DPn/hxUf4tfElClr5j6ptEk0iAxjLnKq4IYkgD2zXawQ248yCRYbm5ZtzECBsgcDbhBk5LdiBnr1oGWPsx1G2u3DzxyFzkNa3AfkDJJO1ecdMDrnPFTyRGG5kMcqO25SUI4YZY4YG4Bz0Iz2HTNZCRQ2sUky6cj7PlE8EqwF2ZJPlBjhOQCpyT0LcZxip8qJmMV9qEUsTMYoI5llbPmHK/NGMHJ6jsD1A5ANKFpJI1nt7yHz1PKeYRv8AlQ42/aMZB7+o/E1rqaKKzmaW6V0VnkAglKlwVl3KcSNzu/Tg4wajs3kurEmC7unuYvmaR4ZMsvlJ1xgYz6fWm3rPNcyusUZtW+ZC6yAum51+YswJxlkwPU8c5IBzOsaQLXWJtd8L6pb2d5873UMsSS2l0VkiA37chHJKlnXBGBwME07T/E9pP9l0zV7BtP1NiixWErxuJcqo3QyLC6yKduDt5AP5dJp0k8ZvbgJY/ZWST51SUMdyLIxyr4AxGe2fu8YrNvING1yyEGs6fBPpwlZVFzcsD1IJRmlypySRjB/DFAGydNigmjn+zzXMysQwNu0abfkOCEtu2T6fXpVYWE7afO91ZNIhidUQW2WyyOp4EC8ZIHJ9+Kw7HR9R0FbdvDuu2lzpoz5Wnan5LbFAjYgXIZnGAqjlWAGM0o8Wi1spV8TaNd6ZFLCyiWJItSgA2yBSWhU55xwQOc07COmktJhMhklEaST7Vja1eELhwpHyyAEZbr34JqeN2t7XyXM106wMIzDNICW2AkbfPJwNo67fYjdXIr4m8LPKh07XNJk07zUD7pUtZAMxElozGCejDPb8OH2Xinwwks6S67HJdSwrAiWMrXNxMPL7KiEn5uePqcdKQzrNSuRKRCkbs6pgJJclCy/vdrAmbI+6Blhn69uV1yWa20+O88U6zYWjxSeao+2DMb+WikJvckkZPK5zg8fNmrU8/i3XfL/suJfDlpMcJeanayz3xXe2D5UYKJgED5zng8DNcVc/CrR9WmW+1/UvFGrXchO64lnK7sBiesLFQCBgZz9BQBuWs2neIPKutH0DUNddIo4Y5UgitlZADhkabGRz1wQSSQemN2EXMSrFeeFdRsGVSc3ctnKG2hM5VASf4TkjuKg0Pwu+geTaWGra21nCRBEt5suVKCXy/l2srxouQcDA4zgU250Gwt7KW78O/Y9FvRE7pA7qRNkB8ndKWKkMeDkegXghiNrTdNsNT17RtO1GGB7cXzIyGJEDbI5ZFjAEakoxXceSDjHQ16jqnhLQtTgMdxplsj4wk0CeVLH7pIuGU/Q14la332+aV47c6XrFpKs4geRNgnjkcqVlLjehLqpwMbW9xn3jw1rEGv6FZ6najbHcRhihOTG3RkPurAg+4pAeWa1pOo6FqqWd5ceZBcMVs7xQwMgKkMjqp/1gA3ccMOQAVIFRWkiDyafd3OS582ZFm3qNwbGSxHXoBnGSO5r1zxNott4h0K70u84jnTAcDmNgcq49wwBH0rxax02SLzZLqHZeJHJHO6L8qSRkRlsCAhjuTrzhWHWgZlW9i9jqMOm2B8+xu0McW9m3xTqGYwg7h8rFXYDJ+YOAcYFbFlZxPevcXswW3ZlZ3SZo2Rg0Ry2ZeF+bdjA/HNUfF9ndyW2kXEJtpLe31S2ur0y2xVgiXBBbf5S/dDMCD1Vifrb1GeV766s7eM2EkFuklzcxgrNBlYfKgjyABISWZmCnCjP3ugBQ8R+JNI02Au+p2NlFFEpuL2cC8kVmTASOFQ3mHawyWYKMpndnFdp8OfD0Ws6e1w+lXunaBM/ntFqGBd6tIST51wB92LnKxDAOSSAMA4HgjwtY63raWlvGkVjpI867Kxhxc3oG2Fp2YEysoDvgkgZQ/wAQx6r4umuotFtrKK5aK7v547I3MI2sm/77oOcHaGx1wcHnFAFObUX1/UrnQ9Aka3sLFhFf3sS4Cnvbwn+/j7zD7gOB8x+XqbS2hs7WG2tYkhghQJHGgwqqBgACsXwpc2scEmj29olm+m4heGNi6LwDwxAzkMDzzzk1znxJ+JmneE1m0+ytbnW/EJi3pptkrMyg9GkZQfLH15PYUCOy1PWdP0yRY727hjneN5UhLDe6opZiF64AHX6etJ4ejlj0KxFyzNcGFWlLHJLkZb9Sa+fdYhstVntY9cbUh4m1q+tB5tzaTQGM+YMxxbwFRFQyDYu4kElmya+kwMDA6UAcz458Yad4PsoLjU57eITs0cYmlEYZtpwAT6sVBPQAknpXJWPxLspNOWy8NSjX9QVik+ofNHYRzMdzDzSCW6nbHGHYjA4615t49g1Hx98SG1yDTrPU/C+jqbS1tb+ZoVu5A+JZEOMJ82VDvgHZxk9PYPh3DoOq6MZbKza0uoR9nnsZIvs8lgSMmERjGwEHOR98EEk8UDMHR7G6vNUnvbn7TrepzHyppp4xHHEnXyliU4WPIzsdwxJywYgV11leXjQvbP4Y3WgABjhCKrEY5xJsHbsCOnNdVFGkUapEioi8BVGAPwp1AjnV8M6VM0zrpNkltqCD7bbyRjDsoO07QSm4ZIJ6nA54FSLaXehx5sGmvtOQc2sjF5owP+ebk5YdPlY59D0Fb1FAGTeWNrrNm00Erfvo2QOjsFcEEYYAjI5Ix1HbBrxzwpLPD4mvNF1e1uLC7tUSG2ZiS8toE3yMH7sqAoSCTumJ717Utiba+a4syFWds3ERJ2scffUdA3TPrj1qjrXhfTdbluDqcCzQzIg2jKujruAdHBBVsNjIweKBnKaVo9lqIis5orUXBiUstxC843lFkcKhbaiqJYwPriuc+Ivw01OWztpvDX2KHUopRJFqFraeTPZbQTlNr/MrfdKgHOc4OOdjVNGn8LQwRWVrPcTxzRDTL6J3JL4CeXcjdt+ZBt8wjDcZwwUn1OgDxXwJ8SdY03TY08ewMYbaQ2V9qGwI9lcrjInUfL5ZDKVlXswyoHzV6jYaks3iO+sRcrKn2WC8hAIOEcupxjqMx5z71yHjCxtYPGLXAhhA1G1EVyblljjZkyUbLRuCSpdTkdAue1cN8HNPtvBfxa1LRvMvfsGq6er6Q9zIkqFY3ZpIopEO0hS5YAAcE5APUA+gawfFvhu18Rw2aXd1d2jWswmhmtJBFKj4IG18EjqeB16HI4rerK8RC0nsvsl22nFpiNkV8AySEHPQkc+46UCOd8OXsl5rOu+EfEUttqyWqI8cksabp4GUZWZB8u4EjnADAg4HNRSfC/RoJml8P32teHiTnytKvnihz6+S26P/AMdrI+HzLN8SdXmt9N060tjYIVktDky5cDLfKuQSrEHng+2K9F1e+NjbL5MXnXUzeVBDnG9yCeT2AAJJ7AGgZwxk8d6Bd29hbX+keKSxDbLqNrK5jizje7puQ+mdq5PQHmmzXuqDVIdQvfha0t+hJW7t7qzlkQ+oZmVq7vSrAWMTl5DNdTN5k8zDBkb+gA4A7AfjV6gTOQg8R+JboYg8FXdu3re6hBGv/kMuf0q7ZReKpp1kvrrRbWHOTBBBJMwGenmM6jp32VoX2qCK6FlZxG5vyu7ywcLGvZpG/hHp1J7A4NXbYTCBBdNG02PmMYIXPsCTQBLRRRQAUUUUAFFFFABRRRQB8veE5Ej+K3xI3OYmbXIwJMkKoxMTnEif3Rxz9K7mK3EYDwMsbDOfMlZRtxGQy4nwQSc498GuM8EosnxZ+JQaJ3YawpjYBtobEwGSEbHX/IrsE+1mOBr+2uAhXMSmKf5gUUjG1eCMH/vk8c0DEkt5BbXYYPBdJMkaLHsQEKZ/mz5xIXLevHHBzxlNc2z6obyIWyvbZW4O62EbsQx2nL7sg7cc9eCa0I7aC0muDf3kqWZmVXSWCd8PuYcDjAwc46cj0qjturuWL7JHDFFHGjJbznzSo8pnJOZB8xUDHULjHvQBNAZDZQDzbexMUq26edZqu6QqUK8KwfcF429lX61eKLewMscOyPJcxGBUVh8pADi3BJ2/TGR17R2DJEkIle3WUSvF5eG+8ZD0XzcH73Jz8uCOlSBdLKRLPHYxyNtZsPCRv2Jkj95wTjBOCDxQBW8v59tvb/Z5JYpkdlhYsjlHUlWS3BznHPbsKt24uZYZI4o55IwXeRTMw6EblGViwcgEc+/NM1B3uYpZlWO3YRuRulg2/K7hgMNwccdfUHHWspLi2k23N1cXUt6x2+WhikY8IThQjOegGR+PrQBpQH92jzXxQwIELO8gHmCOPkDzhj39dvuKltryYspXUpVtplKhDPg5ZyNoJnDYxKO46LTLW0CeY0f2i5dyWjQ2kgDDbhQpEAA7Ej1BqG+1NtI8NXV7rcDxWcETzSkrIBjemEVmjB3MSAACOSOg6AGF4k1+ysNPtbK2s11LVGaSSCG6nURlAq7ppHMrlIlIJ6/NnA7kV9F0yaz1mQ3V7b3V+YmaW7aaMSSuoZBFhshIjuyqj+EjPzE1JbeHbm2s7nVdYJTVruPdcRFZiqEiUJbK24HaiqFHOA2WyRitqC5/4mTW9vbwLvy4lkmwBieNc8ybgQmCBxkgc54oEWZUiuVQXGnxRBY3kQfZ13HJjYAbY+ANxzjuKW60srALZfIs4IY0zIqJucqHy2DbkjJHqaIpGRYQ0UVy5MUc0LgBU3rFlt3mEKcEN9COTiprZ7q3WMXLus9uPnvYrU7pTHs3L8uRgne2MjILnjlaBjbWxFtqtu9xZbQ+5owY2QysZEPVIVIIyxxz68daYhu57E2rpqIlRv8AR90soPyqPm2nax49yM+/FTwnULWT7BJq1zJLF+6aZ9g8kkMoYt6ZjXjBPO4/xLVPU/FNno73D+I7y1topWjVI55BFKQQ7s2GXA++V24z+75OWFAFbxBpOoXQXVrJXXUYiDGj7l+0/MCEALHJIkcAE/xAZCsaTwN4ymsZLjULFoGtZ333WnXJNvKNoYNJ87NskUIFIY/OVPIPNYT/ABD8J2tt9rm13Sb5J0aSSONClzEMjBH7rYxznchwccjPStyO00jxTZ/2vYB72WVxsv8AR7l4yPmbAcrbgIdxOcjOOTnoQD1OL4g+HDbySXV89k8a7nguoHjk+iqR8/UD5N3tXnHlafqks+oyxRJLcTXU6QXJRXVZOVBDEAMVAbrwfcGqrwajF/oWq6ncNK8bGPajAMu6EFs4H7xcfMOMjkABsCxa3OnxLHFI92LeXBijY3SNI2SMKhkUtlcZAztHUDNAFvVI7UaZqpvEtmtktp1Zo1jMsifNvAKnOfnGe5I49/P/AA74naeK6uYbSSW5kvEhit5FaKae7SONBEQRhAP3a969EvLuKDS5L+/vbbStGgYNG8szzq22RWXzF8z5jnG2NCSSOSRxXL/D3R9Z1Lxx4o1x7R7S3gvbe+sbK7QbzNIu0GUM+Eby/mIzuzKrckKKaA9w8DeHYfC3hmz0yEKZUXzLmVf+W07fNJISeTliT9MDtWZeTx6z8SrGxgmV4tCt3u7qMLnbPMNkIJ7HZ5xx7qe4pnxB8V3/AIe8JQy6fpwn8TagVtrDTQwcvOwyQSMZVAGYngYXqM1w3wHt9V0Lw7qmra5E91d3up3Z1W5jbzGMscnlh1HeMbX+7k+gx0QHqPi3Uh4e8O6nqVra+debMxQxL89zOQEjT3JO1a4z4a6RFb3MbFD9scfaLmQKHaSVuWeR+mWOSD94jptQAGT4garBqHiLQ9Ptl+0wxW76nJIjEqm4iKE4X5nL75dqqQWK9QMmrnhW3NvcRQx3k0Dy3Ime3ADoSiFGT5MYwAmcfu1KKozzkA0PiRaw3FvoMl2iyWsOr25kQnBO/dEpB6gq0isCP7tRSrceGtP8V6le6hPLp1pbtJAstw0hULFvZiWJIOTjggYx8vcnjye4mtdEtpEEBm161jxu3CREl8wEfURjjsc9etP+KoS58LxaUxO7Vr62sQPVWlUv/wCQ1c/QUAeffCh1utI0rSdS0+Tw3rEVojW9ncBlE8eBmWJweTk/MoIfJ+Y4IFdJqWgXekzSeINOW4sdTTgzSMJFnjGT5U8US4EZ5/eZLISDnGQfQNY0mx1mwey1O2juLZ/4WH3T2Kkcqw7EYI7Vzdte33hGZLPXbiS90SSQR2upSHdLAT0juPUdhL/33g/MQDe8N63b69pou7ZXidWMc8EgxJBIPvIw9RkexBBGQQa1K5zX4k0iabxJaqxMcX+nRxgt9ogXJ3ADq6ckeoyvcEbtpcw3ltHcWsiywSKGR1PBFAiaiiigAooooAbJGksbJIodGGCrDIIpUUIoVRhQMClooAx/EUEbnTp1jU3sV1GIHxyoLAOM+hTdmvDPij4h3at4XXw3psFj4mnvIrtXLgxwg8CZwOCkiMy54JwVPIGPYrvW/OtrqxuJEt5o2kS6nQ4WKIHG8Zz8zZAA55J645818cwW114p8KahHBDBewa5aW0MOwK4jIx5GRzlYy8jDnblB2oGdX4Y+JMl1rdto/iHTFsZ51xFfQzBrSZ/7gLYIc84XnOOCateLNRuLUaz9gvDqLpC8rWV1bBoYgi5YJIq4U7ez7gTxwc1var4S0jVLU293biWE9Um/fKfbbJuA+owfeuE1fStV8JafYaWpi1DRb++jtr2dYZDeTQtlQh2nbn7q7uMjceG5IB0Pwl0UaboMt+8TwDUGWWGKRQjQW4QbEKjhMku5UdDIRW9osqaxePrCEvaBTDZEjhlz80g9mIAB9FBHDVh6jbXni/fpdxvsNJB2XMEMn7xk/55u6nCkjHyKTgZ3HkLUnibxBcySTeG/BIgm15VVJJdubfTEP8AHKRxux92McnjgLk0AdNHqMTPds2I7W2O1rh2AQsPvD8OAT65HauX1Txh/aEkFj4YJf7VOLX+1mj3W0LFWY7M485sKcBcqD1Paufv/CekeF9LsrnxLf3XiC/DpDDLqjs1tE+MBlt1+QH0ABZmIGcnNR6Jb634l8Xwwa3eTQadpy3LRwwFEkkLCJQJNg2qAruAqkkHcCxxQB2lg8WnwPp/h2Jr+7EjfaLmaTKiX+JpZO7f7K8jAGFGMdFbLMsCC5dJJgPmZF2qT7DJx+Zpljax2VnDbQACOJAg4AzjvgAD8hU9AgooooAKKKKACiiigAooooA+U9BkSP4p/EktHHLKusLJFG7oPMdTIAoDqwLfNkdOldithNNdSI1pv2/LED5Mm9T8hIPkdflwMdR1INct4ZkSD4nfFCefXdR0yFdVAMdncxwmY/vCPvoQTkYHI+9XXpp9k9/F5njHUXmWdipXULQnb5hXdy3HPfrnPHagY9YLlrtJL22TKsWjZtgki2vGdxVIQOcA85GKdJaSTlJFgVlWIKzI5Xyx5UuThoQTwRnHfimx6TcMhaz8Y30KFVY4WxmR8hOMtzkZ+hGMe63g1FJFhGraPeztlSk9skLyHZICQUlf5j838HI7cGgBtnHdWqwgxyRkTh2ZfNDFTIA3KqAchjkD0zxg1aWZkhMouZsvbKXijmmZ3IQ5yokXDHB7dhXM6hcHzXvtdsDpMscbO11byrPbpkKVJdEYp9xtwZRwRnjNb0VnbT3MU9nObsMSILi3VZ43UhlyHFuQOnIB759KYiS5kZTIFklEjIZGgd7gO6qx6Ez9cHuPrVVxDHFczvIrTbjLsukjlY4iyQPMmwD8oPBH06mpwrC4E6RzPNKNnmFGOxRtKj5rckABh6E/nVlrF73T7tTEGkLEBJYdwyqSjlGgA4HGBz2yO6AqLbfZtQimmt7QSK6LIqxW6GTMh7BSSw4HXt7ZOF4ljttQ1jT9JW3t2gt2Gs34hMbKQFRYI8qq8NLljnOfL79K6aJ0S8iWKMxOLkRmNleHYhdW4zMMEbmxgde1cd4Gu7m7m8SavIkAk1G+Fknnyom6K1QRBuZBu5LnbkgnHzcUDN/VoFtzfXtrYjVHG4M+/DcB1GFSMhhz7n6YzT9FsJGuLm5WIeUJ8mNp/LZmJQrhTGCyhxjqPvY9KnuWkKXMenorXfnFijXgyqhip4WdiOGb5VHJxxWxaQpBJJNBNDGSrbZEdmZg2Ordl+9wATwCASSAARq8ltG0jRiJfMVYx9pPlswd2VVLY+XBAIzjA45DYjuJ/wCyrS7aS5a0tLdnuGnK+WuxCTJjOWJwkeWA/iB74MxWMRvdrO5DxshUsXxAGZWKnByW5PPH3MLliBiaX4ZPxE8aXk2rNIPDOkyp9otJETFze43FN4JzGqmPcBjc2AeFAABWsLC78bWH2mznm0rwk7MBfvC013qG4ci2jcExry4DkE8ZUAZrYstC8L6GjT6ZoFu0u/DajeRC+uZHHcyyNtDcdFZyMfdGMV6ZNb6bqN5Bbrfho4EI+wQzKI2AI5ZRyQOBjOPUVseVH5apsTYvAXHA/CgR5dNMmo25ha1a9bbhFjuIcqT/ABCLy1LEHsVIrmtf8O+Fb1zfyeHrvSr+PIkvdElFkyEHjzFB2D6yfSvXtU8K6LqUbLcadbhmOd8aBWz65HU/XNcfqmk3OjXkUEFxdXClsWpnxkZB+RJCwIPsCuf7jc0Aeb3h1LQraaG/t18R6SArmZbRI7+2wOGePG2YDA+ZCG6nBrWtPEuipYjW11KwstJlha4NxLK29lyNkYyCzMoPC55YEEcV0C6W12YXS0dI5HIjljYInmAnMbYA8l89PlCMeGRWxVPwh8PvDUGuXUOr6BpV+motK6z3Nspljmx+8Q7hkbgS23J28kEqQQDD4V2U/jXWpte8QWk0Wn6NMsWl2F0Pm85o0drqRckbyrJtH8AJ7811Y1G78LXF7bx+H7+7NzezXTSWkLSmfe+VwQNoIXap3suNvcYq54D0670S+1XT54Zfsm9DbzEEhgkaRjJ9fLWL6kP6V2VAjmPDuj3jX0mveIdj6vKhSG2Qho7GI8+Uh7seC79yABwBXL6F4y0bRfAmmRTSR3ut3atMuj2TiS5lnkdnZAg5GGLBi2AMHNennpXlfh/wpN4guV8TR6tPplzfo32r+z0ihkSQMQYyfLO7YVCnfuJOTxgCgDkpZ9f8JakurfEA2aDxBMzn7Cx83TsKBsZuhVYsxq642vKTzuzXp2ip/Zw+Xy4VhEYumgQMZZCAUt4hzhFDL0659Sxrg/F/gPxFceJvMm1u28TxzafJaLp9+y2twkDMPMKeXhHyduSy9lrJ8DNb6Etppl5Yt4a1iN4g8WozozsyIEEltyTLGwX5o14HOCuBQM9M+KMsNkfDGqXuxbLT9VE80kjlEjBgmRWZsEAbmUZPGSORVfw/dHx14pt/EMKyp4c0oOmml0K/bbhgVe4AIzsVSUQ9yznpitbw94sjvlZdQESKZWhiu48iGQg42MG5ik9Ubr/CWrb8QBjot2ElELFMCUuU8v8A2gRzkdcDrjHegRoVkeI4Wmt7YCKSdEnSQwRoCZCpyoLE4VcgEnuBjvXn+pfFWay1x9Bs9JuNX1uKNJGtbCNpXXcThZTwkTbQpJLHBbocVPrPh3x742sHt9Y1q08KafKPmtNKU3Fwwz0edtoHuEXn1oA2dOvkttDutNJtJYIoxChllaOMqw55wSBksFUckLxximaP4ms9MilM+42JkUyXap5ccbuTklSflTlAP4jyxGMsall8MnttkknjTxS88abEdJoY1QeyiLAJ7nqe5NYWufD/AMStFI+keK7fW4zEwWx1a2jAKMBwrwhcAgHgqVOckGgZ668m1VdEeUOwHyEHAPfk9Ko6tLc2Usd7CJZ4BiOa3QZOCeHUdcjPI7j3Arwb4b/FeHwrr8/gfxml9pcUSgWUl+2WteP9Q8g++gx8kvQj04x6lZ+LYYbbYsiTb8Nv+0SzNggcriIg8dADgn8TQB3VFYnh2+kmkubOWNk+zhdhmuVlncEZJkVfuHOQBk/hW3QIKKKKAPOtZFrY6hI5u0jih3O9xIQAHBd5X4B5DPCoOCQTgDI45nSoDr/xU0K1t7bdp+hxSalPNJHt+dw0cKqMnaCWlfqWJXcxJ6O+L/izSfDVhNJcRB57i6Wzt4XdYhI5PzkseEVEduT0MgY8kVJ8Mm1Sx0ueHw1pk+pahqM5vNQ17Ut8Fo0jdog372ZFHC4AUgZ3DNAz2QMCSAQSOo9K4P4meJ49MudI0u3sNS1a8nnFxJaaYm+dIowWDHkbAZNi5JHU46VVTwRFaQXd34y8U6xqzy77iSIXTWcA2rltsURBIAHQlsAVLoc3h/wX4Ukl060t4r8rCk6DO+a4aMMqNI3LYU7jydq5NAENtpvinXrWGG9eHwXoR4FlYyK97Lk/dabGyLP+wGbk/MDVjRZdJ0e90u18PwI+npbL5SWinE8s7/K5JJ3HZDI5ZiTjnJzXG+ML7xDrWlaZZKjXd/DaSXc0lshJWUxsrtGinJKtKsaA9G3k5KZrsvDvgacXEl7q93Nb9IraxspdiQW4SNFRmA3F9sYyQRjcwHHJANvUbe68QTGG3vRZw2N2Q7xoJPOwgI2knAZWbuGAZenFXdN0cafrEs1sI0sjaRwogJLhw8jMTnrneDnOSc5rTtbaG0to7e1iSGCMbURBgKPYVLQIKKKKACiiigAooooAKKKKACiiigDwj4PaPpmqfE34snU9Os7wx6umw3ECybf9Z03A46CvX/8AhF9AAIGh6Vg9R9kj/wAK8v8AgZ/yUz4u/wDYXj/9q17RQBzcvgTwtKWJ0DTk3HcRHCEBPrhcc8Dmqtx8PNAkj2wR3tqdwcNb3sy4YdCAWI7nt3NddRQB5ZqPw+1myVxo1/FfwBmkWO8d4ZQSrKQrRkJ/EMfKo4wc9a5C90iddQnn0W3Oga6haW4tpmh2XRBGA6scLuLKPPQHvyeBX0FWF4wsZJ9Ka8sY92p2ANxbEdWIGWjP+y4G0j6HqBQB5VptxZ6hpRLPBaOnmJPHMsQIkEabozxyRk4IBBBDDIIp9ytnuVgbXeszF2xBymZBlWA7g4PvmszWDHHq1vqVlcXVvZ3Sx21/MRLh43QJBPu8zqrMFOSPlk6cA1tXSyXbCFXuoIoppEdmcuHZXYMob7QOBnGfbHtQMraZratb2/8AZ2544rld4jt5AqgGMs/TB4zg9yec81x3gGZ7fwDo5LTQO0E1+ShmCvHJNMWVdn3mxtwOT+Jrrbe3Gpanaw2Kp5sqSwvIlsWz+73AbxK3AKofwHNcT4JFpP4W0AXC2HnGztLeNZXXdICXVhtYH8sdQD2oA9D0273QXN1BPcLGiZJmdokVTsA3CTI/jORtYnPAyRWjbIBbGRJpziNSqykbVKjgHaQw6K244PTkkgVl+Gp5lt7yW2gW1gjtVMjWlsY2OfIJKtGowAC3qMAEjjFaTTxNa74rUG3kTEEuMoNz4Khef4ivTOMjrg0CMPx1ealovhHUr6CCU3YheCAAn5ZHYRxuAW3bi0i/KBxnqCCrdSvgyw8O/DzwroM8Mdzb2V9a/aFkQMs0jvtdmHfLyE8+1cLqNsk+t+E0aIILvxBbzMdrBZFRp3TCk4AKhWx/tZ46D2rxvA9x4U1MQ7jNFF58e3rvjIdcfiopgYl9oWlaD4t8L3Wk6TYWSyyz2cjW0CxHDwlxnaBnmEda7euW8aSwz+GrTV4t7x2Vxb6gjR9SgYbj9PLZ66mkAVleKNo0O5aWOGS3Ta84m6CJWBdh/tBQxHuBWnLGssTxyDKOCrD1BrjfELOljf6PefaDYXsElsDJ874ZSuY2H3zg52H5+Djd0oBGFLJqlzArX8erXNxexRynT9HSJREhyEM88mNzkDkggDHA4BORrOma3J9oa21ia1ukAeXdfw6gIGTJR5YjEjqFJBLI2RjoQK6TQWHiPTTDBqH9j+Jls1gvDb4cSptIWZAfvISSyOOQSQedy1fvfDuqi3tU06HSYHsyfsska+W8ZKMm5sqwIYMcrgdfvEjNAF3SNevzPbWXijTYrC4nI8i4tbjz7adhztDkKyseoVhyAcE11FcZ4v8AC+o6n4VbRtCn0uwUx5DSWzsI5gwZHjw42YYZHXHHFUbvxvqss15pmk6LnWrExR3X2oyeQjyAsuwxozSAqpbOFAGMkH5aAOk1HVNR0+xNxcWVmZA+xUW6fMhP3QgEZJYnjGPxrxTX9Q+Iui/EPSLvT49F0+XVYZbm+0eIyzRKke0eZO6qcOxZU3oByBncBXp5uPHMDQ3lzougakUXmK0vpYpBn+4JE25we5X6ivNL7xjb+I/ifM40rU7C8i0yO1t7PUbNo55H85mkMYVskDCDINAHoMOs2Pjb+xYZLCW01a3ulluba5jKzWYCsxdCcZRigUSLwQ3Y8Dq/E3hjRPFFmlr4h0y11CBGLIs6bthIxlT1Bx6V5I1prU+oz3xS103ULY+XY3JRkuYiR8+7zNzSIcgbSNp5IOQDWjqXxQ1rwaqTeM9NtL3SF2JPqWmB4XiY8Atby8kZ7qx+nagZ0tn8LdD0VLj/AIRCW88PSTrtkW1l82GTtloZdyMcd8Z9653Ufh7411S4hi1jx3qN1bW0nmxpaRR2KyjGApeMbkYdQcMPoeno/h7xLpPiC3il0u7EhkjWURSI0cm0jIJRgGx74rYoEcp8OfDFj4T0Q6fYW80RLmSR7hUMsjEnJeRR+8OcncecEZxXV0UUAFYHjbZFoMt4ZbeCS0eOdJZxwCrg4zkEbvu5z/FW/TZI0lRklRXRuCrDIP4UAeK/Ejwj4e+KV7pcjqzXCJHA19akoQGmGQpPDrtjmIOCMEMOozX0v4SeIPBd2JNA1qXX9EjBCaRfyCJ4+wMchVkJA4wygdeh5r2jTLCPT7Yxod7s5keQgAux78e2AB2AA7VcoA8KfxbqVjdra/8ACMeJdOvQhkjEtk08aPtILJ5H7tiM915zxW/pnxbvJXlk1PwL4ktbFBuW4jiWZmXru8oEPjHXAOOhr1G5SF4HFyEMQG5t/QY5z7Y9a8g1TxF/bGqPYfDq0n1+483D324x2NuwOG33GPnbBODHlwQOSDigZo3Hx8+HkFr5z6zP0yI/sM4Y/gUq7a+M9d8W2Qfwl4VuU0+cFV1DWLg2KkY+8iKGlYc8HC57Gl8K/DWOG5i1XxreL4g1xTuTfGEtLYnGfJh+6DkZLEZJyeM16LQB5a3gzSYta09/FV1Y3mpmMs80yrFFEmeIbaNiQgLElmBLnHJ+YY0xrNzpaw6dpiWkFvZ3Dy33mHf9mtjI3kxIikfvJBgKOijsflB6DxI/2q6t9MEkUCSRvPPcOATHEuAdmeAxLAZPQZPXFc/4I8H6ZCLu/tWnXTbm5a4sbUNiOFdgQSLxuyQGYEnjeSME0AcQniDU9bNnp17b3V5rN5EsRjiXMcQuJXlmBboI444kiLZydzAZORWvYfCy81rTtO/4S3UJopYpLyWaO1l+dmnLZbzABhiGOcDgBVHAO71TSdOtdJ022sLCIQ2ttGsUaDsoGBz3PvVugVyrp+n2mnQRw2cCRJGgjGBztGTgnqeSTz3JPerVFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHi/wM/wCSmfF3/sLx/wDtWvaK8X+Bn/JTPi7/ANheP/2rXtFABRRRQAUUUUAeOatplvatq2j3CWkVokksO7lHEEyuykEKxwhkAye6egrEtLzWbu0uIxo1vqV7auY7gWs4WW4GxJDLGfK2BZMqyhmDZJ9K9A+JOmtFeadrFvcG1zLHaXMoZxhC42N8p65LJ3/1ucHFcbZNIrQfblV7uS3Qv5SRFWBjRgCW2sDjPHbjgUDItM1ePU4p47RmjktY/KuoH8xprZiJOJIxHlGDYIHIIBxXPeCra7tdCttNto8Xdle3FhPIXkZW8m4wAqZUDPmjnP1q5mPxFfNBJaw6P4h02R1juXdLqO5Rg7E52gSxMCq7T8y/w8qTWJpOprc+J9b0KF10u5keHVri1VFdY33IkwicRlXVtkMgYYGCc9CKAOp0e0kt1cSM1tK0YDRJHudcJDjAdiisCg+bbnHTkc7VrD5iOl3tjiWRkiAcsfMw3JI27xkvtUcgOSSCxFc29jDplys9vA9xdxF2mKQNtbajjokeC2cDp69a2k1GDFsbSIQL5JYwWdmsYfYzb87gpOXZQAAMvv4xkUCMLVxFaa34W1CNJ42i120jna4cM213kUDPORmQ/wARx143Ln6IdVdWV1DKwwQRkEV85eO9MfTvCWoyWgkW6tXS78tUwhlikSUornYCrBB8oAOY87TgZ+h9Pu4b+wtry2cPBcRLLGw6MrAEH8jQBznha3iu/DeoeHr5SyWLy6ZIhbloSv7s+vMTp+tWvA13Pc+HooL8k6hYu1lckjBZ4zt3f8CXa49mFRXmNJ8Z2t2SEttWjFnKewnTLRH8VMi+5CCq+ozxeGvFq387FNO1lVgmIUkJdID5Z4/vp8n1RAOTQB1tQ3lrBe20lvdRLLC4wyt3/wA+tOtp4rm3jngdZIpFDKy9CDUlAHmd94fjvNdGj3I897fNxZ3cZ2zWjHJDsykNtYgo6/xfKf4jjvdGthb2oAkumHTZcS+YyY4xuJJP4kmpbaxht7y8uk3GW6ZWcsc42qFAHoOM/UmrQAHQYoAKwda0W6k1Aarod2lpqgjEUgmQvDcoCSqyKCCMEnDA5G49QcVvUUAcp4Z8UjWbibSdXtJtG8QW53SWcjg+YoI/eQv0kjPTI5HRgDWfqNjp3izVrrw14t0V7v7J/pNrfNEY124T5kkBDLJlsfJj7vWup1zRNO1y2SHU7ZZljYPG4JR4mHRkdSGU+4Irzb4eav4mMFzd3lgdfa1km07z4Z1huVWKVwokSTarsylW3qwDAjjPJAN6H4VeHU84Sza5crMdzrPq9y4P4F6l074TeAtOx9m8J6SSOjTQCY/m+TVqXxldR7SfB/idlIzlYYGx7YE2aytS+J66fNZQTeEvFAur6XyLSFreINM45IH7zgAcljgAd6eoHexWtvCkCRQRIkC7IgFA8sYxhfQY44qauJtPFmrvehNY8P3Oh20bEvJODdb0wOVaHci9f4m7dK6y01G0vLSC5t7hHgnOInzjeeeBnvwaQFqiimyOkUbSSMqIoLMzHAA9SaAHUVxVz8QbC7kltvCNtP4mvozsZbAjyI29JLg/u1+gJPtTLex8d6uzNquq6ZoFsw4g0yI3M4+s0o2g/SOgDqdZ1jTdDsmvNZv7WwtV6y3Mqxr9Mk9fauOj+IF5r2F8D+G9Q1OJz8uo3o+xWWP7wZxvcf7qHPrV/TPhx4ctL8aheWsusamDkXmrStdyKf8AZ35VP+AgV2I46UAcDc+AJ/Ekwm8d6vPqcOcjSrUm2sV9mUHfKR6u2D/dFdxZ2tvY2kVtZwRW9tEu2OKJAiIo7ADgCpqKACiiigCpqGm2OoiMahZ290I23IJow+0+ozVuiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPF/gZ/yUz4u/8AYXj/APate0V4v8DP+SmfF3/sLx/+1a9R1fxDZaTq2l2F6Jlk1FmSGURkxqy7eHb+HJYAZ6mgDXooooAKKKKAK+o2UGo2FxZ3ieZbzxtHIucZUjB57fWvH5NPvdOvLnSpb6/S7gdVilE+BIvlkRSrlcDITDDd94N0BFe0Vy3j3wy2v2UM9i0UWr2ZL20siKwYEgtG24MAGwBuwSpwR0wQDzHWrS61RYxo8hTxFYSLNavcEKoORgSHzm+Qsx6DI54IJBrXLaX4gsrS+Cw6ZrejOu4zON9q2w74H3S7jE6hgD0YMGU9a09NlVAsEMN+byBkW4jNspeOX90GD7cY5GQcYYcgYrP1zRb28vLPVdItZ7PWlUoxMUyx3EO1h5M22Ebhnbgsfl7EdaExlp7eMqsFjBby3JxGm/53EZdS5DCZjgA++eaztGkhtGt/tS77UbpfLESq6jyoy0iLhdrFW6844PJUEaum3kt157v9rttUhWOOezukkaS1cypkMI+q8sVbJDAccZAgnjngie4vb13uRAWkhxMigmD7w3HhuME+4yM80CH+dCkKEBJEmVRJFKUaOJVDh4/MUjHyknCAYLLnFdJ8E9bSLw/ceHLydXn0J1hhm6LPaPzDKvJ+XGU6/wAHPPFcpHL9lmnuYbVRi5dXcyMGO6TkALIBk8gNweh7YqvrVnNdarFq3h2XTtSureMQTaXNKkKT2jxhpYB8524IVgz/AHSBjdk0DPcfEOmDV9IuLQSGGVgHhmHWKVSGRx9GAP4Vm2zQ+L/C1xbX8ZgnJa3uo1ILW9wh6qfUMA6n02mq/gPxtpnizTTJbsLa8hys9nK4EsO0kHcp5GCOc9Pyy7WlbRdSPiKxUy2UqBdShiG4ug+5OoHVkHB9U9SqggjlJtVvNLS9kk1NLe+jkEeoW7MqbH423EYI5jfAbn1KknHy9v4R1C/1KzuJdRgWNRMRC6spEiYGcYORhty8gHjkZzWZ4z0FdWjtta0kRyX8MW3Me0m6t25MYYgjP8S5yM8HhjR4BnszFKkEhEkvzhVJEcgBKllU8ow4RkPKFQD2JBnYUUVR1W6/s+MXkhme3TCSRxoG+8yjf64XnOOxJ7UCIxqsTxabcRljb3rBE+TnJUsCeeBhT2PUVpV4hq9qPDnxh8M6boHnPp9/Gt3JbtclliSMSBnXcDhfnU43KM84JJr0bUfHGkwLFDZPJe6lc/8AHlZIjI91n+JCwAMY6mQZUDn0yAafiDU/7NSzC8zXFwIUTIAPysTk4OFABJPYCvEfiT8WNM+HOswN4ctpdUSTTXszIjE2xnRwYsydHKhpdwU5+YDjt6jF4Jg1W7j1PxsINZ1GPPk25Um0tAeqxxnhj2LsCTjsOK8m8c/DS78b+IBrXxD1m28MeGLPMOnaVE6eYsI6lj9xXbgnG4jgdhQB8qXfiTWrrVrnU5dUvBfXErTySxzMhLsckjBGPwr2v4AaX488ey3U9p4+1DTrGwkVJ83DzTNuyw2qx244PJPrwa8f8faDF4b8W6jptrNJPZRybrWaRCplhblH5AzkHr3xXWfs+eLm8K+PI4pL24s7PVU+xTSwqjMjE5RwHBXIbAyQcBjRYD7q0+JPD+ixx6nq890I/v3l+6B3J9doUfQAVfiuUlUSqD9nMYkWYkBSD+vTnkd6840uy8Q31wJdP0aXTpGBP9reI51ublM/887eNiqn23IPY9K1IfhvZ3e5/Fer6v4jdm3mK9uClsD6CCPahHswagDL1n4qQXXiuy8K+C4ItR1i9MgS8uCyWUXlqWc7wMykYxhOM8Fgc1pp8Phqsgm8cavdeIm6izkUQWKH2gXhvq5auW8T28Np+0Z8Ore1hjhgj0y9VI41CqoCNgADgCvZKAIrS2gs7eO3tIYoIIwFSOJAqqPQAcCpaKKACiiigAooooAKKKKACiiigBGIUZJAHvS0HnrRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeK/Axl/4Wd8XU3Dd/a0ZxnnH73mvSPHfh8eItBe3jEf2yFxPbGUfL5gzwfQMCVz1GcjkCvBfBenRXvxU+KMkkYV4tUAS4QOJYSfM5Vk+YdORkA9+1dwLnV5IZDY67r0Ub7mKmSMsAAuQpkhcjBJ6mgDqvh94uN8ltpGtM0eqiENBLKVBvEBZScA8SKUYOvqCRx07qvD73Td8NpAttftZRoDHMyOX3maQpLvDg7gXZy2Mjd2rc0HxprVtBNDILHW0gTesn2pYJ2XBbHQo+APvZXOM49QD1CCaK4hWW3kSWJxlXRgyn6EVJXjXgzU73wpp8hs7K0bSpJpJHsUu4v3GZGw0Uu7awI2ghtvzAnIya9Q8N6/YeIdOW706QkYHmRPxJC39117H9D1GRzQBq0UUUAcz4s8MjVUnu9NaG21cxeUJJF3RTDnCyqOoB5DDlTyO4Pl99LPbSSwa4LWK8UgvayRwswAMw3jcQWU7lIbpliOuQPdqy/EGh2eu2iw3olV0O6KeGQxyRN6qw/kcg9wRQB4nO8d0LUWzGK5O9bc2sVu03GzG0M+GQFz8pyO/GAar2mqtp8h0zVLCXTLnydwntreNoroKoBKoiMyNzyhyRzjIGa2PFHh/V9DlD3Fv9otIgxi1GCMukShX/ANZHvG3PyKeCvU5XtR0S80u8tLdZxcXST7laHnbLtkf5c+bsbJb5TnI2j8AZpfZ7F03rLK8NwJTDhwFlDSJj/llkYL54yc+o4Ektrp8Wm3EbwzPbmHeIppZGwwhJGRsGP9XnOexI9KzUsJbSxnvNC1hEu2KTtHOyTI2Vj4kJmz/X5eDwKkl1rW7cKmqaDbNDJEY/P0q8FyrjEgy0TMrDGcHhsnI7CmI43UPBf9n+IV8X+CtRhGoQzSTT6dcXs2Lgs5QFZDkrIQQMOSM9eOK7nwV8SzDm1ktL4yxqHn0+4jKXMA/vBMfMuMncgKn/AGSay08W6bLa3El9bzwtMoZ/tumPCm8OCTueAg5Bzz021oXOnWOtJYyi2iv5YspbzWyGKSFgpyYpUg3KQwB4PbPqCDOr0XxAujanKtvAf+EWl/ejc+JbBjy37ogHyc5JIyFPfafl0/Evh2d7hNa8MyILjeLiSBWAWdtuBKh6CTacHPyuOGxwy8vpeqeNdBh2m4s/EFgAuyHUBLBeKDgbTMsex+T1ZVPHNVdL8V6/4e1BpYPBl3B4TYNJOq3sT/Z2wTut0yGKna2Y8DnlcZwUI9Y0bVLXVrMT2khbadkiOpR4nHVXQ8qw9DU+owm4sLmBWKtLEyAjqMgiufiTTvFECa14b1PyLwAxi6gGc46xzRnrg/wthl5wVrzbxlrXxC0kXcfibVbbStLyfJv9D07zDKoUnDSSyEQsenI6kYagDR8H6fpGmeJLO68W+J7KXxXcaaLW5028uoswqTlI40yMKAzAgglsg8c5b8VdZ1/w5420PUtA0saj5VnNb/Yl+cpEzI0kwVTn5SkagD72SBXLwaFDp2i6jaXugWGqalrl2zQ6a9w0w80oBsaZpNzNtjZ2kHGQ2O1aulJpEVh9o06zs7cyR7oJWWSR8KAAkgMxfKHcu3+E8DvkGbE3iLVdaUBbLX7mIuFJljfR7Y57ZG+dj6jpVS2h1uzeaSzh0PSJTGSlzHa3l9dH/Z86aMBfxDdhirF0BeKglFtmHMcbMFLPhkLZMkZYH5gOp6D0rLmn0qwsWmv/ALFHbw2/2maSVIm+QCXcQyxj5sjHHfHAoEeVftPaIJBp+oteX97q9skgumu1AdrbzAqyALGgCh2A4B/1nXjNfPikgggkEHORX3Z4E8FR+LvDuva94rtDFceKoGihtiADZWJJMSDHRuRIT/exnkV8T+K9Cu/DHiPUtF1FcXVjM0Lns2OjD2IwR7GgD75+BvjWPx18PNO1BnBv4FFrer3EqgZP/Ahhvxrv6+O/2OLzW7PxbfQwadez6BfQ7Z7hE/cwypkoxY8cjcuBzyPSvsSgDyDxj/ycp8Pv+wdff+gNXr9eQeMf+TlPh9/2Dr7/ANAavX6ACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD5n8EWwn+KXxNcxNiHWUkeVbdZPlHmZXJBK5ODkDt1Fd7NBY3FuVnNlHbuA+XEIfkAAkGE9MAdcjFeeeD4/EL/FH4oHw7okGqL/AGoBIZdRNr5Z3MRxg7sgH6V3OoH4gTSBv+ECglOFB/4qMFSQSc7SgHU9OKBivHFeCOYlpskEt5UbGQM8bHgw88YPHP161IsKtp8SaUpuT5IBMbDaU2SAD7gVQCMYx3Ge1VTN4v3rLqHw9v1dXyBaalBLubaBklpF4wOOOKrTeIhb2Ig1bw34s0xWTy22aS85RQHBw8bsMDcDnrxQBYsrSKfULlrwyoNy/uTG+4BZ2IbYAB2BIzUUSyX1ut/pplt7uKGNLe4gWVZF+VGVSNzAx5+UqQep6ZNc/ceL/A098jHV4oJoXEjHVLGSFsF1IBDL2ywzz+ua6XSH0rV7eK3sLvT5TBtMTWEsah1YbCpCBlOQTnAz9MUAem+HPEkGrf6LcobLVox++s5cg5HVoyQPMT0Yfjg8VvV5MNIFzZpFdQBoISTEBbrlZCU5DCAbeoO5eePxqxouratoUULW5v8AWNOCbZIrppJJ/MAJJjkMYHRTlWOM4wV6EEeo0Vy6eO/DwO27vTYyAEsl3E0W3HX5iNpxg8gkV00UiTRJLC6yRuAyupyGB6EHuKAHVzOp+C9Ku7gXVosmnXgO4S2jbVLcctGcox4HJGfeumooA8v1Hwl4mjmmla6tdVjVVMZQvDMSqgY2l9hJIzncOWPtWVe3Wo2yRnUtO1zTlh3RsjyOyMpJ/wCWkbso4bIO7PHavZaKAPCdO8WWzyPLHrlqNkZV4pL5ip+QcsryY/hxk+p/GXUItG1iSMtDpEzM5CzxRoDuEjBvmjbcScDuMbfQ17XPa29z/wAfFvFL/voG/nWRqeleGrW2efVLDR4bcctJcwxKo9yWGKAPKLSw05Iv9G/ersVgUnKjISJvuySEHGQSpB6degqtdR3Onwtc3MMdzYoJC7ypCnkowmUgpG2HUAuTjBHHBGa6PUrzwXNI0Xhfw5YXt4/3biKEWtsC38RmwA44z8m4msfTkv5Io4J5dQmiiG5Xd5WE2WzuJEoAHzKPYDHzHmgCsY7vTriLWbC8g0qOK3LSzW80JCqscZzIoYrKgXLAHkBhgjOa3/Cnxetb6zMfivT3s0KfPdxpvhZTnBliyXhyuGIO4KDy1cdpOinW7PT4b+5km0DfPJYWkPmiF7cySGJ5Rk+aF2DYq4AXaST0ra1SSXSNL1TUdK06a6vsNJC0ULSs8m4qrbN+7nOWyOg6ZoGejeHPCvhqLU4fEGggOjxMIBBctJaqHPLxR5KISOMqBxkVzfjDSH0bXJJraOdtP1ZyRsc/ubs/w4wQElOD0PzqR/y0qnY+Mx4c8Opp+jaJHZWtjFs8zUrmOIu+Nxby4t53MTu5K5LY6mjxTPq17o923iDxFHa6cOZo7O2hiRVVzzvd3cH5AcjBHbBHABJbJKbJhLK8JcPJuEssQAHlZHKrgDkbsgdemTjB8IaJcfEq+tbq9/5EbT5lkiVtx/tadOjENz5KNnHTeeSPRmj6JdfFCcKls1h4B3b5p2RUm1jAjO1BtDRw7o8lurdvb3W0toLO1htrSGOG3hQRxxRqFVFAwAAOgAoAlAAAA4Arhtc+FfhDXvGP/CTazpMd5qPlpGVlYmIlejFOjHGBzkYA4ruaKBEdtBDawJBbRRwwoMLHGoVVHsB0qSiigDyDxj/ycp8Pv+wdff8AoDV6/XkHjH/k5T4ff9g6+/8AQGr1+gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA8X+Bn/JTPi7/ANheP/2rXtFeL/Az/kpnxd/7C8f/ALVr2igAooooAhubW3uoyl1BFOh/hkQMP1rkNZ+FfgbWCpvfC2l71zh4IRA3PfMe05rtaKAPJz8FNP05H/4RPxJ4i0N2xiOO78+HgcZjkBzjjv2rObw38SvD8KRW6+HfFNsm4ElP7PuXU7uDgGP+I9q9pooA8B/4TKfS5C/iTwTr+gMrnzZorU3MJ+6c+bEozyuMEEY69TViw8V+FJEU+GPFttZ3JAJit7j7LuJJ3Zt3VkDA7eiZOTnPFe7Vi654U8Pa8uNa0TTb/nObi2Rzn6kZoC5y66v4niS3+x3lhqME5/dzSWUzcZAyXjAU8n+6v+EY13xmnF4mixME3Yhs7qXJ2k9TtA7Dvzn0qtefA7wY7btMh1LRm7/2dfSRg85+6SV6gdqhuPhbq8UUi6Z4zmbcSR/amlWt2ec5G7arc5PfvQBft/Eni3zIz5Wi3cTnb8kN1EwbJwPut1x16A9agfxt4kCL52nadatJnYWW4k24VWII2KCfnwPmAJUjPSsqPwd8Q7Wdt1z4L1K3ORsksGtSVLFtp2q3GT/I81l3ui+L7d1kuvAceoyqctJZ6vbAEY2gYeBScDH6c0AX7vW9X1ZY5bvWp/J2Bwlmv9nxgbZPnY+aXKgqvV1HJ71Vn021ivI3hjDXTMsxvWlE0uMjJDyTMduG9R29OaZ1/WdCDf2f8OvGhuGk8whJIyuC+4ruQsCOg6ZwKzIvF/jG8DxXfg/xJp0YkLGU6fPeTE4HQB40HPQ4P0oGdjfF41u5Ir61VbOEFWZosEBWHzbnKhRyOR/B7E1yWoXkvjKCVNOOpWOgH97LfNbiO5u1ITKQiOPMSn/nqw+bJA4yQ23mjvJm/tvwf8StbIy6jU7FWihbcThIlkVMjJwxBI7H06A3viS/Mv8AY/w51GQyr+9l1aeK1JIVAvWR2OPLGD1HbvkAu2FnIsNl9mkNvCseSoh+VUIdSoBt+McALkDH6z6hYy5a6llNtDCxaa4kTYvDr87EwgbsE5Gfcd6ot4Q+I+tujz3XhnwzCFdNttbtfzbWOTlpMKeSSKu2fwM0O5vWvfF+p6r4munbey3k3lwlvXy48D9TQK5xTeL7W+K6X4MhufFuoiIx7dO3pHACm1WkmZQMe3Y12mj/AAsvdeu4NS+J2ojVGiYSW+i27uLG2OSRuBOZW5PLcckcjFeo6XptjpNmlppdnb2dqn3YbeMRoPwHFW6AEVVRQqAKoGAAMACloooAKKKKACiiigDyDxj/AMnKfD7/ALB19/6A1ev15B4x/wCTlPh9/wBg6+/9AavX6ACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDw+P4e/EbQvGXirVvCOveH7a11y8+1NHdQvI4ALbR93A+8elaP9j/ABs/6Gfwn/4Bv/8AE16/RQB5B/Y/xs/6Gfwn/wCAb/8AxNH9j/Gz/oZ/Cf8A4Bv/APE16/RQB5B/Y/xs/wChn8J/+Ab/APxNH9j/ABs/6Gfwn/4Bv/8AE16/RQB5B/Y/xs/6Gfwn/wCAb/8AxNH9j/Gz/oZ/Cf8A4Bv/APE16/RQB5B/Y/xs/wChn8J/+Ab/APxNH9j/ABs/6Gfwn/4Bv/8AE16/RQB5B/Y/xs/6Gfwn/wCAb/8AxNH9j/Gz/oZ/Cf8A4Bv/APE16/RQB5B/Y/xs/wChn8J/+Ab/APxNH9j/ABs/6Gfwn/4Bv/8AE16/RQB5B/Y/xs/6Gfwn/wCAb/8AxNH9j/Gz/oZ/Cf8A4Bv/APE16/RQB5B/Y/xs/wChn8J/+Ab/APxNH9j/ABs/6Gfwn/4Bv/8AE16/RQB5B/Y/xs/6Gfwn/wCAb/8AxNH9j/Gz/oZ/Cf8A4Bv/APE16/RQB5B/Y/xs/wChn8J/+Ab/APxNH9j/ABs/6Gfwn/4Bv/8AE16/RQB5B/Y/xs/6Gfwn/wCAb/8AxNH9j/Gz/oZ/Cf8A4Bv/APE16/RQB5B/Y/xs/wChn8J/+Ab/APxNH9j/ABs/6Gfwn/4Bv/8AE16/RQB5B/Y/xs/6Gfwn/wCAb/8AxNH9j/Gz/oZ/Cf8A4Bv/APE16/RQB454d8CePJvibofijxprWiXkemQTwpHZRPGxEiEd1APJFex0UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFACFcuGyeARjPBpaKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Often, delivery of the head is easily accomplished with continued expulsive forces from above, suprapubic pressure, and gentle traction. Cephalic flexion is maintained by pressure (heavy arrow) on the fetal maxilla (not mandible!)",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Gabbe, SG, Niebyl, JR, Simpson, JL (Eds). Obstetrics: Normal and Problem Pregnancies, 4th ed, Churchill Livingstone New York 2003. Copyright &copy; 2003 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42682=[""].join("\n");
var outline_f41_43_42682=null;
var title_f41_43_42683="Diagnostic criteria for MDS-MPN unclassifiable";
var content_f41_43_42683=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F85789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F85789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN, U)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        The case has clinical, laboratory, and morphological features of one of the categories of MDS (refractory cytopenia with unilineage dysplasia, refractory anemia with ring sideroblasts, refractory cytopenia with multilineage dysplasia, refractory anemia with excess of blasts) and &lt;20 percent blasts in the blood and bone marrow",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         And",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <p>",
"         Has prominent myeloproliferative features, eg platelet count &ge;450x10",
"         <sup>",
"          9",
"         </sup>",
"         /L associated with megakaryocytic proliferation, or WBC count &ge;13x10",
"         <sup>",
"          9",
"         </sup>",
"         /L, with or without prominent splenomegaly and has no preceding history of an underlying MPN or of MDS, no history of recent cytotoxic or growth factor therapy that could explain the myelodysplastic or myeloproliferative features, and no Philadelphia chromosome or",
"         <em>",
"          BCR-ABL1",
"         </em>",
"         fusion gene, no rearrangement of",
"         <em>",
"          PDGFRA, PDGFRB, FGFR1,",
"         </em>",
"         and no isolated del(5q), t(3;3)(q21;q26) or inv(3)(q21q26)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        The patient has",
"        <em>",
"         de novo",
"        </em>",
"        disease with mixed myeloproliferative and myelodysplastic features and cannot be assigned to any other category of MDS, MPN, or of MDS/MPN",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MDS: myelodysplastic syndrome; MPN: myeloproliferative neoplasm",
"    </div>",
"    <div class=\"reference\">",
"     From Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon, 2008. Reproduced with permission. Copyright &copy; 2008 IARC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42683=[""].join("\n");
var outline_f41_43_42683=null;
var title_f41_43_42684="Serotonin modulator antidepressants - Pharmacokinetics";
var content_f41_43_42684=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F88062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F88062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Serotonin modulator antidepressants: Pharmacokinetics",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"8\" width=\"12%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Bioavailability",
"        <br/>",
"        (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Time to peak plasma concentration",
"        <br/>",
"        (hours)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Primary metabolism*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Active metabolite(s)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Elimination half-life",
"        <br/>",
"        (hours)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect(s) on drug metabolism",
"        <br/>",
"        (significant)*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clearance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"8\">",
"        Trazodone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Immediate release",
"       </td>",
"       <td>",
"        65",
"       </td>",
"       <td rowspan=\"2\">",
"        <p>",
"         1 (unfed)",
"        </p>",
"        <p>",
"         2 (fed)",
"        </p>",
"        9 (unfed)",
"       </td>",
"       <td rowspan=\"2\">",
"        CYP3A4",
"       </td>",
"       <td rowspan=\"2\">",
"        Yes",
"        <br/>",
"        (",
"        <em>",
"         m",
"        </em>",
"        -chlorophenylpiperazine)",
"       </td>",
"       <td>",
"        5 to 9",
"       </td>",
"       <td rowspan=\"2\">",
"        P-gp inducer",
"       </td>",
"       <td rowspan=\"2\">",
"        Hepatic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extended release",
"       </td>",
"       <td>",
"        87 (preferably taken on empty stomach)",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vilazodone",
"       </td>",
"       <td>",
"        72 (preferably taken with meal)",
"       </td>",
"       <td>",
"        4 to 5",
"       </td>",
"       <td>",
"        CYP3A4; dose alteration needed with strong or moderate inhibitors of CYP3A4",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Hepatic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nefazodone",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        20 (modestly decreased by food)",
"       </td>",
"       <td>",
"        0.5 to 2 (delayed by food)",
"       </td>",
"       <td>",
"        <p>",
"         CYP3A4",
"        </p>",
"        CYP2D6",
"       </td>",
"       <td>",
"        Yes",
"        <br/>",
"        (Triazoledione, hydroxynefazodone, and",
"        <em>",
"         m",
"        </em>",
"        -chlorophenylpiperazine [mCPP])",
"       </td>",
"       <td>",
"        <p>",
"         2-5 (parent)",
"        </p>",
"        2-33 (active metabolites)",
"       </td>",
"       <td>",
"        Potent inhibitor of CYP 3A4 and P-gp inducer; can cause numerous dose-dependent drug interactions",
"       </td>",
"       <td>",
"        Hepatic; avoid in hepatic disease or in setting of elevated transaminases (complicates monitoring); half-life and serum concentrations increased in hepatic insufficiency",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CYP: cytochrome P450; Pgp: P-glycoprotein efflux transporter.",
"     <br/>",
"     * Drug interactions and management suggestions may be determined by use of Lexi-Interact, the drug interactions program included with UpToDate.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Not a first or second line choice. Rare reports of fatal hepatotoxicity lead to market withdrawal in many countries.",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br/>",
"     <ol>",
"      <li>",
"       Spina E, Trifir&ograve; G, Caraci F. Clinically significant drug interactions with newer antidepressants. CNS Drugs 2012; 26:39.",
"      </li>",
"      <li>",
"       Frampton JE. Vilazodone: in major depressive disorder. CNS Drugs 2011; 25:615.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42684=[""].join("\n");
var outline_f41_43_42684=null;
var title_f41_43_42685="MPI algorithm post CABG";
var content_f41_43_42685=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Proposed algorithm for the appropriate use of stress MPI after CABG in relation to the time after surgery and symptoms",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 386px; height: 261px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Stress MPI is specifically indicated in patients who have an abnormal ECG response to exercise or baseline ECG changes that may interfere with identification of ischemia induced during exercise. Stress MPI can also be performed during initial exercise ECG testing because it provides added value with respect to risk stratification and possible therapy.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42685=[""].join("\n");
var outline_f41_43_42685=null;
var title_f41_43_42686="Bilateral facet dislocation xray";
var content_f41_43_42686=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F73643&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F73643&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bilateral facet dislocations (C4/C5)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 416px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bilateral facet dislocations occur when flexion forces extend anteriorly, causing the inferior articulating facets of the upper vertebra to pass over the superior facets of the lower vertebra. Complete spinal cord injury most often results.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Mary Hochman, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42686=[""].join("\n");
var outline_f41_43_42686=null;
var title_f41_43_42687="TTTS5";
var content_f41_43_42687=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F76546&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F76546&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    TTTS5",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sagittal view of the recipient twin at approximately 25 weeks of gestation. The fetal head is&nbsp;to the right and the fetal buttocks are&nbsp;to the left. Arrow&nbsp;points to&nbsp;fetal ascites indicating the presence of hydrops (Quintero Stage IV TTTS).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kenneth J Moise, Jr, MD &amp; Anthony Johnson, DO.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_43_42687=[""].join("\n");
var outline_f41_43_42687=null;
